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Q U I L L  O N  S C A L P E L  This section
provides a medium through which Canadian 
surgeons can declare themselves, briefly and in­
formally, on the day-to-day affairs of surgery.
TREATMENT OF BREAST CANCER
For decades the surgical literature has in­
dicated that the classic Halsted operation 
for breast cancer has a predictable but 
limited effectiveness, and that, despite more 
extensive surgery, survival rates were not 
improving. We are now well into a new 
phase in the history of breast cancer treat­
ment; the classic method is being chal­
lenged by those who believe that less exten­
sive surgery is at least equally useful. This 
challenge is being resisted and at the 
moment a stalemate exists.
The literature is replete with arguments 
and counterarguments about the place of 
radical surgery in the treatment of breast 
cancer; advocates on both sides of the issue 
continue to publish data. Many surgeons 
have not accepted the reports of Crile,1 
Peters2 and Mustakallio3 because the data 
are often based on case selection and the 
use of incomparable groups, different treat­
ment regimens and different classifications. 
While it is true that criticisms about the 
methodology may be valid, it has been 
shown that at least some patients can be 
treated adequately with conservative sur­
gery. The contribution of Mustakallio can­
not be dismissed. He has accumulated a 
large series of consecutive patients treated 
with conservative surgery; survival figures 
are equivalent to those obtained at 5-, 10- 
and 15-year follow-up periods with radical 
mastectomy.
While it is wrong to say that the results 
have proven the case for conservative sur­
gery, it is equally wrong to assume the case 
has been proven for radical surgery. The 
classical point of view is supported by tra­
dition, but not necessarily by fact. The 
radical approach based on anatomical con­
siderations may be regarded as close to dog­
matism. The conservative approach based on
biology and systemic considerations is 
viewed as heresy.
Many believe that trials of lesser surgery 
are unsafe for patients and are therefore 
ethically wrong. Nevertheless, there is a 
group of patients embodied in the above 
reports for whom this operation seems to be 
safe and effective. It cannot be denied that 
these patients, no matter how selected, have 
done just as well as those treated by radical 
surgery. It is therefore ethically right to 
obtain a definitive answer and this will re­
quire properly controlled prospective trials. 
It is ethically wrong to insist on continuing 
with radical surgery when we do not know 
what is the correct course. To ignore this 
compelling logic on the one hand and the 
legitimate needs of the individual woman 
on the other, is to ignore the social and 
scientific responsibilities placed on the sur­
gical profession.
Too many of our colleagues adopt a wait- 
and-see attitude, indicating that they will 
accept the new therapy once it is proven 
or given general acceptance. This is wrong 
if it serves to delay the acquisition of data 
necessary to answer the question. If the 
study is theoretically acceptable it is our 
ethical responsibility to participate in the 
evaluation of this new form of treatment.
The current protocol of the National Sur­
gical Adjuvant Breast Project compares 
total mastectomy with segmental resection 
with and without breast irradiation; patients 
in any group who have positive nodes on 
axillary dissection will receive adjuvant 
chemotherapy. The study is proposed as a 
well-conceived, scientifically and morally 
correct investigation. There are certainly 
other studies with equal credentials. I sub­
mit that all primary cases of breast cancer 
should be entered in some protocol so that
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information can be gathered in a meaningful 
way. Only then will we have a proper guide 
to the treatment of new cases. It is the re­
sponsibility of every surgeon to seek affilia­
tion with some collaborative group so that 
we can obtain some scientifically valid an­
swers to these important questions.
R. G. M a r g o l e se , m d , f r c s [c]
Department of surgery,
Jewish General Hospital,
Montreal, PQ.
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PRIMARY RENAL MALIGNANT TUMOURS
Primary malignant tumours of the kidney 
are relatively uncommon and constitute only 
3% of all malignant tumours, yet, in Can­
ada in 1974 they were cited as a cause of 
death is only 638 instances.1
Hypernephroma is the most common 
renal tumour. The incidence of metastases is 
low during the early and presymptomatic 
stages of hypernephroma.2 We must there­
fore try to diagnose this tumour at the 
earliest opportunity.
Like tuberculosis and syphilis, hyperne­
phroma is frequently referred to as the 
great imitator. In more than one third of 
cases, when symptoms do occur they im­
plicate body systems other than the geni­
tourinary tract.3
Benign renal cysts are a frequent inci­
dental finding at autopsy.4 Thus, when a 
space-occupying lesion is found by intra­
venous urography, it is natural to assume 
that the abnormality is due to a cyst. Indeed 
95%  of these abnormalities are benign cysts, 
but there is a risk that an apparent benign 
cyst may be a hypernephroma.r> The risk of 
misdiagnosing a hypernephroma as a benign 
cyst is compounded by the fact that a hy­
pernephroma may be quiescent for a long 
time before its malignant nature becomes 
clinically apparent.0 Therefore, a space-oc­
cupying lesion that has not changed at the 
time of repeat urography should not en­
courage diagnostic complacency.
A space-occupying lesion demonstrated on 
intravenous urography should be fully 
investigated at the time of initial discovery. 
Cytologic examination of the urine may be 
helpful if malignant cells are found; how­
ever, a negative report does not rule out a 
malignant lesion.
Isotopic investigations are relatively a- 
traumatic and may be helpful in excluding 
normal anatomical variants such as pseudo­
tumours, in which blood flow and nephron 
function are normal. Following an intra­
venous injection of any radiopharmaceutical 
that is both filtered and secreted, a gamma 
camera is used to obtain rapid-sequence 
images of the kidney and, later, an indica­
tion of the distribution of functioning ne­
phron mass. The rapid-sequence images 
provide a measure of regional blood flow, 
which may be increased in a hypernephroma. 
Cysts and tumours displace or replace 
normal nephrons and appear as cold areas 
on the later pictures. Very occasionally a 
tumour may appear as a hot area. This is 
described with tubular adenomas.7
In 1967 Morris and colleagues8 noticed 
that on isotopic kidney scan a hyper­
nephroma often shows, in addition to a local 
cold area, a generalized reduction of isotope 
accumulation in the remainder of the same 
kidney. Rao and Sharpe in this issue of the 
Journal (page 245) have reaffirmed this 
finding. It occurs in about half of the 
patients with renal tumour and Morris noted 
that it was associated with ureteric ob­
struction or extension of the tumour into 
the renal vein.8 Unfortunately, Rao and 
Sharpe do not offer any new explanation for 
this isotopic finding.
Other tests such as ultrasonography and 
computerized axial tomography are also 
helpful in diagnosing renal cancer. Ultra­
sonography should precede the more trau­
matic, yet more definitive, investigations 
such as cyst puncture, arteriography and 
surgical exploration. Computerized axial 
tomography distinguishes between tissues
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having different x-ray attenuation coeffi­
cients. It is helpful in separating solid from 
cystic renal lesions and in staging the 
malignant lesion,'-' but the apparatus is ex­
pensive and not yet widely available.
It is clear that, short of surgical excision, 
there is no simple test or sequence of tests 
that will unfailingly detect all primary renal 
tumours. It is equally clear that consider­
able clinical acumen is needed to diagnose 
hypernephroma early, before metastases and 
local extension have occurred and when 
surgery may be curative.
A. Toi, MD, FRCPfC]
Department of radiology,
McMaster University Medical Centre,
Hamilton, Ont.
E. S. G a r n et t , m rcp  ( lond), m rcp  
(edin), fr c p[c]
Director,
Department of nuclear medicine,
McMaster University Medical Centre,
Hamilton, Ont.
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SURGICAL EPILATION PROCEDURES
There is good archeologic evidence that 
facial shaving began in prehistoric times. 
The Egyptians introduced whole body shav­
ing; Egyptian priests shaved completely 
every 3rd day. Alexander the Great per­
ceived a military advantage in removing the 
beards of his men. (A favourite tactic of the 
Persian enemy was to grasp the beard, flip 
the head back and slash the throat of Alex­
ander’s warriors!) Later Roman emperors 
also adopted shaving, and their unshaven 
enemies were called barbarians.
The origin of the practice of shaving the 
operative area before surgery is unknown, 
but the practice is almost universal. There 
has been remarkably little scientific evalu­
ation of the assumption that shaving the 
operative area reduces wound infection; it 
is generally agreed that hair near the inci­
sion will harbour bacteria that can cause 
wound infection. The few articles1- 2 that 
specifically mention the practice suggest that 
preoperative shaving may do more harm 
than good. On the other hand, there are ar­
ticles describing outbreaks of wound infec­
tion associated with hair carriers of patho­
genic bacteria, these would seem to support 
the practice of hair removal, at least near 
the operative site.3
In this issue (page 269) Hamilton, Hamil­
ton and Lone evaluate the efficiency, safety 
and cost of hair removal with a razor, an 
electric clipper, and an aerosol depilatory. 
Both shaving and clipping caused skin 
breaks that were easily recognized with the 
scanning electron microscope. The depila­
tory removed hair more efficiently than 
either of the other methods —  with micro­
scopic evidence of only minimal inflamma­
tory reaction. This study should encourage 
us all to re-evaluate our belief that the 
wound area must be “shaved” for a “prop­
er” preoperative preparation.
What is the composition of depilatory 
preparations and how do they work?4
Hair is keratined tissue containing ap­
proximately 17% cysteine. The sulfur to 
sulfur group is easily reduced by sulfides or 
thiols acting at an alkaline pH. For the re­
action to occur quickly the oily sebum coat
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must be emulsified and removed. Most over- 
the-counter depilatories use calcium thio- 
glycolate as the active ingredient, sodium 
lauryl sulfate as the emulsifying agent, and 
calcium hydroxide and sodium silicate to 
provide an alkaline medium. A few patients 
are sensitive to the calcium thioglycolate, or 
to the alkalinity. If the depilatory comes 
into contact with the eyes or sensitive 
mucous membranes, application of weak 
boric acid, vinegar or citrus juice is recom­
mended to neutralize the alkalinity.
Seropian and Reynolds1 in 1971 demon­
strated a significant decrease in the incidence 
of clean wound infection when patients in 
whom a depilatory cream was used were 
compared with patients who had a razor 
shave for hair removal before operation. 
Cruse and Foord2 learned from their studies 
that clean wound infection occurred least 
often if no preoperative shave had been 
carried out, occurred most often after a 
razor shave, and was between the two if a 
depilatory had been used. Hamilton and 
colleagues offer an explanation for this un­
expected observation.
Old habits are not changed easily. At the 
Foothills Hospital, Calgary, we shave only 
the hairy areas; approximately half the gen­
eral surgeons use a clip shave and half a 
razor shave, neurosurgeons prefer a razor 
shave, orthopedic surgeons a clip shave, and 
all other surgical services continue to use a 
razor shave. There is no doubt that order­
lies would rather carry out a razor shave 
than a clip shave — it is easier and quicker.
Continual monitoring of wound infection 
rates do not support superiority of one 
method over another. Between 1974 and 
1976 at Foothills Hospital there were al­
most 15 000 clean operations in which the 
preoperative preparation included a razor 
shave. The wound infection rate was 1.5%.
In the same period over 1200 clean opera­
tions followed hair removal with electric 
clippers; among these the wound infection 
rate was 1.4%.
It may be time for surgeons to re-evaluate 
the practice of preoperative hair removal. 
There is no scientific reason why the short 
stubble left by a clipper and the shorter 
stubble left by a razor (both accompanied 
by skin nicks) should lead to a lower bac­
terial population in the wound than hair (no 
shave) sterilized by a standard preoperative 
skin preparation with povidone. For those 
who find the unshaven operative area visual­
ly offensive, a depilatory appears to be 
useful and to provide less favourable areas 
for bacterial colonization. Cost is not a fac­
tor since the saving on one prevented wound 
infection (approximately $70002) will pay 
for gallons of depilatory! A prospective 
double-blind study of a large number of 
cases using a depilatory instead of a clipper 
or razor is needed to evaluate this hypothe­
sis since many other factors could influence 
the already low infection rate in clean 
wounds.
N . T. M c Ph e d r a n , m d , f r c s [c ], facs
Professor and head,
Division of surgery,
University of Calgary,
Calgary, Alta.
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THE CANADIAN ASSOCIATION OF GENERAL SURGEONS
How do surgical specialties develop? A 
need is demonstrated and then a group of 
surgeons attempt to meet the challenge. They 
study the problem and work at it. In so 
doing they develop a new field and gradual­
ly more and more of their time and energy 
are devoted to this new area of interest, A
new language ensues. Associations evolve 
with others who share the same interests and 
a specialty is born. Specialties such as urol­
ogy, orthopedics, neurosurgery and plastic 
surgery have developed in this way. But 
what about general surgery?
General surgery is a specialty in which a
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group of surgeons have developed and pur­
sued their own interests. Among this group 
are people with expertise in diseases of the 
gastrointestinal tract, in endocrinology, in­
tensive care, metabolism and nutrition, on­
cology, vascular disease and transplantation. 
The extent of involvement in these entities 
depends in part on the local working envi­
ronment but also on the interests and ini­
tiative of the individual surgeon. General 
surgery is not abdominal surgery. General 
surgery is not what is left over from the 
other specialties. General surgery is an en­
tity. General surgery is a specialty.
In the past, to meet specific needs, sur­
gery developed into specialties. In the fu­
ture, also to meet the needs, more expertise 
will be required and more subspecialties will 
be developed.
As specialties develop those within the 
field create specialty societies so that mem­
bers can meet with their peers, discuss com­
mon problems, and review training programs 
and manpower needs. It is interesting that up 
to this time in Canada the specialty of gen­
eral surgery has never formally organized 
itself in this manner.
Now a group of concerned general sur­
geons has formed the Canadian Association 
of General Surgeons and the first meeting 
of the association was held in Toronto on 
May 11 and 12, 1977. One of the priorities 
of this group is to work in parallel with the 
Royal College of Physicians and Surgeons 
of Canada and to develop a process of con­
tinuing post-fellowship education.
We look forward with great interest to the 
development of this association and to its 
role in the specialty of general surgery.
D onald  R. W ilson, m d , fr c s[c]
Professor and chairman,
Department of surgery,
University of Toronto,
Toronto, Ont.
SELF-ASSESSMENT
SESAP II QUESTION
580. Findings obtained in a recent evaluation of adjuvant therapy for patients with carci­
noma of the breast include which of the following?
(1) Disease status and survival rates were similar three, four and five years after 
radical mastectomy whether or not the patients received postoperative irradiation
(2) Prophylactic oophorectomy did not alter recurrence and survival rates in patients 
who had radical mastectomy for carcinoma of the breast
(3) Administration of 5-fluorouracil as an adjuvant to radical mastectomy did not 
change survival rates
(4) Use of thio-tepa as an adjuvant to radical mastectomy relieved symptoms and 
increased survival time
For this question one or more of the answers given above is correct. Your answer should 
be:
A if only 1, 2, 3 are correct,
B if only / and 3 are correct,
C if only 2 and 4 are correct,
D if only 4 is correct,
E if all are correct.
For the critique of Item 580 see page 296 of this issue.
(Reproduced by permission of the American College of Surgeons from SESAP II Syllabus. 
Surgical Education and Self-assessment Program No. 2.)
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REVIEW ARTICLE
CURRENT CONCEPTS IN THE MANAGEMENT OF PRIMARY 
BREAST CANCER*
RICHARD G. MARGOLESE, MD, FRCS[C]
F or three generations radical mastectomy 
for the treatment of breast cancer was one 
of the most orthodox of all surgical thera­
pies. All surgeons felt safe and complacent 
about the procedure.
With the development of better radio­
therapy following World War II, experi­
mentation with alternative methods of con­
trolling breast cancer began; this movement 
was led by McWhirter.1 His report indicated 
that simple mastectomy with radiotherapy 
to the axilla was equivalent to radical mas­
tectomy. This stimulated much discussion 
on both sides of the Atlantic and prompted 
intensive reappraisal. There were many valid 
criticisms of McWhirter’s results and the 
main thrust of his contribution was, for a 
time, lost in the debate. The point that 
should have been seized was not that his 
results may not be widely applicable because 
of case selection, but rather that at least 
some patients do just as well when treated 
by less than radical mastectomy, and that 
the recognition and identification of such 
groups should be pursued.
The debate has continued and there is 
now a heated controversy about the best 
way to treat breast cancer. With the arrival 
of new information on adjuvant chemo­
therapy the issue is now even more com­
plex.2' 3 The successful use of adjuvant 
therapy implies that survival figures can be 
improved and that the extent of surgery 
necessary to achieve control of the tumour 
might be reduced.
This communication attempts to update 
these two issues and provide some potential 
guidelines for current management.
*From the department of surgery, Jewish General 
Hospital, Montreal, PQ.
Reprint requests to: Dr. R. G. Margolese, Depart­
ment of surgery, Jewish General Hospital, 3755 
Cote St. Catherine Rd., Montreal, PQ H3T 1E2.
F o r m s  o f  M a n a g e m e n t
Adjuvant Therapy
One of the basic premises in the Halsted 
approach is that cure is achieved by local 
control, that removal of all -tumours locally 
will result in cure if there is not distant spread. 
The converse is implied: if any malignant 
cell is beyond the limits of the operation the 
treatment will ultimately fail. This all-or- 
none concept has been modified by the de­
monstration that patients with breast cancer 
can be separated into at least two identifiable 
subgroups with distinctly different survival 
patterns.4 Patients with negative nodes at 
the time of operation have a favourable 
prognosis; 82% have a 5-year recurrence- 
free rate and 75% have a 10-year recur­
rence-free rate. On the other hand patients 
with involvement of four or more axillary 
lymph nodes have a 10-year recurrence-free 
rate of only 14%; yet these patients had an 
operation that for decades has been con­
sidered curative. In other words, some pa­
tients seem to have occult systemic disease 
when first seen. Zelen"’ has worked out a 
mathematical model of breast cancer time 
histories with four subgroups; only one of 
these groups achieves increased survival 
based on surgery.
The relationship of local recurrence to 
systemic metastases is well documented. 
S pratt <> has shown that the time from mas­
tectomy to the appearance of local recur­
rence correlates directly with the time at 
which distant metastases appear. This con­
firms other experimental work7- 8 indicating 
that distant spread does not arise in a staged 
fashion from nodal metastases but that nodal 
and systemic disease occur simultaneously. 
Thus, if axillary lymph nodes are involved 
at the time of mastectomy, it is probable 
that systemic metastases exist and when 
these metastases become manifest is only 
a question of time.
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The first attempts at additional therapy 
to improve survival rates following breast 
cancer surgery relied on radiation therapy 
(RT) to eradicate residual tumour cells. This 
treatment was based on the erroneous con­
cept that tumour spreads from a primary 
site to the axillary lymph nodes and from 
there to distant sites. Several major studies 
have demonstrated that there is no im­
provement in the ultimate recurrence rates 
or the survival time for patients receiving 
such therapy.”' 11 In some cases RT dimi­
nished the incidence of local skin recurrence, 
but when nonirradiated patients in whom 
skin recurrence developed were irradiated 
the same survival rates were recorded as in 
those patients who were treated primarily.10
The search for a systemic approach to 
adjuvant therapy began soon after it was 
demonstrated that cytotoxic drugs were use­
ful in inducing remission in patients with 
advanced breast cancer. The first adjuvant 
trials were based on the theory, now viewed 
as incorrect, that dissemination occurred 
at the time of surgery and was due to dis- 
lodgement of tumour cells by surgical mani­
pulation.12 The initial studies therefore 
emphasized treatment during and immedi­
ately following the surgical procedure. The 
first major project of this type was the Na­
tional Surgical Adjuvant Breast Project 
(NSABP) evaluation in which thiotepa and 
5-fluorouracil (5-FU) were compared with 
a placebo. No advantage was demonstrated 
with the use of 5-FU. However, among pre­
menopausal women with four or more in­
volved nodes there was a 20% improve­
ment in survival over controls when they 
were treated with thiotepa.13 This 20% 
improvement continued to the 10-year fol­
low-up and helped to encourage further 
studies. This was the first clinical, ran­
domized, prospective study; it was more 
reliable than other retrospective analyses. 
Due to its greater toxicity, 5-FU was not 
recommended for further study, but thiotepa 
remained a potentially useful agent. The 
case for adjuvant chemotherapy was neither 
proven nor repudiated, but the results of 
the study encouraged others to expand the 
concept of adjuvant chemotherapy and look 
for better drugs, better dosages and better 
schedules.
During the time that these results were
being accumulated, important progress ii\ 
the understanding of tumour cell kinetic^ 
was under way. Specifically, it became clea*- 
that cytotoxic drugs affecting tumour cells 
kill by first-order kinetics. Put more simply^ 
a fixed percentage of tumour cells are killed 
by every similar dose.14 (In zero-order 
kinetics, a fixed number of cells would be 
affected.)
With the demonstration that breast can­
cer cells have long cell-cycle times and low- 
growth fractions14' 15 it became apparent 
that prolonged intermittent chemotherapy 
would be superior to the short course of 
perioperative therapy previously employed. 
Skipper and Schabel16 demonstrated in 
animal models the potential for cure by re­
peated intermittent high doses of chemo­
therapeutic agents administered postoper- 
atively. They reported that animals in- 
noculated with a transplantable tumour could 
be cured if that tumour was excised early 
enough; after a certain delay period, how­
ever, surgical extirpation would not result 
in ultimate cure, because, though not clinic­
ally apparent, metastases had already oc­
curred. Although the animals died when 
treated after 14 days by surgery alone or 
chemotherapy alone, a substantial number 
survived when treated with a combination 
of surgery and adjuvant chemotherapy. This 
indicated that micrometastases were more 
sensitive to chemotherapy than were the 
large volume of tumour cells present in a 
clinically apparent tumour. To put it an­
other way, minimal tumour volumes re­
maining after surgical removal of the prima­
ry tumour could be eliminated by adjuvant 
chemotherapy, even though the original tu­
mour volume could not.
The advances in understanding of cell 
kinetics together with a demonstration of 
the effectiveness of combination chemother­
apy for advanced breast cancer13' 17 led to 
a second generation of adjuvant studies 
using single agents and combination drugs 
in prolonged intermittent repeated courses. 
The most prominent of these have been the 
NSABP study chaired by Fisher2 in North 
America and the Milan trial of Bonadonna3 
in Italy. Several other simultaneous trials 
had weaknesses; in some, a variety of oper­
ations was performed, in others small treat­
ment groups made up of disparate types of
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patients were used, and in still other studies 
uncontrolled results were reported, so that 
reliable conclusions could not be drawn. 
The studies of Fisher and Bonadonna were 
both prospectively randomized and well 
designed statistically. The North American 
trial compared L-phenylalanine mustard 
(l-PAM) with a placebo in a double-blind 
fashion. All women included in the study 
had had a radical or a modified radical mas­
tectomy and all had histologic evidence of 
axillary lymph-node metastases. Thirty- 
seven American and Canadian institutions 
from the NSABP, the Eastern Cooperative 
Oncology Group and the Central Oncology 
Group participated. In all, 269 patients were 
found to be eligible for inclusion in the fol­
low-up studies. A report of early findings2 
indicated that there was a statistically signif­
icant difference (P =  0.02) in favour of L- 
PAM-treated patients relative to the disease- 
free interval. In premenopausal patients the 
difference was highly significant (P =  
0.008). However, in postmenopausal pa­
tients, the difference was not statistically 
significant.
Bonadonna’s study was similar in design 
except that patients were randomized post- 
operatively to no treatment or to cyclo­
phosphamide, methotrexate and 5-FU on 
28-day cycles following radical or ex­
tended radical mastectomy. All patients had 
positive nodes histologically. The overall 
treatment failure rate at 27 months was 
24% in controls and 5.3% in treated 
women (P < 10'6); the treated group en­
joyed significantly better results in all sub­
groups.3 The lower recurrence rates for 
postmenopausal women in this study were 
statistically significant, but the results are 
too early to make any comment on survival. 
An updated report18 in 1976 indicated a 
change in the differential between controls 
and treated group at 36 months’ follow-up. 
For premenopausal patients, the treatment 
failure rate was 48% for controls and 16% 
for treated patients. For postmenopausal 
patients the figures were 44 and 41% , re­
spectively.
Smaller studies elsewhere have lent sup­
port to the concept of adjuvant therapy. 
The adjuvant trial with nitrogen mustard of 
Mrazek19 involved 156 women treated be­
tween 1956 and 1964. All patients had a
radical mastectomy and were divided in 
two groups: those kept under observation 
and those receiving nitrogen mustard (0.2 
mg/kg at operation and 0.1 mg/kg IV on 
the 1st and 2nd postoperative day). Similar 
courses were repeated every 3 months. Fol­
low-up revealed a decreased recurrence rate 
in patients with both negative and positive 
nodes in the treated groups among preme­
nopausal patients. For postmenopausal pa­
tients, there was no difference among pa­
tients with negative nodes, but a trend was 
observed in favour of the treated patients 
with positive nodes.
Tormey20 has reported on a study from 
the USSR using thiotepa, which suggests an 
advantage at all ages for both stage I and 
stage II patients. These are only 12-month 
figures and the statistical analysis is not 
available. If longer follow-up and additional 
data continue to substantiate these results 
the larger dose of thiotepa used may 
be responsible for the apparent improve­
ment in postmenopausal patients.
A Scandinavian study by Nissen-Meyer, 
Kjellgren and Mansson21 involved several 
hospitals; each used a different drug regi­
men. There was a decreased recurrence rate 
in the 4th year of the study, which has per­
sisted to 6 years (P =  0.02).
Future prospects.— Many other studies 
have been or are now being launched and 
in the next 5 to 10 years results of a num­
ber of studies using combinations of treat­
ment and schedules will be reported. Even 
if a longer follow-up fails to sustain the dif­
ference in favour of treated groups, the 
simple fact that a delayed recurrence has 
been demonstrated will still be important. 
Other treatments aimed at exploiting this 
difference and lengthening the delay must 
be sought. Among questions that must be 
answered are the desirable and detrimental 
interactions of drug combinations, the use 
of sequences of drugs, the exact timing of 
doses, and the role of additional combined 
treatment modalities, such as hormone ther­
apy and immunotherapy, with respect to the 
above concepts. New studies comparing 
some of these combinations are currently be­
ing carried out. The NSABP has completed 
entry of 800 cases into a study of l-PAM  
and 5-FU and is now entering a similar num­
ber in a study of l-PAM  and 5-FU v. L-
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PAM, methotrexate and 5-FU. Subsequently 
tomoxifen and corynebacterium-parvum will 
be included in these combinations.
Information must also be acquired about 
the undesirable side effects of these new 
therapies. Are alkylating agents truly car­
cinogenic? Are there any unanticipated ef­
fects on the host immune system? We have 
enough evidence now to state there are no 
dangerous short-term effects. We know that 
disease-free interval can be prolonged and 
when it is remembered that 75% of patients 
with involved nodes will be dead at 10 years 
(88% for 4 +  nodes) it seems reasonable 
to expect that long-term safety will not be 
a meaningful problem; but more information 
is needed.
It is clear that these studies should be 
continued, but they must still be considered 
experimental and conducted within the 
framework of controlled protocols where 
additional data can be recorded and 
analyzed. The use of adjuvant chemotherapy 
in widespread general practice is not re­
commended. Long-term safety, or value, 
or both, are not proven and, for the present, 
patients should receive adjuvant chemo­
therapy only within the framework of on­
going studies.
Surgeons should be encouraged to join 
such on-going protocols. Faster accrual of 
data means that less time is taken to acquire 
end results for the many studies needed to 
answer these questions. The 75% failure 
rate for traditional treatment should con­
vert more surgeons from spectator to parti­
cipant whenever it is feasible for their in­
stitution to become involved.
Surgery
With respect to the poor survival figures 
reported for patients with nodal involve­
ment, it is necessary to evaluate those sur­
gical procedures we have always considered 
curative, as well as to explore methods of 
systemic adjuvant therapy. When these end 
results are viewed against the spectrum of 
accepted operations ranging from excisional 
biopsy to extended super-radical surgery, it 
must be asked, “Is any operation curative?” 
and conversely, for patients with early tu­
mours and no nodal involvement, “Is any 
operation not curative?” “Is surgery the 
critical factor?”
In spite of the various surgical modifica­
tions proposed over the past decades the 
overall survival rate for patients with breast 
cancer has not changed significantly.22’ 23 
The explanation might be that the opera­
tions used for the diseases being treated 
offer no appreciable difference in efficacy, 
and that survival depends more on biologic 
factors than on surgical technique. Reliance 
on mastectomy seems to stem more from 
tradition than careful appraisal of the pro­
cedure and there is little evidence of conti­
nued objective testing of radical mastectomy 
as the reference operation. Nevertheless, ar­
guments persist; many surgeons opt for 
lesser procedures, weighing deformity and 
multilation against expectation of cure, and 
no attempt is made to arrive at a scientific 
consensus.
Background.— With the Halsted opera­
tion well established, surgeons were reluct­
ant to accept alternative methods of manage­
ment. McWhirter1 demonstrated the value 
of simple mastectomy and irradiation in 
1948. In 1943 Adair24 reported 63 cases 
of local excision with and without irradia­
tion; the 5-year survival rates were equi­
valent to those achieved with radical mas­
tectomy.
Led by Handley,23 concern about in­
ternal mammary lymph-node metastases 
prompted efforts in two directions — some 
became more aggressive and advocated ex­
tended or super-radical surgery,28 others27 
interpreted internal mammary lymph-node 
involvement as a late sign and advocated 
radiotherapy and lesser surgery. The popu­
larity of super-radical mastectomy began to 
decline after the report by Kaae and Johan­
sen28 indicated that there was no difference 
in survival between patients treated with 
ultraradical mastectomy and those treated 
by simple mastectomy plus radiotherapy. A 
Mayo Clinic report21' indicated that survival 
with less radical surgery was equal to that 
obtained by Urban and Baker28 for the ul­
traradical operation.
Auchincloss38 reported that reducing the 
amount of skin removed or using thicker 
skin flaps did not influence the local re­
currence rate. In another study31 he de­
monstrated, in patients undergoing radical 
mastectomy, that preservation of the pec- 
toralis major muscle was not likely to result
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in inadequate lymph-node dissection; this 
gave impetus to a more widespread accept­
ance of the modified radical mastectomy.
In 1954 Mustakallio32 reported on a se­
lected series of 127 partial mastectomies; 5- 
and 10-year survival rates were equivalent 
to or better than those for radical mastec­
tomy. In 1972 he reported on a 25-year 
follow-up of 702 cases,33 which demon­
strated continuing equivalent survival rates 
to radical mastectomy. Porritt34 and Crile35 
then followed with series of selected pa­
tients treated by local excision with and 
without radiotherapy; results were similar 
to contemporary results with radical mas­
tectomy.
In 1967 Peters33 reported on 124 cases 
treated by local excision and radiotherapy 
in whom the 5- and 10-year survival rates 
were 76 and 45%, respectively; these re­
sults were similar to those obtained with 
radical mastectomy at the same institution.
Despite all these data, radical mastectomy 
continued to remain the procedure of choice. 
The most likely explanation for this is that 
again surgeons were reluctant to abandon 
established positions unless the evidence 
was overwhelmingly conclusive. Among the 
criticisms levelled at these studies were the 
following: there were too many variables in 
the management methods, causing a lack 
of consistency; the groups selected were 
not comparable; there was apparent capri­
ciousness in excluding certain cases and 
there was personal bias in individual case 
selection. As a result the randomized pro­
spective clinical trial emerged as an attempt 
to apply scientific methods to the solutions 
of these clinical problems. At first such 
trials compared radical procedures with 
simple mastectomy and not with partial 
mastectomy; they have, in general, sup­
ported the concept that lesser surgery is ade­
quate.
Comparative studies.—Kaae and Johan­
sen28 compared the results of simple mas­
tectomy with postoperative radiation (4500 
rads in 3 wk) v. extended radical mastec­
tomy with supraclavicular and internal 
mammary lymph-node dissection. They re­
ported no significant difference between the 
two groups 5 and 10 years after treatment. 
However, as pointed out by Fisher,37 and 
Kaae and Johansen, results from patients
with stage II and stage III disease were com­
bined with no indication of the number in 
each group; it was therefore impossible to 
be sure that the results could be applied to 
stage II patients only.
Brinkley and Haybittle38 randomized pa­
tients with stage II disease into two groups 
—  those subjected to radical mastectomy 
with postoperative radiation and those who 
underwent a modified simple mastectomy 
with complete axillary dissection; both 
groups had similar exposures to radiothera­
py. There was no significant difference be­
tween the two groups at 5 and 10 years.
Forrest33 reported on 103 patients 
treated by conservative or radical surgery. 
The methodology of his technique was com­
plex. Irradiation was given on the basis of 
axillary staging information obtained from 
radical, modified radical or excision of the 
lower pectoral nodes. His report concerned 
too few patients to make valid conclusions.
An NSABP trial comparing radical with 
simple mastectomy, with and without axil­
lary radiotherapy, was conceived when the 
results of 10-year follow-up on the NSABP 
thiotepa study indicated that among patients 
in the placebo group 5- and 10-year treat­
ment failure rates for premenopausal women 
with stage I disease were 17 and 24% , re­
spectively. On the other hand the treatment 
failure rates for postmenopausal women with 
more than four axillary nodes with meta- 
stases were §6 and 89% at 5 and 10 years, 
respectively. Since all patients underwent 
radical mastectomy these figures focus atten­
tion on the fact that good cases did well and 
bad cases did badly and that there was no 
substantial difference between 5- and 10- 
year results within either group. These re­
sults were obtained in a carefully controlled 
manner from 23 centres across the United 
States and are more reliable than those 
based on retrospective individual experi­
ences. They indicate that there is no justifica­
tion for complacency about the long-term 
value of radical mastectomy in stage II 
cases. Furthermore, these figures suggest 
that the surgical procedure used is not a de­
termining factor in the ultimate prognosis 
of patients with breast cancer.
A study was then conceived to compare 
in a randomized prospective manner the 
conventional Halsted radical mastectomy
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and the total (simple) mastectomy, with and 
without axillary node irradiation. Those pa­
tients with untreated axillas who subsequent­
ly developed axillary lymph-node metastases 
were then treated by axillary dissection. Pa­
tients with clinically positive nodes were not 
randomized into the group treated only with 
simple mastectomy. In all, 1646 patients 
were available for follow-up. Preliminary 
evaluation by life table analysis at 42 months 
showed that within the clinically negative 
group there was no significant difference for 
the three treatment methods. Similarly, with­
in the group with positive nodes, there was 
no significant difference between the two 
treatment methods.40- 41 Although these 
are preliminary results and the follow-up is 
too short for reliable conclusions, there is 
support for the previously described studies 
indicating equivalent results for modified 
or simple operations.
Segmental resection.—It is clear then that 
the radical and the extended radical opera­
tions are no better than a modified radical 
mastectomy. McWhirter1 and the early re­
sults of the NSABP trial18 showed that the 
radical mastectomy is equivalent to simple 
mastectomy plus axillary irradiation. The 
next logical step was to evaluate the poten­
tial value of segmental resection now refer­
red to as lumpectomy.
Crile42 reported a series of cases treated 
by local excision with and without radio­
therapy; his studies were based on personal 
case selection. Of 465 patients with stages 
I and II disease his 10- and 15-year results 
were equivalent to those of the National 
Cancer Registry (NCR) for more radical 
procedures. In a critique Angelm and 
Leber43 claimed that a possible bias existed 
in this work, for all of Crile’s patients were 
treated in a private clinic, whereas the NCR 
patients were widely dispersed in smaller 
community hospitals. Angelm and Leber 
also pointed out that Crile’s method of 
staging may have resulted in bias, in that 
patients who underwent radical mastectomy 
were staged on histologic grounds, whereas 
patients who underwent lumpectomy were 
classified as having stage I disease only when 
no axillary nodes appeared with the passage 
of time. Angelm also noted that the aver­
age diameter of cancers treated by radical 
mastectomy was 3.1 cm compared with 2.1
cm for the partial mastectomy. Crile44 ac­
cepted some of these points of criticism. He 
admitted that case selection was important 
and could be reliable in choosing patients 
for therapy; he countered by claiming that 
microdeposits of cancer found in serial sec­
tions of lymph nodes may never grow into 
established cancers. Indeed much of the 
controversy about conservative surgery cen­
tres around this point.
Multicentricity.—The key to partial mas­
tectomy from the anatomical viewpoint is 
the factor of multicentricity. The incidence 
of multicentricity varies widely (an incidence 
of 54% has been reported45), but most 
studies suggest that 32 to 37% of patients 
with breast cancer have cancer foci in sec­
tors distant from the primary tumour.40'48 
Fisher and associates,40 reporting on the 
1674 cases in the NSABP, found an inci­
dence of multicentricity of 13 %.
The anatomical incidence, however, is 
not the true dimension of the problem. There 
is controversy over the biologic importance 
of multicentricity. In Crile’s follow-up of 
610 patient-years of exposure after partial 
mastectomy,47 six new cancers appeared in 
the contralateral breast and four in the af­
fected one. This suggested that the danger 
of new cancer in the affected breast is less 
than might have been anticipated. Indeed, 
since the breast is a bilateral organ the in­
cidence of multicentricity must really in­
clude both breasts. Urban50 reported that 
random biopsies of the contralateral breast 
of women with known cancer revealed mul­
tifocal disease in 14% of cases. Sandison31 
showed that 25% of patients with cancer 
have multicentric cancer in the other breast.
Rosen and colleagues48 performed pre­
liminary, wide, local or quadrant excision on 
patients scheduled to undergo mastectomy 
and then analyzed the mastectomy speci­
men for residual carcinoma. They found that 
38% of patients had residual tumour after 
simulated partial mastectomy. Half of the 
cases had evidence of invasive carcinoma.
However, Slack, Nemoto and Fisher52 
in reviewing 2734 patients found that the 
overall incidence of a contralateral second 
primary carcinoma was 1.9% in a 6-year 
follow-up. The majority of these were in 
patients with large primary tumours and in 
patients with positive axillary lymph nodes.
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They concluded that if a bilateral proce­
dure was used routinely for prophylaxis, the 
maximum gain in the relative survival rate 
over 5 years would be 0.5%. It is difficult 
to see how multicentric foci in a remaining 
ipsilateral breast would behave differently 
from the contralateral breast.
Much of the multifocal carcinoma seen is 
intraductal. What is the importance of the 
existence of multifocal carcinoma to the 
future incidence of clinically diagnosed can­
cer? For many years surgeons have argued 
»about this problem as it relates to carcinoma 
of the prostate in patients over 50 years of 
age and to patients with bilateral papillary 
and follicular carcinoma of the thyroid. 
Certainly multifocal cancer exists anatomic­
ally. On the other hand, the results reported 
by Crile,33 Peters,30 Mustakallio32- 38 and 
others24- 34- 53 do not fit our expectations, 
especially when one remembers that many 
multifocal cancers are invasive. Atkins and 
colleagues"'4 noted that local recurrence in 
the remaining breast was not an important 
factor in those' patients who had treatment 
failures following local excision of breast 
cancers.
Thus the anatomical event of multicentric 
cancer may not conform to the biologic 
event in time. The debate about multicentric 
foci will never be resolved by anatomical 
studies alone and properly designed pro­
spective clinical studies with adequate fol­
low-up are necessary.
Controlled studies.— Atkins and collea­
gues54 compared 370 patients randomized 
into two treatment groups: half the patients 
had a radical mastectomy with postoperative 
irradiation to the lymph-node areas and 
the other half had extended tylectomies with 
similar radiation of 2500 to 2700 rads as 
well as 3500 rads to the breast. Some pa­
tients in both groups had thiotepa in the pe­
rioperative period. The 5- and 10-year re­
sults for patients with stage I disease were 
similar in both groups, but the 10-year sur­
vival for patients with stage II disease de­
creased for those treated by lumpectomy. 
The authors noted that staging was clinical, 
and subsequent pathological evaluation of 
the radical specimens indicated a significant 
error in the accuracy of clinical staging. On 
analysis of these results it is apparent that 
the difference in survival was related mainly
to axillary recurrence and that local recur­
rence in the chest wall or in the remaining 
ipsilateral breast was not an important fac­
tor in either group. The dose of radiotherapy 
to the axillary region was only 2500 to 2700 
rads —  well short of the currently accepted 
tumoricidal dose.
In his review of this study Fisher37 asked 
if the suboptimal irradiation, by means of 
tumour cell or host alteration, could have en­
hanced dissemination or augmented tumour 
growth. Schabel14 showed that when par­
tially irradiated cells were mixed with ali­
quots of transplantable tumour cells and 
injected into experimental animals, fewer 
transplanted cells were required to kill the 
animals. In other words, inadequate irradia­
tion may be worse than no irradiation at all.
Mustakallio,33 in his study of 702 conse­
cutive cases treated by lumpectomy, reported 
a 5- and 10-year survival of 90 and 81% , 
respectively, for premenopausal women; sur­
vival rates were 83 and 58% , respectively, 
for postmenopausal women. Wise, Mason 
and Ackerman53 reported on 96 patients 
treated by local excision and radiotherapy. 
These patients were compared to 207 others 
treated with radical mastectomy; the results 
were comparable.
Prospects for Surgical Management
of Patients with Breast Cancer
Some patients appear to do just as well 
with less radical surgery as with radical 
mastectomy. Whether these patients form 
a highly selected group or are representative 
of the widespread application of conserva­
tive methods to the average patient remains 
to be proved.
Mueller and Jeffries33 have argued that 
all breast cancer patients do badly if fol­
lowed long enough. In their analysis of data 
from the Syracuse Cancer Registry, 80% 
of all women were dead 20 years after diag­
nosis of breast cancer and 88% of deaths 
were due to breast cancer. Zelen3 created 
mathematical models for four behaviour 
patterns of breast cancer and showed that 
in only one is surgery of critical importance 
in determining the final outcome. These 
attitudes do not necessarily imply a nihilistic 
approach but lend support to the view that 
conservative surgery is just as effective (or
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ineffective) as radical surgery. The role of 
the choice of operation must be evaluated 
to see if it is truly a factor in influencing 
outcome.
Most of the reports cited above suggesting 
that conservative surgery is equivalent to 
the radical surgery are not examples of well- 
controlled trials. To date the only large- 
scale prospective randomized trial for evalu­
ating partial mastectomy is that from Guy’s 
Hospital, London.'14 As previously men­
tioned, Atkins showed that stage I patients 
did equally well with either operation, but 
stage II patients, who all had partial mas­
tectomy and inadequately irradiated axillas, 
did less well than those who underwent 
radical mastectomy.
Current reports on adjuvant chemothera­
py indicate that this treatment can eradicate 
or delay the emergence of micrometastases 
and the growth of residual tumours; evalu­
ation of segmental mastectomy is therefore 
still more important. The use of appropriate 
chemotherapy postoperatively in patients 
with positive axillary lymph nodes may 
make it possible to achieve control of micro­
scopic residual disease either in the breast or 
in metastatic deposits. Two large trials have 
been launched to test this hypothesis. In 
Italy a trial led by Veronese compares ra­
dical mastectomy with local resection. In 
North America the NSABP study includes 
operable stage I and stage II patients; they 
are randomized into groups undergoing seg­
mental mastectomy alone, segmental mastec­
tomy with irradiation of the breast and total 
mastectomy. All patients undergo an axillary 
dissection so that the lymph nodes may be 
staged on histologic grounds. Patients with­
out axillary lymph-node involvement con­
tinue to be watched closely but those with 
positive lymph nodes receive l -P A M  and 
5-FU therapy. When a recurrence develops 
in the breast, the patient will undergo total 
mastectomy. Thus, information is expected 
on the effects of breast irradiation, the ques­
tion of multicentricity, the value and place 
of segmental resection and total mastec­
tomy. Since all patients undergo axillary 
dissection and all patients with positive 
axillary nodes receive chemotherapy there 
are no other variables within these subsets. 
It is hoped that information derived on local 
breast recurrence and ultimate survival will
be meaningful for all surgeons in North 
America.
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MORBIDITY AND MORTALITY OF INCIDENTAL SPLENECTOMY*
DIAMOND KASSUM, MA, MB, BChir 
and EDWARD J. THOMAS, MB, BS, FRCS, FRCS[C]
Between Jan. 1, 1970 and Dec. 30, 1974, 374 
splenectomies were performed in Hamilton, Ont. 
Of these, 76 were performed incidentally during 
upper abdominal procedures. These 76 patients 
were compared with 130 others, matched for 
age, sex, diagnosis and operative procedure, 
who did not undergo splenectomy. Mortality and 
morbidity are discussed; particular attention is 
drawn to the associated infections in the lower 
lobe of the left lung.
Entre le le r janvier, 1970 et le 30 decembre 
1974, 374 splenectomies ont ete realisees a 
Hamilton, Ont. Dans 76 de ces cas il s’agit d’in- 
terventions secondaires, pratiquees pendant une 
operation abdominale superieure. Ces patients 
ont ete compares a 130 autres qui ne subirent 
pas de splenectomie mais qui ont ete apparies 
pour I'age, le sexe, le diagnostic et le genre 
d’operation. La mortality et la morbidite sont 
discutees; un interet particulier est porte aux 
infections associees du lobe pulmonaire infe- 
rieur gauche.
Splen ecto m y  has been discussed recently 
from the viewpoint of the mortality with 
which it is associated and the morbidity that 
may follow in the immediate postoperative 
period and during long-term follow-up.1 We 
undertook a retrospective study (from Jan. 
1, 1970 to Dec. 31, 1974) of the effects of 
“incidental splenectomy” on mortality and 
morbidity. Incidental splenectomy refers to 
the unplanned addition of splenectomy to a 
surgical procedure in the upper abdomen.
*From the department of surgery, McMaster Uni­
versity medical school and the Hamilton General 
Hospital, Hamilton, Ont.
Reprint request to: Dr. E. J. Thomas, Department 
of surgery, Hamilton General Hospital, 237 Bar­
ton St. E, Hamilton, Ont. L8L 2X2.
In these circumstances splenectomy is 
deemed necessary because of an intra­
operative hazard or difficulty with dissec­
tion. Removal of the spleen as part of an 
extended omental and lymphatic dissection 
for total gastrectomy is therefore not in­
cluded as part of this study.
M aterial and M ethods
A total of 374 splenectomies were per­
formed at three major Hamilton hospitals 
(Hamilton General, Henderson General and 
St. Joseph’s General) of which 86 (25%) 
complied with our definition of incidental 
splenectomy. Of these 86 patients, 76 (group 
1) underwent surgery of the stomach, the 
diaphragmatic hiatus or the biliary tract 
(Table I). The remainder were operated 
upon for pancreatic lesions (four), aortic 
aneurysm (three), resection of the left colon 
(one), resection of the sigmoid colon (one) 
and repair of a traumatized left diaphragm 
that required mobilization of the large bowel 
(one).
A matching group of patients was 
obtained from the hospital records for the 
same 5-year period. To match the patients 
as accurately as possible the surgical pro­
cedure was the essential identifying point; 
patients having an upper gastrointestinal 
procedure were chosen; age and sex were 
also matched as closely as possible. A group 
of 130 patients was selected (group 2). 
(Table I). Group 1 patients ranged in age 
from 32 to 81 years (mean, 57.2 yr); in 
group 2 the age range was 36 to 84 years 
(mean, 55.1 yr). The ratio of men to women 
was 38:38 (group 1) and 71:59 (group 2).
TABLE I.—Operative P rocedure P erformed on P atients in Groups 1 and 2
Operative procedure
Vagotomy and drainage.
Hiatal hernia repair.......
Partial gastrectomy.......
Esophagogastrectomy.
Cholecystectomy............
Additional procedures.. .
Group 1 (n =  76) Group 2 (n —  130)
No. (and %) No. (and %)
38 (35.2) 
33 (30.6) 
15 (13.9)
1 (0.9)
12 ( 11.1) 
9 (8.3)
74 (39.1) 
52 (27.6)
25 (13.2) 
1 (0.5)
20 ( 10.6 ) 
17 (9.0)
Total 108 (100.0) 189 (100.0)
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TABLE II.—F actors Considered in Comparison 
of Groups 1 and 2
1. Complications and morbidity
2. Mortality
3. Other factors:
Length of hospital stay 
Length of anesthesia 
Use of interaperitoneal drains 
Use of physiotherapy
Site of incision and the problem of adhesions 
Preoperative morbidity 
Pathology of spleen
Postoperative thrombocytosis and thrombo­
embolism
Thirty percent of group 1 patients and 32% 
of group 2 patients had more than one pro­
cedure performed during the same anes­
thetic. For the two groups several factors 
were compared (Table II).
F indings
Complications and Morbidity
The principal complications are sum­
marized in Table III. Morbidity in group 
1 was 75% and in group 2, 47%.
Respiratory complications were recorded 
as an infection when persistent pyrexia on 
the 3rd postoperative day was observed in 
conjunction with either radiographic evi­
dence of pulmonary disease or a positive 
sputum culture. Atelectasis was diagnosed 
on the basis of clinical evidence. Effusions 
were diagnosed clinically and supported by 
radiographs. A wound infection was based 
on clinical observation and confirmed by 
bacteriologic study of the discharge. Fifty- 
three percent of patients in group 1 suffered 
infective pulmonary complications com­
pared with 18% of group 2 patients. When 
sepsis in the form of a wound infection or 
an abdominal abscess occurred in group 1 
there was always a coincidental chest in-
TABLE III .—P rincipal Complications in 
Groups 1 and 2
Complicatiom
Group 1, 
%
Group 2, 
%
Respiratory complications. 68.4 32.3*
Wound infection................. 17.1 9.2
Intra-abdominal abscess. . . 10.5 0*
Anastomotic leaks/fistulas. 7.9 0.8*
Thromboembolism.......... 5.3 2.3
Pancreatitis.......................... 2.6 0
Urinary tract infection. . . 10.5 6.9
Septicemia.............. 2.6 0.8
O ther........................... 10.5 12.3
‘Difference significant, P < 0.05.
fection; this rule did not hold for patients 
in group 2. Noninfective pulmonary com­
plications occurred in 15.4% of group 1 
patients compared with 14.3% of group 2 
patients. The left lower lobe was the do­
minant site of complications, occurring in 
59% of group 1 compared with 18% of 
group 2. Wound infection developed in 
17.1% of group 1 patients and 9.2% of 
group 2 patients.
Intra-abdominal abscess was diagnosed 
when reoperation was required for drainage, 
or when discovered at autopsy. In group 1, 
10.5% of patients had an intra-abdominal 
abscess, but no patient in group 2 had such 
an abscess.
Suture leaks or fistulas, which were all 
confirmed radiographically, occurred in 
7.9% of group 1 and 0.8% of group 2.
Thromboembolic phenomena were dia­
gnosed when pulmonary embolism was con­
firmed by a positive lung scan; deep vein 
thrombosis of the calf veins was diagnosed 
either clinically or by clinical judgement 
supported by venography. Thromboembol­
ism occurred in 5.3% of group 1 patients, 
but in only 2.3% of group 2 patients.
Pancreatitis, the diagnosis of which was 
supported by increased serum amylase 
values, occurred in 2.6% of group 1 pa­
tients. Pancreatitis did not develop in any 
of the group 2 patients.
Septicemia was diagnosed only by a 
positive blood culture. The cumulative sepsis 
rate in group 1 patients (53%) was greater 
in all categories than in the control group 
(32%) (P < 0.05).
Mortality
Mortality was recorded if the patient died 
without leaving hospital after surgery or if 
the patient died during a second admission. 
Readmission was indicated to manage com­
plications of surgery performed at the time 
of splenectomy. The results were assessed 
by chi-square analysis and the independent 
sample t-test.
Five patients in the study group (group 1) 
died and three patients in the comparison 
group (group 2) died. Statistically valid con­
clusions cannot be drawn from such small 
numbers. In four of the five group 1 patients 
who died, a fistula developed after opera­
tion. The actual causes of death were varied;
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they included deterioration after gastro­
intestinal hemorrhage, congestive cardiac 
failure (on the 85th day) and cerebrovascu­
lar accident (26 d after operation). No pa­
tient died from sepsis associated with sub- 
phrenic abscess. In group 2, myocardial in­
farction, hemolytic jaundice with renal 
failure and intractable bleeding from gastric 
erosions in a patient 83 years old were the 
causes of death.
Other Factors
Duration of hospital stay.— The length of 
postoperative stay in hospital ranged from 
7 to 84 days in group 2 and 7 to 122 days 
in group 1. More important, 50% of group 
2 patients were out of hospital in 9.5 days, 
whereas, on the average, 50% of group 1 
patients did not leave hospital for 14.5 days. 
Six (5%) of the 130 group 2 patients were 
still in hospital beyond the 23rd day 
whereas 19 (25%) of group 1 patients were 
in hospital beyond that time.
Length of anesthesia.—Table IV com­
pares the length of anesthesia with and 
without complications for the two groups 
of patients. The duration of anesthesia 
ranged from 60 to 280 minutes (mean, 138 
min) in group 1 and from 60 to 255 minutes 
(mean, 116 min) in group 2. On average, 
patients in group 1 were under anesthesia 
22 minutes longer than patients in group 2. 
The distribution in both groups was com­
parable on each side of the mean.
Intraperitoneal drains.—Forty-one per­
cent of group 1 and 40% of group 2 had 
a drain placed at the time of operation. 
There was no increased incidence of post­
operative abdominal complications in those 
patients with drains compared to those with­
out drains; 82 patients received drains, 124 
did not. Abdominal complications devel-
TABLE IV.—Length of Anesthesia with t
TABLE V.—D istribution of Incisions in Groups 
1 and 2
Group 1, Group 2,
Type of incision % %
Midline................................... 55 56
Right upper paramedian . . 20 29
Left upper paramedian. . .  . 16 6
Transverse.............................  4 5
Thoracoabdominal................ 4 2
Left subcostal........................  1 2
oped in 6 of those with drains (7.3%) and 
in 11 of those without drains (9.2%).
Physiotherapy.—In group 1, 50% of the 
patients were given chest physiotherapy in 
the immediate postoperative period, com­
pared with 65% of the patients in group 2. 
Chest complications developed in 68% of 
patients in group 1; 39% developed this 
^.complication despite the addition of physio­
therapy. In group 2, 24% had problems 
despite physiotherapy.
Site of incision and problem of adhe­
sions.— The site of incision is set forth in 
Table V. In group 1, 38% had previous 
abdominal surgery compared with 46% in 
group 2. In group 1, 21% had received this 
surgery in the upper abdomen and in group 
2, 16%. Abdominal adhesions were noted 
in 34% of group 1 patients and 18% of 
group 2 patients.
Preoperative morbidity.— Chronic ob­
structive lung disease was closely associated 
with pulmonary complications in group 1 
(8 of 10 patients); however, in group 2, 13 
patients with a similar condition had no 
such postoperative problems. Obesity was 
subjectively associated with postoperative 
complications —  18.4% of group 1 patients 
were described as obese, compared with 
5.4% of group 2 patients. There were five 
diabetics in group 1; none of these patients 
suffered specific complications. Previous 
myocardial disease was identified in 23 pa­
tients; two of these died; both in group 2.
> without Complications in  Groups 1 and 2
Group 1 Group 2
Duration of operation No. land %) No. (and %)
With complications
Above the mean..................................................... 31 (54.4) 34 (55.7)
Below the mean..................................................... 26 (45.6) 27 (44.3)
Without complications
Above the mean....................................................  6 (31.6) 33 (47.8)
Below the mean....................................................  13 (68.4) 36 (52.2)
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TABLE VI.—Splenic Pathology: 76 Spleens 
R emoved at T ime of Upper Abdominal Surgery
Pathology No. (and %)
Norm al..................................... . . .  63 (83)
Capsulitis................................. 2
(4)
Acute inflammation............... 1
Lipid granulomas.................... 5 1
Lipid histiocytosis.................. 3
(13)
Cavernous hemangioma........ 1
Focal hemosiderosis................ 1 j
T ota l......................... . . . 76 (100)
Pathology of the spleen.—Of the spleens 
removed 83% were normal (Table VI); 
only 4% had evidence of subcapsular in­
flammation, which may have contributed to 
the formation of perisplenic adhesions. *
Postoperative thrombocytosis and throm­
boembolism.— Platelet counts in the post­
operative period were poorly recorded. 
Three or more counts were performed in 
36 of the 76 splenectomized patients. Counts 
of more than 500 x 1 0 s'/ /  (normal range, 
150 to 450 x 10s’//) were recorded in 23 of 
these and counts greater than lOOOx 10 s'/ /  
were recorded in 5; there were no throm­
boembolic complications recorded among 
these 5 patients. In the two patients with 
deep vein thromboses no platelet counts 
were done. One patient with deep vein 
thrombosis had a normal count; one patient 
with deep vein thrombosis and pulmonary 
embolism had normal counts at the time of 
diagnosis and a later high of 500 x 10s'//. 
In another patient with pulmonary embolism 
the platelet count reached 550 x 10s'//. The 
patient who suffered a fatal cerebral vascu­
lar accident had a single platelet count of 
520 x 10 s'//.
Discussion
Attempts have been made to assess the 
effects of performing splenectomy in addi­
tion to surgery of the upper abdomen.2-6 A 
25-year review by Fabri and colleagues4 
referred to 28% operative mortality in pa­
tients subjected to incidental splenectomy 
for upper abdominal procedures. Danforth 
and Thorbjarnarson2 reported a mortality 
of 15%; they referred to the experience of
others who reported a 10 to 18 % mortality 
rate.4'6 In our own series the operative 
mortality (6.6%) does not emerge as the 
outstanding feature; however, the clinical 
similarity among patients who died as well 
as the emphasis on the postoperative left 
supradiaphragmatic infection deserves some 
comment. In group 1 the mortality was con­
centrated among patients who underwent a 
gastric procedure. Furthermore, prior to 
their eventual death, a leak developed at the 
suture line in all but one of these patients. 
However, since 20% of group 1 patients 
were subjected to one or another form of 
gastric resection, this association can only 
be recorded and not described as a causal 
relationship.
Pulmonary Infection
The common location of pulmonary in­
fection on the left side appears to relate 
to the extra retraction of the lower ribs and 
the subdiaphragmatic dissection required to 
remove the spleen. The continuing disagree­
ment among surgeons about the value of 
drains to evacuate serous and blood-stained 
material in the left subdiaphragmatic space 
is not settled because of our small sample 
size. However, if the diaphragm is ex­
periencing temporary paresis resulting from 
intraoperative manipulation, simple post­
operative physiotherapy seems inadequate. 
A more vigorous program of postoperative 
physiotherapy might offer respiratory sup­
port; patients with post-traumatic contused 
lungs or those recovering from thoraco­
abdominal procedures are assisted by this 
treatment.
Postoperative infective processes were 
frequent in this review. Sepsis related to 
splenectomy is emphasized by Kiesewetter7 
and Eraklis and colleagues;8 these papers 
referred mainly to observations in children. 
Hancock and colleagues9 and Ravry and 
associates10 made the point that splenec­
tomy in adults augments the risk of infection 
when patients have previously been sub­
jected to immunosuppressive therapy. Nei­
ther Hancock nor Ravry referred to sepsis 
as an immediate postoperative phenomenon. 
The context of delayed risk of sepsis was 
raised in a recent editorial11 quoting Ram­
say and Bouskill.12 The editors stated they 
“could find no evidence that the risk de-
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creased with time”. In Ramsay and Bous- 
kill’s series the high incidence of infection 
was usually first detected in the immediate 
postoperative period. The location of the 
bulk of the infective respiratory complica­
tions encourages us to believe that the ad­
ditional dissections and the delayed effects 
of extended retraction for left upper quad­
rant surgical procedures contribute to the in­
creased incidence of sepsis.
Thromboembolism
It is impossible for us to draw any con­
clusions about the relationship between 
thrombocytosis and thromboembolic phe­
nomena. The patients whose postoperative 
platelet counts were highest suffered no 
clinical thromboembolic phenomena.
Postoperative Mortality
The most striking finding was the rela­
tionship between splenectomy and post­
operative mortality. Danforth and Thorb­
jarnarson,D evlin , Evans and Birkhead,4 
Fabri and colleagues4 and Peck and Jack- 
son'1 considered the postoperative mortality 
to be associated with splenectomy. In our 
series it was not possible to identify the 
immediate difficulty leading to removal of 
the spleen. Rich, Lindner and Mathewson1' 
had a similar experience. A number of fac­
tors including obesity, chronic airway 
obstruction, intraoperative adhesions and 
anatomical variance making mobilization of 
the stomach difficult, may have contributed 
to the rate of sepsis, but such factors are 
usually not referred to in the operative 
notes. The presence of adhesions has been 
emphasized but only after splenectomy has 
been carried out; the objectivity of the com­
mentary could be questioned. The fact that 
such series are collected from the experience 
of many surgeons makes comparisons dif­
ficult; in addition, the lack of accurate 
matching for age, sex, weight, antecedent 
morbidity and intraoperative technical prob­
lems makes each case almost an individual 
observation. There is, however, room for 
some forward planning. From our ex­
perience, the most obvious plan would be an 
intensive program of postoperative respira­
tory care, which, depending on individual 
circumstances, would include positive-pres­
sure ventilation.
Suture Line Breakdown
Breakdown of the suture line occurred in 
four of the five patients who died after 
splenectomy; in three the breakdown was 
associated with partial gastrectomy. It is 
conceivable that the blood supply to the 
gastric remnant may be compromised by 
the addition of splenectomy. Protection of 
the suture line by prolonged proximal de­
compression might be indicated; this would 
be carried out either by proximal gastros­
tomy or prolonged nasogastric suction ac­
cording to the judgement of the surgeon 
at the time of operation. One would have 
to take into consideration the standard con­
traindication to prolonged nasogastric suc­
tion such as applies to patients with chronic 
respiratory disease.
Conclusion
In most reviews of the subject of post­
splenectomy infection, intuitive conclusions 
are drawn. Danforth and Thorbjarnarson2 
believe that incidental splenectomy does 
contribute significantly to the morbidity 
and mortality of the primary operation, 
and that without good reason this added 
procedure should not be lightly undertaken. 
Splenctomy is never added light-heartedly 
to a surgical procedure; it must always be 
done only when mandatory as the cir­
cumstances of the individual operation 
demand.
The causal relationship between splenec­
tomy and this morbidity is difficult to 
establish, but its frequency cannot be 
ignored. Current objective data is limited; 
prospective studies and therapeutic protocols 
to reduce morbidity and mortality are 
necessary.
We thank the medical records departments of 
the three hospitals concerned and Mrs. Janet 
Stazyk who typed the manuscript.
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THE ANTERIOR CRUCIATE LIGAMENT:
ITS ANATOMY AND A NEW METHOD OF RECONSTRUCTION*
J. G. HORNE, MB, ChB and C. J. PARSONS, MD, FRCS[C]f
Many methods for the reconstruction of the an­
terior cruciate ligament have been reported but 
none restore the normal anatomical course of 
the ligament. The authors have studied the 
anatomy and some aspects of the biomechanics 
of the anterior cruciate ligament and have 
developed a new method for reconstruction of 
the ligament based on sound anatomical and 
biomechanical principles. The early results of 
four cases are presented.
Plusieurs methodes de reconstruction du liga­
ment croise anterieur ont ete decrites mais 
aucune ne retablit le trajet anatomique normal 
du ligament. Les auteurs ont etudie I'anatomie 
et certains aspects biomecaniques du ligament 
croise anterieur et ont mis au point une nouvelle 
methode de reconstruction de ce ligament qui 
s'appuie sur de solides principes anatomiques 
et biomecaniques. Les premiers resultats obtenus 
chez quatre patients sont presentes.
W it h  the increasing interest and participa­
tion of the public in body contact sports, in­
jury to the anterior cruciate ligament (ACL), 
indeed to all knee ligaments, is becoming 
more common. The literature contains many 
studies on the anatomy and function of knee 
ligaments, and several methods for re-
*From the department of orthopedic surgery, St. 
Joseph’s Hospital, Toronto, Ont.
Submitted for the 1976 Davis & Geek Surgical 
Essay Award.
■(Orthopedic consultant, Joseph Brant Memo­
rial Hospital, Burlington, Ont.
Reprint requests to: Dr. J. G. Horne, c /o  ortho­
pedic department, Toronto General Hospital, To­
ronto, Ont. M5G 1L7.
construction of the ACL have been pro­
posed. However, most of these methods fail 
to provide anatomical reconstruction of the 
ligament.
M eth o d s  o f R epa ir
The presently available methods of repair 
fall into two groups. Liljedahl, Lindvall and 
Wetterfors1 obtained excellent results in the 
repair of complete (acute) ruptures of the 
ACL by suturing the torn ligament, ir­
respective of whether the tear was in the 
middle or at one end of the ligament. 
In the treatment of old (chronic) tears, 
however, there have been few published 
reports of large series. Aim and Gill- 
quist2 repaired a tom ACL in 164 pa­
tients using the medial one third of the 
patellar ligament as described by Gillquist, 
Liljedahl and Lindvall.3 Follow-up was for 
2 or more years and 108 (66%) patients 
were able to participate in preinjury athletic 
activities; 8 patients required reoperation for 
a second ligamentous injury and in 6 of 
them a viable transplant was found. Jones,4 
in a follow-up of his own technique of repair 
with the central one third of the patellar 
tendon, reported that of 46 patients, 27 re­
turned to their preinjury level of activity, 
but only 19 of these engaged in some type 
of athletics (7 played football).
Because of the unsatisfactory results of 
treatment for chronic ACL insufficiency, 
recent efforts have been directed at pros-
May 1977 THE CANADIAN JOURNAL OF SURGERY 215
thetic replacement of the ligament. Early 
experience with nine patients using Dacron 
or Teflon tubing was reported by Rostrup;3 
having followed seven of the nine patients 
for a minimum of 18 months he recom­
mended caution in the use of these ma­
terials. Kennedy6 reported encouraging 
results with a high-density polyethylene 
prosthetic replacement.
Failure of Repair
There are three likely reasons for failure 
of these methods of repair. The first is the 
lack of blood supply to the substitute liga­
ment. Failure of the Hey-GrovesT techni­
que, in which a free strip of the fascia lata is 
rendered avascular at the time of operation, 
can be attributed to the immediate degenera­
tion and rupture of the avascular fascial 
strip. The second cause of failure is abrasion 
of the ligament at the ligament-bone inter­
face. Many of the previously described 
techniques have used the passage of tendon 
or fascia through both tibia and femur; the 
constant movement of the substitute liga­
ment in the bony canal through which it 
passes results in mechanical wear at the 
ligament-bone interface and eventual failure. 
Excessive stress on the substitute ligament 
from nonanatomical placement accounts for 
the third cause of failure. The ACL has its 
tibial attachment in front of the anterior 
tibial spine and the spine itself. When a strip 
of patellar tendon is passed from the tibial 
tubercle through a hole in the lateral 
femoral condyle by way of the joint, the 
normal anatomy is not re-established. Such 
a method will fail because the tibial attach­
ment arises posterior to the tibial tubercle 
rather than from it.
Blood Supply
There are two recognized sources of 
blood supply to tendons: first the intrinsic 
vessels that approach the tendon from the 
muscle-tendon junction and the tendon- 
periosteum junction; second the extrinsic 
vessels that approach the tendon through the 
paratenon. The survival of a tendon after 
the exclusion of its extrinsic blood supply 
depends thus on an adequate intrinsic 
longitudinal collateral circulation. Until 
recently it has been generally accepted that 
tendon blood supply is segmental and that
destruction of the extrinsic supply would 
render the tendon avascular. However, 
Lundborg,8 utilizing intravital microscopic 
techniques, carried out an in-vivo study of 
the blood supply of rabbit tendon; he 
showed that after mobilization, division of 
paratenon and proximal musculotendinous 
transection, there was still an observable 
blood flow in the tendon. The success of any 
form of ACL reconstruction with tendon 
grafts depends on preservation of the in­
trinsic microcirculation of the tendon.
The purpose of our study was to devise 
an operation for the anatomical reconstruc­
tion of the ACL.
A natomy of Anterior Cruciate
Ligament
Material and Method
The anatomy of the ACL was first in­
vestigated by dissection of two cadaver 
knees and two fresh knees; particular at­
tention was paid to the femoral and tibial 
attachments. The fresh knees were ob­
tained from patients undergoing above-knee 
amputation for peripheral vascular disease. 
The autopsy specimens were cut in an 
oblique sagittal plane to expose the full 
length of the obliquely running ACL with­
out the need for further bone removal.
Before complete dissection of the fresh 
knee specimens a small anteromedial ar- 
throtomy was performed; in addition, the 
tibial attachment of the ACL was defined 
and a Week clip attached to it. Similarly, 
through a small posterolateral arthrotomy, 
the femoral attachment was defined and a 
Week clip attached. Lateral radiographs 
were then taken of the knee in full extension 
and in 15°, 30°, 60° and 90° of flexion, 
with the Week clips as markers. We were 
thus able to measure the angle subtended 
by the ACL with the tibial plateau and the 
femoral shaft through the full cycle of knee 
flexion. With the help of these findings we 
were able to design a new method of ACL 
repair using the semitendinosus tendon as a 
distally based graft.
Results
The femoral attachment.—The femoral 
attachment of the ACL is to the most 
posterior and superior part of the medial
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face of the lateral femoral condyle (Fig. 1). 
It does not attach to one point but has a 
large fan-shaped attachment that cor­
responds to the curve of the medial margin 
of the lateral femoral condyle. The margins 
of its attachment are at all times intimately 
associated with the attachment of the posteri­
or capsule. The posterior capsule separates 
the femoral attachment of the ACL from the 
distal end of the lateral intermuscular 
septum. The septum at its distal end divides 
into two limbs; one passes distally and at-
Fig. 1.—Femoral and tibial attachments of an­
terior cruciate ligament (A CL). AC =  anterior 
cruciate ligament, PC =  posterior cruciate liga­
ment, PCP =  posterior capsule, LFC =  lateral 
femoral condyle, F =  femur, T =  tibia, P =  
patella.
Fig. 2.—Angle change between ACL and tibia.
Fig. 3.—Angle change between ACL and femur.
taches itself to the superior margin of the 
lateral femoral condyle while the other 
passes posteriorly and blends into the poste­
rior capsule. As demonstrated by Walker 
and Shoji'1 the femoral attachment of the 
ACL corresponds closely to the instant 
centre of rotation of the knee.
The tibial attachment.—The tibial attach­
ment is more compact than the femoral at­
tachment (Fig. 1). While approximately 
two thirds of the ACL takes origin from the 
tibia immediately anterior and medial to the 
tibial spine, the remaining one third attaches 
to the anterior margin of the spine.
Analysis of the lateral radiographs of the 
knee with Week clips on the ACL as 
markers revealed that from zero to 90° of 
knee flexion the angle between the tibia and 
the ACL changed only 25° (Fig. 2). How­
ever, a much larger change was noted be­
tween the ACL and the shaft of the femur. 
Almost 90° of rotation of the femoral at­
tachment around the femoral condyle was 
noted during 90° of knee flexion (Fig. 3).
O p e r a t iv e  P ro cedu re
Concepts of Technique
As a result of the radiographic studies it 
seemed that any method of ACL reconstruc­
tion that involved the passage of a substitute 
ligament through the femur would fail be­
cause of abrasion at the tendon-bone inter­
face. However, because there is a small 
angle change at the tibial attachment the 
substitute ligament could be passed through 
the tibia. Such an arrangement would allow 
the substitute ligament to exit immediately 
in front of the anterior tibial spine. The 
work of Lundborg encouraged us to con­
sider a tendon as the substitute ACL. The 
tendon would be divided at the musculoten­
dinous junction and its extrinsic blood sup­
ply disrupted; it was hoped therefore that 
the intrinsic blood supply from the tendon- 
periosteum junction would be sufficient.
The tendon of the semitendinosus muscle 
attaches to the tibia along with the tendons 
of the sartorius and gracilis muscles to a 
point approximately 8 cm below the medial 
joint line and 3 cm posterior to the sub­
cutaneous border of the tibia. A hole drilled 
from the tibial attachment of the semi­
tendinosus muscle to a point immediately in
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front of the anterior tibial spine would en­
able the semitendinosus tendon to be passed 
through this hole and be drawn upwards 
and laterally through the joint with little 
angle change at the tendon-bone junction 
(Fig. 4). Owing to the risk of abrasion, the 
tendon would not be passed through the 
lateral femoral condyle but rather through 
the posterior capsule adjacent to the femoral 
attachment of the ACL, with the two limbs 
of the distal end of the lateral intermuscular 
septum as a suspension point.
Method
The musculotendinous junction of the 
semitendinosus is exposed through a short 
posteromedial vertical incision in the thigh 
(Fig. 5). The muscle belly of the semi­
tendinosus is sutured to the semimembra­
nosus before transection of the tendon. A 
medial parapatellar incision is then made 
beginning approximately one finger’s breadth 
medial to the patella; it is swung down across 
the joint line and curved posteriorly and dis- 
tally to expose the pes anserinus tendons 
(Fig. 5). This incision may be curved proxi- 
mally and posteriorly to visualize the medial 
collateral ligament and the posteromedial
Fig. 4.—Proposed route of semitendinosus ten­
don.
capsule. The proximal end of the semi­
tendinosus tendon is grasped with a Kocher 
forceps; with gentle traction the tibial 
attachment is visualized. The medial re­
tinaculum of the patella is incised over the 
tibial attachment, and the tendon is identi­
fied and drawn down distally. A ten­
don stripper may be used to detach the 
paratenon. A specially designed jig and 
guide (Fig. 6) is then used to drill from the 
tibial attachment of the semitendinosus up­
wards, laterally, to a point immediately in 
front of the anterior tibial spine (Fig. 7). 
The point of the guide is placed on the tibial 
attachment of the ACL; a 14-inch (0.625-
Fig. 5.—Detachment of semitendinosus tendon.
Fig. 6.—Jig and guide used to drill from tibial 
attachment to point immediately in front of an­
terior tibial spine.
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Fig. 8.—Semitendinosus tendon passed through 
Fig. 7.—Jig in position. tibia.
cm) drill is then directed through the guide 
towards it and finally the tendon is passed 
through the tibia and drawn up by way 
of the knee joint (Fig. 8).
A third incision is then made along the 
lateral aspect of the knee immediately an­
terior to the iliotibial band and just above 
the lateral femoral condyle. The fascia lata 
is incised along the line of the incision; the 
vastus lateralis muscle is swept off the 
lateral intermuscular septum exposing the 
lateral aspect of the shaft of the femur. Dis­
section is carried distally to the distal 
end of the lateral intermuscular septum 
where the division of the septum into two 
limbs is identified. The two limbs of the 
lateral intermuscular septum are often 
covered by a small venous plexus; this 
should be cauterized and removed. A small 
incision is made in the posterior capsule 
between the two limbs of the lateral inter­
muscular septum and a curved Kelly forceps 
is passed through the knee to grasp the 
semitendinosus tendon. The tendon is then 
drawn through the incision in the poste­
rior capsule; with the knee flexed at 90°
and the tendon pulled tight, it is sutured to 
the lateral intermuscular septum with non­
absorbable advancing sutures (Fig. 9). The 
lateral incision is then closed. After all other 
reconstructive procedures have been per­
formed the arthrotomy incision is closed.
Fig. 9.—Semitendinosus tendon exiting through 
posterior capsule and lying on junction of two 
limbs of lateral intermuscular septum.
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The leg is protected in a long-leg cast with 
the knee at 60° flexion for 6 weeks; the cast 
is then removed and physiotherapy begun.
Results
To date the procedure has been carried 
out on four patients. The results of the pro­
cedures are detailed below by four case 
reports.
Case 1.—A 19-year-old boy sustained a 
valgus injury to his knee while playing foot­
ball. Examination 4 days after the injury re­
vealed a complete tear of the medial collateral 
ligament plus a tear of the ACL. These find­
ings were confirmed on examination under 
anesthesia the following day. At operation, 7 
days after injury, the medial collateral liga­
ment was repaired by O’Donohughe’s tech­
nique followed by an ACL substitution. The 
cast was removed 6 weeks after operation and 
physiotherapy was begun. Four months after 
operation the patient had a range of move­
ment of 5° to 150°; he was asymptomatic 
and was able to play hockey.
Case 2 .— A 24-year-old man sustained a 
valgus injury to the knee while playing hockey. 
Examination on the day of injury revealed 
tears of both the anterior cruciate and medial 
collateral ligaments. At operation direct suture 
of the medial collateral ligament followed by 
ACL substitution was performed. His post­
operative course was complicated by a reac­
tion to the sutures on the medial side. No 
bacteria were grown from wound swabs. The 
cast was removed at 1 month and mobilization 
begun. Six months after operation his range of 
movement was 15° to 110°; the knee was 
clinically stable, but there was some residual 
stiffness.
Case 3 .—A 17-year-old boy sustained a 
valgus injury while playing football. He was 
treated initially in a tensor bandage. When 
first seen 6 weeks after the injury both the 
medial collateral and the anterior cruciate 
ligaments were tom. At operation a lateral 
meniscectomy and an ACL substitution were 
carried out; the medial collateral ligament was 
not repaired. The cast was removed 6 weeks 
after operation and mobilization begun. While 
running 5 months after the operation the knee 
felt unstable. Arthroscopy revealed that the 
cruciate repair was intact; under anesthesia 
no draw sign was present. However, a pivot 
shift was demonstrated and therefore a lateral 
pivot shift repair was performed. One year
following the original injury he had a full 
range of movement; he had returned to sports 
and was asymptomatic.
Case 4.—A 21-year-old man injured his 
knee in a fall from a truck. At examination 
following the injury he was thought to have 
a partial tear of the medial collateral liga­
ment; he was treated with a compression 
bandage. Before referral for ACL substitution, 
a medial meniscectomy and pes anserinus 
transfer were performed; in addition a torn 
ACL was diagnosed by arthroscopy. Under 
anesthesia at the time of the arthroscopy he 
had a positive anterior draw sign. Two and a 
half years after the original fall an ACL sub­
stitution was performed. The patient’s post­
operative course was uneventful; the cast was 
removed 6 weeks after operation. When seen 
15 months after the operation he had a full 
range of knee movement and the knee was 
stable; the patient did suffer from an oc­
casional effusion after prolonged exercise.
D iscussion
Several intra-articular ACL substitutions 
have been described in the literature, in­
cluding one utilizing the medial meniscus.10 
McMaster, Weinert and Scranton11 de­
scribed a method using the gracilis tendon; 
in this method the tendon is passed through 
the tibia from the pes anserinus to the an­
terior tibial spine and then through the 
lateral femoral condyle. C ho12 later de­
scribed a similar procedure utilizing the 
semitendinosus muscle and claimed excel­
lent results in seven patients. Both methods 
are unsatisfactory because tendon failure is 
likely to occur at the tendon-bone interface 
as the tendon enters the femoral condyle.
Any technique of anterior cruciate sub­
stitution utilizing a tendon that has been 
divided from either its musculotendinus or 
tendon-periosteum junction and has had its 
paratenon divided relies on its intrinsic 
blood supply to maintain viability. Solonen, 
Hjelt and Rinne13 studied the histologic 
events in the semitendinosus muscle of rab­
bits. The studies were done where the ten­
don was used as an ACL substitute follow­
ing division of the tendon-periosteum junc­
tion, the muscle attachment to the ischial 
tuberosity and the paratenon. Sixteen cases 
were followed from 4 Vi to 24 weeks; in 
15 the tendon was viable. In these cases the
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intrinsic blood supply was sufficient to 
maintain viability. These findings comple­
mented the description of tendon blood sup­
ply by Lundborg.8
We studied the anatomy and some 
aspects of the biomechanics of the anterior 
cruciate ligament in order to develop a new 
method of ACL reconstruction. Previously 
described methods failed because reconstruc­
tion was not along anatomical lines; there­
fore in devising our technique we paid parti­
cular attention to this aspect and to bio­
mechanical principles. The early results in 
four patients in whom we performed our 
operative procedure have been gratifying.
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SURGICAL TREATMENT FOR PULMONARY EMPHYSEMA
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Three in-vivo observations stimulated interest in 
surgical treatment for emphysema: (a) the de­
structive changes are rarely generalized, (b) the 
central portions of the lungs are frequently less 
seriously affected, and (c) marginal folding pro­
duces obstructive change in the more normal 
lung tissue.
If destroyed avascular space-occupying areas 
can be removed, the compressed lung tissue 
may be stretched to fill the pleural space in a 
functionally effective fashion. Residual elastic 
tissue will then maintain patency of terminal 
bronchioles.
Preoperatively the extent of the destructive 
change can be defined most accurately by pul­
monary angiography, and zones of functioning 
capillary circulation can be identified.
Forty-seven patients with multifocal space- 
occupying emphysematous change have been 
treated surgically. The postoperative mortality 
was 21% but worthwhile long-term improvement 
has been obtained in 45% of patients presenting 
with disabling dyspnea. In these patients, sur­
gical treatment warrants consideration if signi­
ficant space occupation accompanies the bullous 
disease, provided alveolar vascularization can 
be demonstrated in the compressed adjacent 
normal lung tissue.
Limited resections that preserve all vascular­
ized and potentially functioning lung tissue are 
preferable. It is essential that obliteration of the 
hemithorax be obtained promptly in view of the 
high incidence of postoperative complications 
requiring secondary operative procedures, if 
“ leaks” and residual spaces are allowed to per­
sist. Postoperative care in a respiratory inten­
sive care unit is mandatory.
Trois observations in vivo ont cree de I'interet 
pour le traitement chirurgical de I'emphyseme:
^Division of thoracic surgery, Toronto General 
Hospital, Toronto, Ont.
fDepartment of medicine, Toronto General Hos­
pital.
IDepartment of radiology, Toronto General Hos­
pital.
This paper was received on Apr. 26, 1976. Publica­
tion was delayed owing to the loss of the original 
illustrations.
Reprint requests to: Dr. Norman C. Delarue, 
Ste. 530, 170 St. George St., Toronto, Ont. 
M5R 2M8.
(a) les lesions sont rarement generalisees,
(b) la partie centrale du poumon est souvent la 
moins serieusement affectee, et (c) un repli 
marginal produit une obstruction du tissu pul- 
monaire normal.
Si on peut proceder a I'ablation des zones oc­
cupies par les surfaces detruites non vascu- 
larisees, le tissu pulmonaire comprime peut 
etre etire pour remplir I'espace pleural de fagon 
a reprendre un fonctionnement efficace. Le tissu 
elastique residuel maintient alors le fonctionne­
ment des bronchioles terminales.
Dans la periode preoperatoire, I'etendue des 
aires detruites peut etre definie avec le plus 
de precision par I’angiographie pulmonaire, et 
les zones oil la circulation pulmonaire est fonc- 
tionnelle peuvent etre identifies.
Ouarante-sept patients presentant de multiples 
foyers de changements emphysemateux ont ete 
trades par chirurgie. La mortality postoperatoire 
a ete de 21% mais une amelioration significative 
de longue duree a ete enregistree chez 45% 
des patients presentant une dyspnee invali­
d a te . Chez ces patients, il y a lieu de consi- 
derer le traitement chirurgical si un espace 
occupe appreciable accompagne la maladie bul- 
leuse, en autant qu'on peut demontrer une vas- 
cularisation alveolaire dans le tissu pulmonaire 
normal comprime qui lui est adjacent.
II est preferable de proceder a des resections 
limitees qui permettent de conserver tout le 
tissu pulmonaire vascularise, potentiellement 
fonctionnel. II est essentiel d'obtenir une obli­
teration rapide de I'hemithorax, en raison de la 
haute frequence des complications postopera- 
toires exigeant des interventions secondaires 
lorsque des “fuites" ou des vides residuels 
persistent. Les soins postoperatoires doivent, 
de toute obligation, etre prodigues dans une 
unite de soins respiratoires intensifs.
A ccepta n ce  of surgical interest in the 
management of patients with emphysema 
has been grudging by surgeons as well as 
physicians. The indications for surgical 
treatment have developed sequentially.
Initially, treatment was restricted to the 
management of complications of bullous 
disease —  primarily spontaneous pneumo­
thorax, and specifically when it was per­
sistent, recurrent, or life-endangering. The 
surgical techniques for treatment of this
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complication date back almost to the time 
when open thoracotomy first became 
feasible.
Disabling dyspnea is another complica­
tion of bullous disease, a result of progres­
sive space occupation. The “disappearing 
lung” syndrome is an apt description for 
advanced stages of this change. Surgical re­
lease of the compressed normal lung was 
required for preservation of life.
Interest in the potential value of sur­
gical treatment was also aroused by the 
assessment of the type of emphysematous 
change discovered at the time of thoracot­
omy for treatment of other disease, notably 
lung cancer. It became apparent that the 
change was not really diffuse or generalized. 
The central portions of the lungs seemed 
less seriously affected, and the marginal 
folding that was frequently seen in the com­
pressed adjacent normal lung tissue pro­
duced secondary obstruction of the terminal 
airways. It also became obvious that plain 
chest radiographs did not differentiate bullae 
and the “cotton candy” changes that tended 
to be more diffuse in extent.
Further speculation was also generated 
by a consistent observation after lobectomy 
for carcinoma of the lung in older patients 
with chronic obstructive lung disease; name­
ly, that there was improvement in air entry 
that was restricted to the ipsilateral hemi- 
thorax. In addition, postoperative function 
in these patients was frequently better than 
had been anticipated from preoperative 
evaluation.
On the basis of these observations a 
cautiously enlarging program of definitive 
treatment was initiated. Discussion of this 
program is the purpose of this report.
i
Development of Definitive Surgical
Treatment
Patients, Methods and Rationale of
Treatment
The surgical experience covers two pe­
riods. The first —  between 1950 and 1964 
—  formed the basis for a preliminary report 
in which the early results of treatment were 
reviewed.1 The second —  between 1965 
and 1974 —  is the period during which an 
attempt was made to develop more specific 
indications for surgical treatment.
In both these periods some cases were 
selected for detailed investigation, while 
others were treated more routinely. In those 
undergoing detailed study an attempt was 
made to define areas of lung capable of im­
proved function and, therefore, worth con­
serving. Long-term changes in respiratory 
function were evaluated objectively to de­
termine whether the reports of subjective 
improvement could be substantiated by 
sophisticated testing. Respiratory function 
testing included tests of ventilation, me­
chanics of breathing and of gas exchange. 
Although not all these tests showed uniform 
improvement, improved exercise tolerance 
was demonstrated when several aspects of 
pulmonary function showed improvement. 
In these cases the effect tended to be main­
tained for long periods.
In a simple classification pulmonary em­
physema has been defined as focal or multi­
focal and space occupation described as 
unifocal or multifocal. Identification of bull­
ous disease is a less accurate clinical meth­
od of assessment since it is impossible to 
distinguish accurately between bullae and 
the more diffuse “cotton candy” change 
prior to thoracotomy.
Within the context of this classification 
a review of the records of 118 consecutive 
patients formed the basis for this current 
report (Table I), which considers, particu­
larly, those with multifocal disease. The 11 
patients with diffuse or generalized multi­
focal change (i.e., without recognizable focal 
or multifocal space occupation) where sub­
jected to complete respiratory function test­
ing and followed for more than a year as 
a control group. Of the 55 patients who 
had multifocal disease with space occupation 
8 presented with an emergent complication 
of spontaneous pneumothorax and, because 
of the special problems encountered in their 
management, have been considered sepa­
rately. There remained, therefore, 47 patients 
with multifocal disease and space occupa­
tion who were managed by a definitive sur­
gical maneuver; 25 of these (5 from the 
period 1950-64 and 20 from the period 
1965-74) underwent detailed preoperative 
assessment and were subjected to similar 
postoperative follow-up assessment (group 
1). In the other 22 patients who were treated
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TABLE I.—Classification of 118 Patients with E mphysema
Period
1950-64 1965-74
Classification No. of Postoperative No. of Postoperative
of emphysema patients mortality patients mortality Total
Focal.............................................................  1 0 21* 0 36
14*
Focal with
space occupation.................................  10 0 4 1* 16
2*
Multifocal with
space occupation.................................  5 1 42 9 55
8*  2*
Multifocal
generalized...........................................  0 — 11 — 11
Total.............................................................  30 1 88 12 118
‘Patients presenting with pneumothorax.
at a later stage in the study, treatment was 
specifically designed to excise only destroyed 
lung tissue (group 2). The detailed clinical 
and laboratory data from these patients re­
present the basis for the present report.
Unifocal disease is usually not associated 
with an appreciable extent of space occupa­
tion and becomes a surgical problem only 
if recurrent, persistent or tension pneumo­
thorax requires control. Occasionally this 
type of unifocal disease may develop space- 
occupying proportions, in which event treat­
ment will be necessary in order to relieve 
increasing dyspnea. The results achieved, as 
reported previously,1 are excellent: the pre­
senting complaint is completely controlled 
and respiratory function shows gratifying 
improvement (Table II).
In patients with unifocal disease the in­
dications for surgical treatment are straight­
forward. It is in the group of patients with 
multifocal change that surgical considera­
tions become more difficult. The problem
centres on the risk of surgical treatment and 
the need to answer the question, Can worth­
while functional improvement be obtained 
in a worthwhile proportion of patients by 
accepting the risk and pursuing aggressive 
management?
The decision to undertake surgical treat­
ment will be acceptable if the potential 
value can be considered to exceed the risk 
of treatment in patients who are completely 
disabled and who believe that they cannot 
be productive at their current level of cardio­
respiratory sufficiency. All patients included 
in this study suffered from dyspnea of grade 
4 or 5 (0 —  no dyspnea, 1 — dyspnea on 
strenuous exertion, 2 —  dyspnea on walking 
up hills or stairs, 3 —  dyspnea on level 
when walking quickly, 4 —  dyspnea on 
level when walking slowly, 5 — dyspnea 
on talking or dressing or at rest) and most 
had grade 5 disability. Associated pulmon­
ary hypertension was a notable feature of 
the clinical situation in every patient.
TABLE II.—Results of L eft Lower Lobectomy to Relieve Increasing Dyspnea in 54-Year-Old 
Man with Unifocal, Space-Occupying Pulmonary Emphysema*
Test Predicted Preoperative Postoperative Change, %
Forced vital
capacity (FVC), ml.......................... 3675 2350 3100 +  31
Forced expiratory
volume (FEVi), ml........................... >  2575 1300 1500 +  15
Maximal voluntary
ventilation (MW ), //m in............... 112 44 62 +  44
Dyspnea (grade)....................................... 0 3 1
Retesting performed 6 yr postoperatively.
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R e f in e m e n t  o f  O perative
P ro cedures
The operative technique has varied wide­
ly. Initially lobectomy was preferred (in 35 
of the 47 patients) largely for its relative 
simplicity. Lobectomy alone was performed 
in 20 patients but, in an additional 15 pa­
tients supplementary procedures were also 
utilized. For example, bullectomy was per­
formed in 5, plication in 4, pleuroplasty in 
3, phrenic paralysis in 2 and thoracoplasty 
in 1. With this indiscriminate approach, 
however, good lung tissue was occasionally 
excised and areas of destroyed lung were 
left in situ. However, a variety of supple­
mentary procedures had been used to 
“tailor” the remaining lung.
Subsequently, experience with these tech­
niques of limited resection encouraged us to 
excise only destroyed tissue preserving all 
available functioning lung; of the 47 pa­
tients, 5 had plication and 7 had bullectomy, 
and 2 of these 12 had bullectomy and plica­
tion. This attention to the need to conserve 
worthwhile lung tissue was important in the 
decline in mortality.
Progressive refinement in the techniques of 
management for bullous disease included the 
following procedures:
1. Oversewing small cysts or bullae.
2. Wedge resection of small cysts or 
bullae.
3. Plication-excision of peripheral zones 
of destroyed lung tissue.
4. Opening of cysts with closure of bron­
chial communication and suture of cyst wall 
to exposed lung surface.
5. Use of stapler for bullectomy or plica­
tion. (Note that both rows of staples should 
be retained in these cases since closure is 
not air tight and the divided lung tissue 
should be oversewn superficial to the 
staples.)
Pr eo per a tiv e  Investigation
Once this changing emphasis on “tail­
ored” resection was accepted as a guiding 
principle, it became increasingly important 
to delineate preoperatively as accurately as 
possible the outline of vascularized and non- 
vascularized alveolar tissue.
The techniques of investigation included 
the following:
1. A detailed clinical assessment of areas 
of diminished air flow.
2. Fluoroscopic examination to demon­
strate poor darkening on exhalation.
3. Perfusion lung scanning.
4. Ventilation lung scanning.
5. Pulmonary angiography.
6. Cinebronchography.2
There proved to be a good correlation 
between the results of these various tests. 
For example, diminution in inspiratory 
breath sounds correlated with poor dark­
ening of the lung field during exhalation;8 
diminished vascularity on the perfusion scan 
correlated with the findings of pulmonary 
angiography;4 and diminution in ventilation 
on xenon scan correlated with the clinical 
findings.
Although these correlations were satis­
factory, the most accurate definition of areas 
of functioning lung tissue could be made 
by pulmonary angiography. The alveolar 
“blush” in peripheral lung tissue was the 
most reliable indicator of persisting capillary 
circulation (Figs. 1 and 2).
Further evaluation led to the realization 
that preservation of vascularity was almost 
invariably associated with unimpaired local 
air flow. It became apparent that pulmonary 
angiography was the single investigation that 
was most important in determining the 
feasibility of surgical treatment for these 
patients (Figs. 3 and 4).
R e su lts  of  T r e a tm e n t
Survival
In 25 patients in group 1, followed up 
with detailed clinical and laboratory studies 
repeated at least 1 year after operation, 
mortality must be emphasized in view of 
the fact that 8 of the 25 patients (32%) 
undergoing surgical treatment died as a 
result of the operative procedure; 7 died 
as a direct result of operation and 1 had 
increasing symptoms followed by early 
death.
However, in the 22 patients in group 2, 
in whom attempts were made to excise only 
destroyed lung tissue and specific treatment 
was used to ensure rapid obliteration of the
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Fig. 1.—Right upper lobe pulmonary angiogram 
— arterial phase — with normal pattern of arbor­
ization and even microvascular “blush” in marginal 
parenchyma.
Fig. 2.—Parenchymal area delimited by black 
arrows shows wide branching angles, vascular 
attenuation, delayed filling and irregular sparse 
microvascular “blush”.
pleural space, only 2 patients (9%) died, 
reflecting the value of the “tailored” treat­
ment.
Those whose condition was unimproved 
(2 in group 1 and 7 in group 2) or who 
had only a transient response (2 in group 
1, 1 in group 2), although not representing 
worthwhile dividends, do reflect the tech­
nical feasibility of conducting the surgical 
exercise in these high-risk patients.
Despite these discouraging aspects, the 
most striking figure none the less is the 
number of patients who did have a worth­
while result.
Vol. 20
Fig. 3.—Multifocal destruction of microvascular 
circulation. Black arrows point to zones in which 
normal microvascular “filling” has been retained.
Fig. 4b
Fig. 4.—(a)Focal avascularity. Bullous emphy­
sema with multiple space occupation and crowding 
of vessels in areas of normal microvascular filling, 
(b) Coned view of “boxed” area of multifocal 
change from (a). Black arrows indicate zone of 
retained microvascular circulation. Area between 
white arrows represents avascular “cotton-candy” 
change with “stretched” proximal vessels.
In group 1, 12 patients (48%) had an 
appreciable improvement in respiratory re-
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serve with long-term survival averaging well 
over 5 years. Now, eight of these are dead 
after surviving between 2 to 10 years (aver­
age survival, 5 yr) and four remain alive 
with a range of survival from 6.5 to 8.5 
years (average survival, 8 yr). One patient 
in group 1 was lost to follow-up.
In group 2, nine patients (41%) have 
had long-term survival. Among them, two 
are now dead after surviving 2 and 4 years 
respectively and seven remain alive with 
a range of survival between 3.5 and 10 
years (average survival, 6 yr). Three patients 
*in group 2 were lost to follow-up.
In the study group of 47 patients almost 
one half (45%) showed a worthwhile im­
provement with long-term survival (Table 
III).
TABLE III.—Results of Surgical Treatment 
in the Study Group
Result
No. of 
patients 
(and %)
Postoperative m ortality................... 10 (21)
Unimproved....................................... 9
Transient improvement (>  1 y r) .. 3
Long-term improvement (>  2 yr). 10 |
> (45)
Long-term survival........................... 11 )
Lost to follow-up.............................. 4
47
One can compare these results with those 
at the end of 1 year for the 11 patients who 
had generalized disease without focal space 
occupation and who were not treated sur­
gically. Five had died of respiratory failure 
and in the other six respiratory function 
tests revealed progressive deterioration.5
Postoperative Complications
The complication rate was worrisome 
(Table IV): serious postoperative complica­
tions developed in approximately one half 
of the patients. The majority of complica­
tions were related to delayed expansion of 
the remaining lung and failure of early 
obliteration of the pleural space. Because 
of the frequency with which complications 
developed we are convinced that these pa­
tients must be nursed in a respiratory in­
tensive care unit until the clinical situation 
has stabilized.
TABLE IV.—P ostoperative C omplications in  37 
Survivors from the Study G roup of 47 P atients
Complication
No. of
complications
Respiratory insufficiency
(requiring tracheostomy). . 3*
Pneumothorax
Ipsilateral........................ 2
Contralateral................... 2
Persisting space
Thoracoplasty (trache-
ostomy, 1).................... 2
Pneumoperitoneum........ 1
Hemothorax (torsion right
middle lobe, 1 ) .................... 2
Wound infection (dehiscence, 1). 3
Infected effusion..................... 1
Bronchopleural fistula with
empyema.............................. 1
Pulmonary edema................... 1
Recurrent pulmonary emboli. 1
Thrombosis femoral artery... 1
T otal......................................... 20*
*2 patients died postoperatively.
TABLE V.—M ortality in 55 P atients w ith
M ultifocal D isease with Space Occupation
Postoperative
No. of mortality
patients 0and %)
1950 - 64 ....................... 5 1 (20)
1965 - 74 ....................... 50 10 (20)
Group 1 ......................... 25 8* (32)
Group 2 ......................... 22 2 (9)
Presenting as
penumo thorax.......... 8 2 (25)
55 12 (22)
*2 deaths attributed to high epidural anesthesia.
TABLE VI.—Causes; of D eath
No. of
Cause patients
Cardiac arrest
(myocardial failure)............. 4
Septicemia................................ 2
Respiratory complications. . . 3
Pulmonary embolism............... 1
High epidural anesthesia......... 2
12
Mortality
The mortality (Table V) is not surprising 
in view of the patients’ serious preoperative 
state. The causes of death have been tab­
ulated in Table VI. Uncomplicated primary 
respiratory insufficiency did not cause a 
single death, although problems with tra­
cheobronchial toilet did produce two late
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complications. Bronchopleural fistula was an 
ever-present potential hazard in the imme­
diate postoperative period.
Pneumothorax in Bullous
E mphysema
The development of spontaneous pneu­
mothorax in patients with bullous em­
physema may constitute an emergency 
indication for surgical treatment if the 
pneumothorax is recurrent, persistent, or life- 
endangering. When simple closed drainage 
does not solve the problem, additional man­
euvers are required, and once this situation 
is declared treatment must be pursued with 
care in view of the anticipated mortality 
(Table VII). It is similar to that encountered 
in the definitive treatment of patients with 
otherwise uncomplicated multifocal disease, 
even though pneumothorax usually occurs 
in patients who have not demonstrated 
severe impairment of cardiorespiratory func­
tion previously.
TABLE VII.—M ortality after Surgical T reat­
ment of P atients with P neumothorax in Bul­
lous Emphysema
Classification 
of emphysema
No. of 
patients
Postoperative
mortality
Focal............................... 21 0
Focal with
space occupation....... 2 1
Multifocal with 
space occupation....... 8 2
31 3
The primary surgical procedures in the 
31 patients with pneumothorax encountered 
in the recent series (1965-74) as well as 
the nature of secondary operations required 
in the management of continuing complica­
tions are set forth in Tables VIII and IX. 
It should be noted that almost one half 
of these patients (47%) did, indeed, require 
additional surgical treatment following the 
initial primary procedure.
Among eight patients with multifocal dis­
ease accompanied by space-occupying 
change who presented with spontaneous 
pneumothorax, two died postoperatively 
(one of myocardial failure and the other 
of respiratory insufficiency). The mortality
experience is, therefore, similar to that re­
ported in the definitive management of 
similar patients treated without the emergent 
indication of an uncontrolled pneumothorax.
Although detailed preoperative investiga­
tion is not possible under these circum­
stances, the findings indicate that the opera-
TABLE VIII.—Surgical P rocedures in 31 
Patients with Bullous E mphysema P resenting 
with Pneumothorax from 1965 - 74
Primary procedure
No. of 
procedures
No. of 
patients 
requiring 
a second 
operation
Bullectomy.................... 3 2
With talc poudrage. . 8 2
Pleurectomy.......... 5 3
Pleurectomy +
poudrage............ 2 1
Pleurectomy +
pleural abrasion. 2
Plication with talc
poudrage.................... 2 _
Pleurectomy -f-
pleural abrasion. 1 —
Talc poudrage............... 7* 5
With tracheostomy 1
Segmental resection —
decortication.............. I t —
Salvage resection.......... 1 1
Salvage resection +
thoracoplasty............ 1 —
34 14
*2 patients had bilateral sequential procedures. 
(Subsequent contralateral procedure.
TABLE IX.—Secondary Operations in 14 
Patients with Bullous E mphysema Presenting 
with Pneumothorax
Procedure Number
Bullectomy with talc poudrage........ 2
Pleurectomy............................... i
Pleurectomy +  poudrage.........  1
Plication (oversewn or resutured
bulla)..............................................  2
With thoracoplasty and
tracheostomy.........................  i
Talc poudrage....................................  2
With pleurectomy.....................  1
Closed pleural drainage....................  2
Thoracotomy for:
Postoperative hemothorax . . . .  1
Postoperative hemopneumo-
thorax.....................................  i
Thoracoplasty...................................  i
Tracheostomy....................................
_______________________________________16*
*2 patients required 2 secondary operations.
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Fig. 5.—(A) Apr. 24, 1967, before surgical treatment. (B) Oct. 28, 1967, after peripheral
plication right lower lobe. (C) July 18, 1974, after excision of tension cysts and plication of left 
lower lobe with prophylactic osteoplastic thoracoplasty.
five precautions should be similar to those 
used in the definitive management of space- 
occupying multifocal disease.
The type of worthwhile result that may 
be achieved by surgical treatment is illus­
trated in the following case report (Figs. 5 
to 7, Table X). In this patient the plication 
technique was used to preserve a critically 
depleted vascularized pulmonary bed and, 
when necessary, a space-reduction proce­
dure was performed in order to avoid life- 
endangering postoperative complications re­
sulting from a lack of proper “fitting” of 
thoracic cage and remaining lung.
C ase R epo r t
A 39-year-old man sustained a spontaneous 
pneumothorax in 1952. A  further spontaneous 
pneumothorax developed in 1964. The history 
thereafter was as follows:
1964: cigarette smoking was discontinued.
1966: the patient was unable to work be­
cause of disabling dyspnea.
1967: investigation showed the upper lobes 
to be compressed anteriorly, the change being 
more noticeable on the right than the left. 
Cinebronchography demonstrated a 75% col­
lapse of the trachea (borderline). Plication 
on right.
Fig. 6.—Sequential right pulmonary angiograms. (A) 1967, before operation. No microvascular pat­
tern can be seen. (B) 1968, after plication right lung. Note focal improvement in microvascular 
“filling”. (C) 1973, before treatment of left bullous emphysema. Microvascular circulation is preserved.
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Fig. 7.—Sequential /e/l pulmonary angiogram. (A) 1967, preoperative showing multifocal lack of 
microvascular pattern. (B) 1968, in which there is progressive multifocal space occupation. (C) 1973
medmstiPn i?s tru c tu [eseft U" g' Ther6 *S contlnumg comPression of residual pulmonary vessels against
1968: pulmonary angiogram improved but 
cinebronchography showed 100% collapse of 
the trachea (the result later achieved by con­
centrating on the management of the pul­
monary change itself would tend to support 
our belief that tracheal support procedures 
are not warranted).6
1969: the patient had pharyngoesophageal 
dysphagia with increasing cough and increasing 
dyspnea.
1969: the patient underwent myotomy and 
gravitational drainage of pharyngoesophageal 
diverticulum.
1970: the situation stabilized. The patient 
was working full time. Physical examination 
showed diminished air entry on the left with
excellent breath sounds throughout the entire 
right lung field.
1973: he had increasing dyspnea with ra­
diologic evidence of increasing changes on the 
left. Left bullectomy with plication and osteo­
plastic thoracoplasty was carried out.
1974: the patient was working full time. 
He felt better than he had for years. Examina­
tion showed the breath sounds on the left 
to be better than those on the right.
1975: the situation was unchanged.
D isc u ssio n
B ran tigan1 • 8 has attem pted surgical salv­
age for patients with multifocal space-
TABLE X.—Surgical Treatment of Emphysema in 39-Year-Old M an*
Measurement
Date
8. 8.67 
23.10.67 
15. 9.67
8. 9.68 
6. 3.69
9. 2.73 
23. 2.73
3. 7.73 
31. 7.74
FVC, ml FEVi, %  M W , l/min MMFR, l/s ml/min-mm Fig
1150 52 15 0.2
Plication of right lung 
1500 47 25 0.2
2050 59 43 0.5
2300 59 37 0.4
2100 43 38 0.32
Plication of left lung — osteoplastic thoracoplasty 
3000 41 55 0.58
3000 45 — 0.5 (V50)
________  0.2 (V25)
4.9
10.8
10.9
9.8
5.4
6.0
8.85
FUco, %
19
24
32
34
19
18
*MMFR = maximum midexpiratory flow rate, Dco 
tional uptake of carbon monoxide, V50 = maximum 
expired flow at 25% vital capacity.
-  carbon monoxide diffusing capacity, FUco = frac- 
expired flow at 50% vital capacity, V25 = maximum
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occupying emphysematous change with an 
identical rationale to that which forms the 
basis for treatment in bullous disease with 
focal accentuation. He used peripheral plica­
tion to reduce the volume of the lung and 
accompanied this procedure with a vagec- 
tomy in an attempt to minimize the cough 
and sputum that prejudices the eventual end 
result. He used the procedure in 17 pa­
tients.0 In this group 6 of 11 remained alive 
and well 3 to 6 years after operation. On 
the other hand, others have suggested that
the poor results obtained when diffuse gen­
eralized change is present contraindicate 
surgical intervention in this group.10' 11 The 
indications for surgical treatment in these 
patients remain to be clarified. However, 
when one can select those with multifocal 
disease who demonstrate space occupation 
and might be expected to be improved by 
re-expansion of compressed normal lung, 
the surgical approach would seem to war­
rant greater consideration.
The fact that subjective improvement can 
be substantiated by objective evaluations in­
dicates that the objectives of surgical treat­
ment are valid. By removing functionless 
space-occupying tissue one may diminish 
the physiologic dead space, improve ventila­
tion and correct local ventilation-perfusion 
abnormalities.
It is essential that fundamental surgical
principles be acknowledged. One must not 
sacrifice potentially worthwhile lung tissue. 
One must “tailor” the relatively good lung 
to fit the hemithorax and where necessary 
“tailor” the hemithorax to fit the maximally
stretched residual lung.
Worthwhile results are more likely when 
space occupation accompanies the avascular 
change in the destroyed lung tissue, provided 
alveolar vascularization can be demonstrated 
in the compressed more normal lung tissue 
and provided obliteration of the hemithorax 
can be ensured in the immediate postopera­
tive period. Similar experience has been 
reported by others.12
Limited resections that preserve all vas­
cularized and potentially functioning lung 
tissue guarantee maximal improvement and 
ensure the best possible chance of avoiding 
life-endangering postoperative complica­
tions, related as they are primarily to bron­
chopleural fistulas and residual pleural 
spaces.
The high incidence of postoperative com­
plications demands careful attention to post­
operative tracheobronchial toilet, myocardial 
support and immediate treatment of mech­
anical complications. Pursuit of these ob­
jectives will avoid the need for tracheostomy, 
although care in a respiratory intensive care 
unit is mandatory.
Within these specific limits it appears that 
surgical treatment has not received the in­
terest it —  and the patient —  deserves.
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TOTAL REPLACEMENT ARTHROPLASTY OF ELBOW IN RHEUMATOID
ARTHRITIS*
D. H. HARDER, MD, FRCS[C] and R. D. BEAUCHAMP, MD
Elbow joints, severely damaged by rheumatoid 
arthritis, have been replaced by a prosthesis 
since 1971. This paper includes a comprehensive 
review of nine such elbow replacements. There 
were no serious complications and pain relief 
was the most predictable salutory effect. It is 
stressed that this major procedure is done only 
in patients with completely destroyed joints.
Depuis 1971, des articulations du coude grave- 
ment endommagees par le rhumatisme articulaire 
ont ete remplacees par une prothese. Cette 
communication comprend une revue d'ensemble 
de neuf cas de remplacement de I’articulation 
du cr ,e. On n'a observe aucune complication 
rie^se et I’effet benefique le plus previsible 
ie le soulagement de la douleur. On souligne 
fait que cette intervention majeure n'est 
alisee que chez les patients dont les articu- 
ns sont completement detruites.
Su r g ic a l  treatment for the stiff, painful and 
frequently unstable elbow has been ad­
vocated for many years.1-3 Historically, ar­
throplasty generally included excision, or 
interposition of fascia or synthetic mate­
rials.1 When the joint was involved in 
rheumatoid arthritis, synovectomy alone or 
with debridement and excision of the radial 
head was common.2 4 This is still consid­
ered the operation of choice where the dis­
ease is unremitting and the joint can still 
be salvaged. Frequently the only surgical 
treatment for an unstable elbow joint has 
been arthrodesis.
While relief from pain is predictable with 
a solid arthrodesis, polyarticular involve­
ment by rheumatoid arthritis results in fur­
ther reduction of mobility of the upper limb, 
and elbow joint fusion was believed unsa­
tisfactory. Pursuit of a surgical technique 
that gives stability and relief from pain 
without loss of range of motion is therefore 
reasonable.5
*From the department of orthopedic surgery, 
Royal Columbian Hospital and the division of 
orthopedic surgery, University of British Columbia, 
Vancouver, BC.
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M a t e r ia l s  a n d  M e t h o d s
Six patients (five women, one man) were 
selected for total joint replacement. Their 
ages ranged from 47 to 70 years. All suf­
fered from long-standing polyarticular rheu­
matoid arthritis; all patients had painful 
elbows and loss of mobility. In all, radio­
graphy demonstrated severe destruction of 
elbow-joint architecture (Fig. 1). A long 
period of drug and physical therapy pre­
ceded surgery in all cases.
Nine elbows (five right and four left) 
were replaced. Seven McKee (London Splint 
Co. Ltd., London, England) and two Schlein 
(Howmedica, Inc, Rutherford, NJ) pros- 
theses were used. Both units are stable hinges 
when articulated. The principal differences 
are that the Schlein model is equipped with 
a humeral articulating surface of high-densi­
ty polyethylene and has a built-in carrying 
angle in its ulnar component. It was there­
fore considered superior to the metal on 
metal articulating McKee implant; when the 
Schlein prosthesis became available, our 
group found it preferable.
The surgical approach was posterior with 
a long curvilinear incision. Wide exposure 
of the entire elbow was gained by incision 
of myofascia along each side of the triceps 
tendon and onto the ulna, allowing elevation 
of a sturdy, thick flap on both medial and 
lateral sides. These flaps included collateral
Fig. I.—Preoperative radiograph showing typical 
gross architectural destruction of elbow joint from 
rheumatoid arthritis.
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ligaments and common flexor and extensor 
tendons. The triceps tendon remained intact. 
The ulnar nerve was transposed. Thorough 
synovectomy and debridement were carried 
out and the radial head was excised. Bone 
preparation and insertion of components fol­
lowed the prescribed techniques in the prod­
uct literature (Fig. 2).
Sodium cephalothin (Keflin) was used as 
a prophylactic antibiotic during the opera­
tion and for 6 days after. Suction drains 
were removed after 2 days and at 6 days 
active movement was begun.
R esults
All patients were subjected to serial 
evaluations; the interval from operation to 
final assessment ranged from 2 to 30 
months. No serious complications were en­
countered.
Immediate active flexion of 90° was al­
most always possible when first attempted 
at 6 days. Ninety percent of the final range 
of flexion was present 2 to 3 months after 
the operation. No elbow instability or 
loosening of components was noted.
All elbows moved through a greater range 
of flexion than they did preoperatively (Fig. 
3). Rotation was minimally improved (Figs. 
4 and 5); it was our impression that further
Fig. 2.—Postoperative radiograph showing pros­
thesis in position after debridement of elbow and 
excision of radial head.
improvement in rotation was prevented by 
pain at the distal radioulnar joint. Flexion 
contractures were improved in every case 
(Fig. 6).
The most pleasing result was the relief 
from pain. All patients but one were en­
tirely free from pain or experienced only
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occasional pain. After recovery from the 
immediate effects of the operation, pain, 
when present, did not impair function. One 
patient continued to complain of pain about 
the lateral aspect of the olecranon.
C o m p l ic a t io n s
There were no clinically apparent infec­
tions. One small flap sloughed; this was 
satisfactorily managed by secondary closure. 
Two subcutaneous hematomas cleared spon­
taneously.
Ulnar paresthesias occurred in the hands 
of four patients postoperatively; nerve 
studies showed a conduction delay in two 
patients at the elbow. By the time of final 
examination these symptoms had disap­
peared.
D isc u ssio n
The continuing pain in one patient was 
disturbing; no explanation for it could be 
found. Occult infection, loosening and bony 
impingement due to inadequate bone re­
moval were considered but were not con­
firmed. Arthrography was not helpful.
Various factors could theoretically result 
in ulnar nerve paresthesias. These include 
compromise of the blood supply to the 
nerve. This could in turn be the result of 
the vasculitis associated with rheumatoid
arthritis or the trauma related to extensive 
manipulation of the nerve during the pro­
cedure. In addition thermal damage during 
methylmethacrylate polymerization could 
perhaps have occurred. Fortunately this 
complication was transient in our patients.
C o n c l u sio n s
The early results of hinge arthroplasty 
of severely destroyed elbows due to rheuma­
toid arthritis were good in all but one of the 
nine procedures carried out.
Replacement of the elbow joint in 
rheumatoid arthritis should be considered 
radical and reserved only for severely dam­
aged joints where all other reasonable meas­
ures have failed. Failure of total replacement 
of the elbow would result at best in a fused 
elbow with a shortened upper limb.
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PEPSIN AND ACID SECRETIONS DURING AND AFTER GASTRIC 
OPERATIONS IN PATIENTS WITH DUODENAL ULCER*
YUKIO NAGAMACHI, MD, PhD and STANLEY C. SKORYNA, MD, MSc, PhD, FACS
Measurement of gastric pepsin and acid secre­
tion was performed before, during and after 
selective vagotomy with antrectomy (SVA) and 
Billroth I gastrectomy (B-l) in 20 patients with 
a duodenal ulcer. Preoperative pepsin concentra­
tion increased during operation and decreased 
gradually 72 hours after SVA and 1 to 3 months 
after B-l. Although the pepsin concentration 
decreased substantially, it was never less than 
70% of the preoperative level in both groups. 
Acid concentration decreased immediately after 
vagotomy in the SVA group and decreased grad­
ually after 72 hours in the B-l group. Although 
there was a notable increase in the pH in both 
groups after operation, a pH of 5 was never 
reached. Decrease in gastric secretory volume 
(about 50%) was approximately equal in both 
groups. It appears that any increase in acid 
secretion occurring after vagotomy or gas­
trectomy may be sufficient to activate highl­
and low-pH-acting pepsins. Extravagal and extra- 
antral stimulation of gastric pepsin secretion 
after operation should be considered an impor­
tant etiologic factor in the pathogenesis of 
recurrent ulcer.
Des mesures de la pepsine gastrique et de la 
secretion d'acide ont ete effectuees avant, 
pendant et apres une vagotomie selective avec 
ablation des parois de I'antre mastoi'dien (VSA) 
ou une gastrectomie de type Billroth I (B-l) 
chez 20 patients atteints d’ulcere duodenal. La 
concentration preoperatoire de pepsine a 
augmente durant I'operation et s'est abaissee 
graduellement 72 heures apres la VSA et de 
1 a 3 mois apres une B-l. Bien que la concen­
tration de pepsine ait baisse considerablement 
elle n'a jamais ete de moms de 70% des ni- 
veaux preoperatoires chez les deux groupes. 
La concentration d'acide a diminue immediate- 
ment apres la vagotomie dans le groupe VSA 
alors qu elle s’est abaissee graduellement apres 
72 heures chez le groupe B-l. Bien qu'il y ait eu, 
apres I'operation, une augmentation remarqua- 
ble du pH chez les deux groupes, un pH de 5
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n'a jamais ete atteint. La diminution (d'environ 
50%) du volume de secretion gastrique a ete 
approximativement egale chez les deux groupes. 
II semble que toute augmentation de la secre­
tion d'acide qui survient apres la vagotomie ou 
la gastrectomie peut suffire a stimuler les pep- 
sines actives a pH eleves ou faibles. Apres 
I'operation, une stimulation de la secretion de 
pepsine gastrique, d'origine autre que le vague 
ou I’antre mastoidien, devrait etre conside- 
ree comme un facteur etiologique important 
dans la pathogenese d'un ulcere recidivant.
T he etiology of recurrent ulcer after various 
types of gastric operation is not well un­
derstood, although acid secretion is an im­
portant factor. The role of pepsin in the 
etiology of recurrent ulcer has been largely 
overlooked, especially if one considers the 
activity of high-pH-acting pepsins.1"8 It 
has been shown7 that when gastric juice is 
collected in the period of emotional stress 
immediately preceding an operation a sub­
stantial increase in gastric pepsin and acid 
secretion can be observed; this is parti­
cularly true in patients with duodenal ulcer. 
In such patients, the inhibitory effect of 
atropine on gastric secretion was found to 
be less pronounced than that in resting 
patients under no emotional stress.7 In this 
paper the results of studies on gastric pepsin 
and acid secretions before, during and after 
various gastric operations in patients with 
duodenal ulcer are reported.
Materials and M ethods
Twenty patients with chronic duodenal 
ulcer were studied; the duration of symptoms 
before operation was 2 years or more in all 
cases. Gastric pepsin and acid secretions 
were measured before, during and after 
selective vagotomy with antrectomy (SVA) 
and Billroth I gastrectomy (B-I). All opera­
tions were performed under general anesthe­
sia with a 50% nitrous oxide-oxygen mix­
ture (6 //min) and methoxyflurane (0.5 to 
1%). On the day of operation, each patient 
received atropine sulfate (0.2 to 0.5 mg) and 
meperidine (35 to 50 mg) as premedication; 
Ringer’s lactate solution (average, 500 ml 
in 30 to 60 min) was administered intra-
240 THE CANADIAN JOURNAL OF SURGERY Vol. 20
venously following the premedication. In 
each patient a nasogastric tube was inserted 
and, starting 30 minutes before operation, 
specimens of gastric juice were obtained at 
30-minute intervals. A final sample was 
taken 30 minutes after operation. Similar 
specimens of gastric juice were obtained at 
24, 48 and 72 hours after operation. In 
most cases a sample of gastric secretion was 
also obtained 1 to 3 months after the pro­
cedure. For the determination of pepsin, 
proteolytic activity was assayed at pH 2.0, 
using bovine hemoglobin solution containing 
2.5 g/dl of protein as substrate; the method 
described by Bucher, Grossman and Ivy8 
was used. Gastric acidity was measured by 
titration to 6.8 with 0.1 N sodium hydro­
xide of gastric aspirates; pH was measured 
by standard spectrophotometric methods.
R e s u l t s
Effects of SVA on Gastric Secretion
Preoperative secretory volume remained 
unchanged during operation but decreased 
immediately after the operation to 14.8 ±
I . 3 m l/30 min; it decreased further to
I I .  0 ±  0.9 ml/30 min after 1 to 3 months 
(Table I). Preoperative pepsin concentra­
tion increased during operation to 195 ±  
41 PUHbx l 0 4/ml* and increased further
‘"The clinical unit of peptic activity. The number 
of pepsin activity units corresponding to the 
colour value of digestion products in 5 ml of 
digestion filtrate read off from the curve set forth 
in the report of Anson (J Gen Physiol 22: 79, 
1938).
after 48 hours; values then decreased gradu­
ally to 68 ±  2 PUHbx lOVml at 72 hours. 
The mean percentage increase in pepsin con­
centration in the first 30 minutes after skin 
incision was 45% within 30 minutes; after 
selective vagotomy a further increase to 95 % 
was observed. The increase in pepsin concen­
tration lasted for 48 hours. Preoperative pH 
of gastric contents increased to 3.57 ±  0.43 
within 30 minutes after SVA; the increase 
was more pronounced after 48 hours. High­
er pH values were recorded up to 3 months 
after operation. The preoperative concen­
tration of hydrochloric acid decreased im­
mediately after vagotomy to 14 ±  3 mmol//. 
A similar pattern of changes in gastric 
pepsin output and acid output were observed 
(Table II).
Effects of B-I on
Gastric Secretion
Preoperative secretory volume remained 
unchanged during the procedure and di­
minished at 30 minutes after B-I to 
13.6 ±  1.8 ml/30 min (Table III). After 1 
to 3 months a mean value of 12.8 ±  1.7 
ml/30 min was observed. Preoperative 
pepsin concentration increased during op­
eration to 223 ± 1 6  PUHb x 104/ml. This 
increase continued 48 hours after B-I de­
creasing gradually to 114 ± 9  PUHbx l0 /m l 
after 1 to 3 months. The mean increase 
in pepsin concentration during the first 30 
minutes after skin incision was 42%. This 
increase continued 24 hours after comple-
TABLE I.—E ffects of Selective Vagotomy with Antrectomy (SVA) on Gastric Secretory Volume, Pepsin and Acid Concentration and
pH of Gastric Contents in 10 P atients*
Before
operation
D u rin g  operation A fte r  operation
A t  start A t  end 24  h 48 h 72 h 1-3 m o
Gastric secretory 
volume, ml/30 m in........ 22.0 db 2.1 26.4 ±  3.0 14.8 ±  1.3b 13.1 ±  l . l b 13.0 ±  0.8b 11.3 ±  1.0b 11.0 ±  0.9b
Pepsin concentration, 
PUHb X lOV m l..............
NS P < 0.001 P  <  0.001 P <  0.001 P  <  0.001 P <  0 001
100 ±  5 145 ±  19* 195 ±  41* 157 ±  21* 207 ±  46* 68 ±  2b 83 ±  3b
Acid concentration, 
m m ol//............................. 51 ±  6
P <  0.05 
51 ±  7
P  <  0.05 
14 ±  3b
P  <  0.05 
17 ±  3b
P  <  0.05 
21 ±  4b
P  <  0.05 
15 ±  4b
P <  0.01 
13 ±  l b
pH of gastric contents. .. 2.07 ± 0 .1 1
NS
1.96 ±  0.12
P  <  0.001 
3.57 ±  0.43*
P  <  0.001 
3.60 ±  0.62*
P <  0.001 
4.79 ±  0.68*
P  <  0.001 
4.64 <  0.41*
P < 0.001 
4.37 ±  0 55*NS P  <  0.01 P  <  0.005 P  <  0.005 P <  0.001 P <  0.001
‘Values are mean ±  SEM, • =  significant increase, b = significant decrease.
TABLE II.—Effects of SVA on G astric Pepsin and Acid Output in 10 P atients*
B efore
operation
D u rin g  operation A fte r  operation
A t  start A t  end 24  h 48 h 72  h 1-3 m o
Pepsin output,
PUHb X 10V30 min . 2320 ±  233 4595 ±  180* 2865 ±  85* 2045 ±  352 2690 ±  60* 1148 ±  66b 919 ±  123b
Acid output,
P <  0.001 P  <  0.001 NS P  <  0.001 P  <  0.001 P  <  0.001
mmol/30 m in .................. 1.12 ±  0.26 1.45 ±  0.24 0.19 ±  0.02b 0.23 ±  0.03b 0.27 ±  0.04b 0.20 ±  0.01b 0.14 ±  0.02bNS P  <  0.001 P <  0.001 P  <  0.001 P <  0.001 P  < 0.001
‘Values are mean ±  SEM, » = significant increase, b = significant decrease.
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tion of the operation and still further 48 
hours after operation. Preoperative pH in­
creased to 2.73 ±  0.56 at the end of B-I. 
This was followed by a still greater increase 
at 72 hours. Preoperative acid concentra­
tion decreased gradually to 15 ±  3 mmol// 
after 72 hours. Preoperative gastric pepsin 
output changed little during the operation 
and up to 48 hours; then it decreased to 
1289 ±  121 PUHb x 10V30 min at 72 hours 
(Table IV). The change in acid output was 
similar to that observed with acid concentra­
tion (Tables III and IV).
D iscussion
In both groups of patients with duodenal 
ulcer, gastric pepsin concentration was rela­
tively higher just before operation in spite of 
the administration of premedication. Previ­
ous work by one of us7 showed that emo­
tional factors such as those associated with 
expectation of an operation are capable of 
increasing the gastric pepsin levels and, to 
a lesser degree, gastric acid levels in patients 
with duodenal ulcer. Plasma concentrations 
of 11-hydroxycorticosteroids were found to 
increase moderately during the preoperative 
period although no such increase was ob­
served in resting patients with a duodenal 
ulcer.7 Oyama and associates9 showed that 
this preoperative increase of corticosteroids 
cannot be attributed to the effects of anes­
thesia. A further increase in pepsin secretion 
can be observed immediately after abdo­
minal incision in both groups of patients.
After selective vagotomy and antrectomy 
the acid secretion decreased instantly while 
gastric pepsin secretion decreased gradually 
to approximately 50% of the preoperative 
level after 72 hours. Following a B-I the 
gastric acid secretion decreased at a slower 
rate than after SVA. The reduction in the 
gastric pepsin level was similar after either 
B-I or SVA. During operation, a significant 
increase in pepsin concentration was ob­
served in both groups; this probably is the 
result of physical stress. Laparotomy (phy­
sical stress) under general anesthesia also 
causes a significant increase in plasma corti­
costeroids.7- 9 It appears therefore that in 
patients with duodenal ulcer increased plas­
ma corticosteroid values parallel the gastric 
pepsin secretion during and after laparo­
tomy.
The increase of pepsin concentration in 
gastric contents during and after operation 
may be due to the use of methoxyflurane as 
an anesthetic agent; this may be related to a 
sympatheticomimetic effect of methoxy­
flurane acting through hypothalamic-pitui- 
tary-adrenal axis.10 Since this increase 
continues for at least 48 to 72 hours it 
cannot be attributed to a direct action of the 
anesthetic agent on gastric mucosa. The ef­
fect of methoxyflurane on the pH of gastric 
contents can be considered beneficial since 
it was also observed in patients not under­
going gastric operation. However, the in­
crease in gastric pH is much more pro­
nounced when SVA or a B-I is performed.
TABLE I I I —E ffects of B illroth I G astrectomy (B-I) on G astric Secretory Volume, Pepsin  and Acid Concentration, and pH of Gastric
Contents in  10 P atients*
B efore
operation
D uring  operation A fte r  operation
A t  start A t  end 24 h 4 8  h 7 2  h 1 -3  m o
Gastric secretory 
volume, ml/30 mi n . . . 24.6 ±  3.5 21.0 ±  2.1 
NS
13.6 ±  1.8b 
P <  0.001
14.5 ±  1.9b 
P <  0.001
12.4 db 2.2b 
P  <  0.001
10.3 ±  1.5b 
P  <  0.001
12.8 ±  1.7b 
P  <  0.001
Pepsin concentration, 
PUHb X lOV m l............ 157 ±  18 184 ±  23 
NS
223 ±  16* 
P  <  0.005
206 ±  20* 
P <  0.05
215 = t 21* 
P  <  0.05
166 db 28 
NS
114 ±  9b 
P  <  0.01
Acid concentration, 
m m ol//............................ 57 ±  7 52 ±  5 
NS
41 db 6b 
P <  0.05
33 db 3b 
P  <  0.001
29 =b 5» 
P  <  0.001
15 ±  3b 
P  <  0.001
24 ±  3b 
P  <  0.001
pH of gastric contents . 1.77 db 0.06 1.76 ±  0.15 
NS
2.73 ±  0.56 
NS
4.13 ±  0.59* 
P  <  0.005
4.41 ±  0.02* 
P  <  0.001
4.28 ±  0.15* 
P  <  0.001
4.26 db 0.32* 
P <  0.001
♦Values are mean ±  SEM, • =  significant increase, b = significant decrease.
TABLE IV.—E ffects of B-I on P epsin and Acid Output in  10 P atients*
Before
operation
D uring  operation A fte r  opera tion
A t  start A t  end 24 h 4 8  h 7 2  h 1-3  m o
Pepsin output,
PUHb X 104/30 m in.. . 3892 ±  439 3723 ±  556 
NS
3113 ±  483 
NS
3271 ±  580 
NS
2740 ±  497 
NS
1289 ±  12l b 
P  <  0.001
1380 ±  124b 
P <  0.001
Acid output,
mm ol/30m in............ 1.58 ±  0.29 1.03 ±  0.14 
NS
0.56 db 0.14b 
P <  0.001
0.48 ±  0.1 l b 
P <  0.001
0.36 ±  0.12b 
P  <  0.001
0.15 =b 0.03b 
P  <  0.001
0.31 =fc 0.04b 
P  <  0.001
♦Values are mean ±  SEM, b = significant decrease.
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Christensen and Skovsted11 observed a 
similar effect of methoxyflurane on the pH 
of gastric content. It is interesting to note 
that cyclopropane does not have a similar 
effect.11 The precise mechanism by which 
emotional or physical stress affects the 
ulcerogenesis is not clear, but the role of 
extravagal and extra-antral control mech­
anisms of pepsin secretion seems to be im­
portant.7’ 10
Vagotomy with antrectomy is generally 
considered an effective method to eliminate 
both the cephalic and the antral phase of 
gastric acid secretion in patients with duode­
nal ulcer.1214 Stern and Walsh1"’ sug­
gested that vagotomy increases basal and 
postprandial concentrations of serum gas­
trin; food entering the duodenum is capable 
of stimulating gastrin release after the an­
trum has been resected. It is likely that the 
increase in concentration of serum gastrin 
after feeding in B-I patients is caused by a 
release of duodenal gastrin. Isenberg and 
colleagues16 observed that patients with 
duodenal ulcer are more sensitive to low 
doses of gastrin. It is well known that the 
effect of pH on proteolytic activity varies 
from about 1.8 to 5.6.4 During the con­
version process to pepsin, which begins at a 
PH of less 5, several basic peptides are 
released from the zymogen molecules.6 Re­
latively greater pH values after SVA or 
B-I were recorded in our patients; however, 
a pH of 5 was not reached in either group.
C o n c l u s io n s
Decreased gastric acid concentration was 
observed in patients immediately after SVA 
or B-I. Values of less than 5 for the pH of 
gastric content may be sufficient to activate 
high-pH-acting pepsins; this can result in 
reulceration or a recurrence of symptoms. 
Extravagal and extra-antral stimulation of 
gastric pepsin secretion may be related to 
emotional or physical stress; these factors 
should not be overlooked in patients with 
duodenal ulcer and should be considered as 
an etiologic factor in patients with recurrent 
ulcer. Other factors should also be con­
sidered; these include the effects of systemic 
corticosteroids, which may alter gastric 
secretion by increasing cyclic adenosine-3', 
5'-monophosphate.17
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SIGNIFICANCE OF UNILATERAL DIMINISHED ACTIVITY IN
RENAL SCANNING*
K. GOPINATHA RAO, MS, FRCS, FRCS[C], FA C Sf and V. J. SHARPE, MD, FRCP[C]t
Renal scanning is an important diagnostic aid in 
assessing kidney function; the authors have 
attempted to correlate the results of renal scan­
ning with the findings from intravenous pyelo­
graphy and the final diagnosis. In non-mass 
lesions of the kidney the renal scan correlated 
well with the intravenous pyelogram and the 
final diagnosis. In mass lesions, a diminished 
uptake of isotope corresponding to the site of 
the lesion seen on the intravenous pyelogram 
was suggestive of a cyst; diminished uptake of 
isotope in the whole kidney including the mass 
lesion on the renal scan was suggestive of renal 
carcinoma. Review of the literature showed only 
one previous reference to such an observation.
La scintigraphie renale est un important procede 
de diagnostic pour 1'evaluation de la fonction re­
nale; les auteurs ont tente d'etablir une corre­
lation entre les resultats de la scintigraphie re­
nale, ceux de la pyelographie intraveineuse et le 
diagnostic final. Dans les cas de lesions non 
tumorales du rein, la scintigraphie renale a pre­
sente une bonne correlation avec le pyelo- 
gramme intraveineux et le diagnostic final. Dans 
les cas de tumeurs, une diminution de la fixa­
tion de I'isotope dans tous le rein, y compris 
dans la masse tumorale, est un indice de carci- 
nome renal. Une revue de la litterature n'a re- 
vele qu'une seule reference anterieure a une 
telle observation.
R e n a l  scanning was first introduced as a 
diagnostic aid by McAfee and Wagner1 in 
1960. Since then the quality of the scan has 
improved remarkably; this improvement is 
due to the use of better radiopharmaceuticals 
and improved collimation and photoscan­
ning instrumentation. Though the renal 
scan is still used as an adjuvant to the 
more conventional methods of diagnosis, 
such as excretory pyelography, retrograde 
pyelography, nephrotomography and selec-
*From the departments of urology and nuclear 
medicine, Brandon General Hospital, Brandon, 
Man.
•(•Department of urology, Brandon General Hos­
pital.
iDirector, department of nuclear medicine, Bran­
don General Hospital.
Reprint requests to: Dr; K. G. Rao, Box 280, 
Brandon Clinic, Brandon, Man. R7A 5Z2.
tive renal arteriograms, it has become an 
important diagnostic aid in patients with 
suspected renal disease. Renal scanning is 
simple to perform and in this sense may be 
considered superior to excretory pyelogra­
phy; coupled with a dynamic perfusion 
study, the clinician can obtain all the infor­
mation required concerning the size, confi­
guration, position and function of the kid­
neys.
In this study we attempted to correlate 
unilateral diminished activity in a localized 
area or generalized throughout the kidney 
with the results of intravenous pyelography 
and the final diagnosis.
M a t er ia l  a n d  M e t h o d s
During a 3-year period Jan. 1, 1972 to 
Dec. 31, 1974, 90 renal scans were per­
formed at the nuclear medicine department 
of the Brandon General Hospital. The pa­
tients ranged in age from 12 to 90 years. 
Excretory pyelography was performed on all 
patients before renal scanning; retrograde 
pyelography and angiography were done on 
selected patients. Rectilinear scanning was 
performed 4 to 16 hours after the injection 
of 400 fiC i of mercury-197. Scanning was 
done with the patient in a prone position; 
a very low energy 55-hole collimater (7.5 
cm focus and 12.5 cm diameter) was placed 
close to the skin. When a lesion was sus­
pected on radiologic or other grounds and 
the prone scan findings appeared normal or 
indefinite, the prone scan was repeated. 
Oblique scans were not performed. Com­
parisons of the activity of the two kidneys 
were made visually and were not expressed 
as a renal ratio. In 25 cases unilateral 
diminished activity was found on renal 
scanning.
In this series 10 patients had mass lesions 
of the kidney. The results of the scanning 
were graded such that a normal scan was 
scored zero, an area of diminished or ab­
sent radioactivity corresponding to the site of 
the tumour was scored +  and termed a scan 
defect, while a similar scan together with a
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TABLE I —Summary of Investigations and D iagnostic F indings in 10 Patients with M ass Lesions
of the K idney
Patient
no.
Age,
yr Sex
Intravenous
pyelography
Rerial
scanning
Retrograde
pyelography Arteriography Confirmation Histopathology
i 59 M + T- + + Not possible Operation Clear cell adeno­
carcinoma
2 63 F + +  + + +  + Operation Clear cell adeno­
carcinoma
3 61 M +  + +  + +  + + Operation Transitional cell 
carcinoma
4 73 M + +  + + Not done Operation Papillary adeno­
carcinoma
5 37 M 0 +  + Not done 0 Autopsy Clear cell adeno­
carcinoma
6 85 F +  + +  + Not done Not done None ? adenocarcinoma
7 69 M 0 +  + 0 0 Operation Benign cyst
8 72 M +  + + Not done +  + Cyst puncture Benign cyst
9 63 M +  + + Not done Not possible Cyst puncture Benign cyst
10 84 M +  + + Not done Not done None ? benign cyst
0 =  no abnormality; +  = abnormality; + +  = abnormality highly suggestive of diagnosis.
reduced amount of isotope in the remnant 
was scored +  + . The radiologic investiga­
tions were graded 0 if there was no ab­
normality, +  if there was an abnormality 
and + +  if they were highly suggestive of 
the final diagnosis (Table I).
R esults
The final diagnosis was based on the 
operative or autopsy findings; in some 
cases clinical and radiologic evidence was 
also considered (Table II).
Seven cases of complete unilateral in­
activity on renal scan were recorded; these 
correlated with complete inactivity in the 
intravenous pyelogram on the same side. Of 
these seven patients, three were later proved 
by selective renal arteriography to have non­
functioning kidneys due to renal artery 
stenosis. Three patients had congenital ab­
sence of the kidney. One patient had crossed 
ectopia of the kidneys; this finding was con­
firmed on intravenous pyelography.
TABLE II.—D iagnosis of Patients with Uni­
lateral D iminished Activity on Renal Scan
No. of
Lesion patients
Congenital absence of kidney.........  3
Nonfunction due to renal artery
stenosis............................................ 3
Crossed ectopia................................. 1
Renal hypoplasia..............................  2
Renal contusion................................  1
Benign renal cysts............................  4
Hydronephrosis................................. 5
Renal carcinoma *............................  6*
* Adenocarcinoma in 5, transitional cell carcinoma 
in 1.
Two patients with unilateral diminished 
activity in a small kidney were diagnosed as 
having hypoplastic kidneys; one was a con­
genital lesion and the other may have been 
the result of trauma to the kidney that the 
patient had sustained 4 years earlier. These 
findings correlated with the presence of a 
small, poorly functioning kidney on in­
travenous pyelography.
Four cases of segmental diminished activ­
ity in a normal-sized kidney were recorded. 
In these instances the remaining kidney 
showed no diminution of activity compared 
to the opposite side. Again a corresponding 
lesion was demonstrated on intravenous 
pyelography. One was diagnosed as a con­
tusion of the lower pole of the kidney; this 
was confirmed by selective renal arterio­
graphy. The other three patients were 
diagnosed as having renal cysts. Two were 
proved by a puncture of the cyst; the third 
patient was not subjected to further di­
agnostic testing because of his poor general 
condition.
In the remaining 12 patients there was 
generalized diminished activity in the whole 
of the affected kidney on the renal scan 
compared with the opposite kidney. Five of 
the scans could be correlated with the find­
ings in the corresponding excretory uro­
grams and a diagnosis of hydronephrosis 
could be made; in three patients the 
destroyed hydronephrotic kidney was re­
moved, while in one patient a pyeloplasty 
was done. In one patient the hydronephrosis 
was secondary to benign prostatic hyper­
trophy and a prostatectomy was performed.
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Fig. la
Fig. 2b
Fig. lb
Fig. 1.—(a) Intravenous pyelography demon­strates normal right kidney and good functioning left kidney with space-occupying lesion in upper pole, (b) Renal scan of same patient showing normal right kidney and markedly diminished activity over entire left kidney. Adenocarcinoma was found at operation.
The remaining seven scans were particularly 
interesting for various reasons. In all of 
these cases the renal scan showed generalized 
inactivity over the whole kidney and the 
changes were greater than those seen on 
intravenous pyelography. In five of these 
patients the intravenous pyelogram showed 
evidence of a mass lesion confined to a 
segment of the kidney and the remnant of 
the kidney showed good function. In two 
patients the intravenous pyelogram ap­
peared normal (Fig. 1) though in one of 
them tomography showed a space-occupying 
lesion in the upper pole of the kidney 
(Fig. 2). But in all the seven patients the
Fig. 2c
Fig. 2.—(a) Nephrotomography shows normal right kidney and functioning left kidney with space-occupying lesion in upper pole, (b) Renal scan of same patient shows normal right kidney and diminished activity of left kidney limited to area of space-occupying lesion, (c) Puncture of smoothly outlined lesion in left kidney of same patient confirmed presence of cyst.
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scan showed diminshed activity not only 
in the area corresponding to the mass lesion, 
but also in the remnant of the kidney. The 
final diagnosis in five of these patients was 
proved to be adenocarcinoma, while one was 
a transitional cell carcinoma of the kidney. 
In the seventh patient, operation revealed 
that the mass lesion was a solitary cyst 
occupying the middle third of the kidney.
D isc u ssio n
In this series, it was evident that an area 
of absent or diminished uptake of isotope in 
a segment of kidney together with di­
minished concentration of isotope within 
the remnant of the kidney was highly sug­
gestive of renal carcinoma. This occurred in 
six patients. In another patient with similar 
findings, however, only a benign cyst was 
found at operation. In three other patients a 
localized scan defect was found; isotope 
concentration in the remnant was normal. 
These patients had benign renal cysts. There 
was no patient with a mass lesion whose 
scan showed complete absence of isotope 
uptake.
Morris and colleagues2 in a study of 22 
proven cases of carcinoma of the kidney 
found 11 patients in whom renal scanning 
demonstrated an area of greatly diminished 
isotope uptake associated with diminished 
concentration of the isotope within the 
remnant of the kidney. Maynard3 found 
the same phenomenon in cases of bron­
chogenic carcinoma; this was especially com­
mon in the more centrally placed lesions. 
The etiology of these findings in carcinoma 
of the kidney is not always apparent. The 
reduction in the amount of isotope uptake 
in the remnant could be caused by obstruc­
tive uropathy, venous stasis, lymphatic ob­
struction, interference with the arterial
blood supply (by obstruction or spasm), or 
by the direct toxic effects of the neoplasm. 
In addition pressure of the mass lesion could 
also interfere with the internal vasculature 
of the kidney. There is good reason to 
accept the explanation of interference with 
the internal vasculature since in one patient 
in our series, the renal scan findings were 
compatible with carcinoma. At operation a 
nonmalignant cyst was removed; a repeat 
renal scan following excision of the cyst 
showed a markedly improved uptake of iso­
tope in the remnant of the kidney compared 
with the preoperative renal scan.
C o n c l u sio n s
We believe that unilateral diminished 
activity in the renal scan is of great im­
portance. In non-mass lesions of the kidney, 
renal scanning correlated well with ex­
cretory urography and helped the physician 
decide on the future course of treatment. In 
mass lesions of the kidney, when renal scan­
ning demonstrated diminished activity 
localized to the area of the soft-tissue mass 
as seen on excretory pyelography, these 
findings were suggestive of a cyst. If more 
changes are seen on renal scanning than on 
intravenous pyelography with a generalized 
diminished uptake of the isotope in the re­
maining kidney tissue as well, then carci­
noma of the kidney must be considered very 
likely.
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COMPARISON OF CRYOTHERAPY AND SURGERY 
FOR TREATMENT OF SPONTANEOUS MOUSE TUMOUR*
D. M. GRACE, MD, FRCS[C]
Spontaneous mammary adenocarcinoma was 
implanted subcutaneously into the flank or leg 
of inbred C3H/HeJ mice. Excision or cryo­
therapy of flank tumours was followed by cure 
in 47 and 52%  respectively. Amputation or cryo­
therapy of tumours of the hind leg resulted in a 
cure in 70%  for each method.
Rechallenge of surviving mice resulted in 
initial delay of growth in mice treated by cryo­
therapy, but final host acceptance and survival 
were the same for each method of treatment. 
The tumour was grown in tissue culture; signifi­
cant antibody levels after cryotherapy could not 
be detected by a mixed antiglobulin technique. 
It is concluded that cryotherapy can destroy the 
tumour, but this method offers little immunolo­
gic advance for weakly antigenic tumours. Care­
ful monitoring of temperature is essential for 
successful cryotherapy. In the same series of 
experiments barbiturate anesthesia and tumour 
exploration did not alter tumour growth or 
mortality.
Un adenocarcinome mammaire spontane a ete 
greffe par voie sous-cutanee dans le flanc ou 
la patte de souris de la lignee consanguine 
C3H/HeJ. L'excision et la cryotherapie des tu- 
meurs du flanc ont entraine une guerison chez 
respectivement 47 et 52% des animaux. L'am- 
putation et la cryotherapie des tumeurs de la 
patte posterieure ont toute deux produit, un 
taux de guerison de 70%.
Chez les souris survivantes, une seconde 
greffe a ete suivie d'un delai de la croissance 
initiale chez les animaux traites par cryothe­
rapie mais la prise finale de la greffe et la 
survie ont ete les memes pour chaque methode 
de traitement. La tumeur a ete maintenu en 
culture de tissu; apres cryotherapie, on n'a pu 
deceler le taux significatifs d'anticorps par une 
technique d'antiglobulines mixtes. On conclut 
que la cryotherapie peut detruire la tumeur 
mais qu'elle offre peu d'avantage sur le plan 
immunologique contre les tumeurs faiblement 
antigeniques. Une surveillance precise de la 
temperature est essentielle au succes de la
*From the department of surgery, University 
Hospital and University of Western Ontario, Lon­
don, Ont.
Reprint requests to: Dr. D. M. Grace, Department 
of surgery, University Hospital, London, Ont. 
N6A 5A5.
cryotherapie. Dans cette meme serie d'expe- 
riences, I'anesthesie aux barbituriques et I'ex- 
ploration de la tumeur n'ont pas affecte la 
croissance tumorale et la mortalite.
C r y o t h e r a p y  is a means of controlled cell 
destruction by freezing.1 Liquid nitrogen is 
usually used as the cold source. Cryotherapy 
has been most useful for palliation of ex­
tensive tumours, particularly those of the 
head and neck.-'4 Primary tumours in man, 
especially tumours of the skin have been 
treated by this technique, although the local 
recurrence rate may be higher than that fol­
lowing surgical excision.5 Cryotherapy may 
stimulate the immune response more actively 
than other forms of therapy.0' 7 Many of 
these studies have been carried out in rats 
with the allogenic Walker tumour8- 9 or in 
mice with chemically induced tumours10 12 
and may not be applicable to weakly anti­
genic syngeneic tumours in mice or to ma­
lignant lesions in humans. We wished, there­
fore, to evaluate the effectiveness of cry­
otherapy in treating a weakly antigenic syn­
geneic mouse tumour and to compare this 
treatment with standard surgical excision. 
Because there has been some controversy 
about the effect of anesthesia and operation 
on tumour growth we wished also to com­
pare untreated tumour-bearing mice with 
those tumour-bearing mice subjected to 
anesthesia and exploration without excision 
of the tumour.
M et h o d s
Spontaneous C3HBA mammary adeno­
carcinoma was obtained from Jackson Lab­
oratories, Bar Harbor, ME. This was carried 
in inbred adult female C3H/HeJ mice after 
trocar implantation of about 0.1 mm3 of 
tumour13 and transplanted 2 to 3 weeks 
later. One tumour was used for 10 to 15 
mice. Experiments were carried out in 
transplant generations 6 to 18 in this lab­
oratory. Tumour was injected into the 
dorsal subcutaneous tissues but while the 
gross tumour injected was the same size for 
each mouse, exact cell counts were not ob-
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tained. For the initial experiments tumour 
was injected into the left flank, 1 to 2 
cm from the midline. Later the tumour was 
placed in the subcutaneous tissues on the 
lateral side of the left lower thigh.
Experiments were carried out with 
tumour nodules of about 1 cm. Four mice 
with similar tumours were selected and 
randomly assigned to four groups: control 
(group 1), incision (group 2), excision (group 
3) or cryotherapy (group 4). Group 1 ani­
mals received no further treatment but were 
observed until death. All animals having 
operations or cryotherapy received sodium 
pentobarbital intraperitoneally. In group 2 
mice the area over the flank or leg tumour 
was shaved; the skin was incised, the tumour 
mobilized and the skin closed with a con­
tinuous suture of 4-0 Dexon. In group 3 
the tumour was excised completely with any 
adherent adjacent skin; the skin was closed 
with continuous 4-0 Dexon suture. Leg 
tumours were excised by amputation through 
the proximal thigh after ligation of the 
femoral vessels with 4-0 Dexon sutures; the 
skin was closed with continuous 4-0 Dexon. 
In group 4 the skin was incised and the 
tumour exposed; cryotherapy was carried 
out with a Linde CE-4 unit using the 7.9- 
mm gynecologic probe and with liquid ni­
trogen as the cooling source. The probe 
was applied without pressure to the tumour. 
The tumour was frozen twice so that the 
ice ball completely encompassed the tumour. 
One hour was allowed between each freezing 
procedure for thawing of the tumour and for 
restoration of body temperature. The tem­
perature at the tip of the probe was set at 
-  170°C and, for leg tumours, the tem­
perature was monitored with a needle 
thermocouple; for freezing the flank tumours 
the temperature was not monitored. Tem­
perature was measured through a needle in­
serted 2 mm beyond gross tumour. Freezing 
was not completed until a tissue temperature 
of — 60° was achieved. (To ensure a tem­
perature of -  60°C at the edge of the 
tumour a larger ice ball was necessary than 
visual examination alone would suggest.) 
After completion of the second freezing and 
thawing, the skin was closed with continuous 
4-0 Dexon suture. Animals were isolated 
from each other but were not discarded 
from the study if tumour necrosis developed.
For tissue culture experiments tumour 
was excised at a size of 0.5 to 1 cm. After 
fine mincing with scissors, tissue fragments 
were treated for 30 minutes with a mixture 
of 0.02% ethylenediamine tetra-acetic acid 
(EDTA) and 0.25% trypsin in Hanks’ bal­
anced salt solution at 37°C. Gross frag­
ments were removed by settling for 1 minute, 
and enzymes in the supernatant were neutral­
ized with 10% fetal calf serum. In a 6-cm 
plastic Petri dish, cells (amount, 104) were 
placed with HeLa cells (amount, 106) 
previously subjected to 8000 rads from a 
cobalt-60 source; 11-mm coverglasses were 
also placed in the dish; 5 ml of medium 199 
(Grand Island Biological Company, Grand 
Island, NJ) with 10% fetal calf serum was 
added; kanamycin (50 /ug/ml) and my- 
costatin (40 |Ug/ml) were added to the 
medium. Cells were incubated at 37°C in 
an atmosphere of 5% carbon dioxide in air. 
The medium was changed at 3 days and 
then every other day. Tumour culture was 
established from a single growing colony, 
which remained on a coverglass 2 weeks 
after initial growth and after all irradiated 
HeLa cells had left the glass. Cells were 
grown in the same medium; 5 x 103 cells 
were placed in each Petri dish. Malignant 
potential was confirmed by subcutaneous 
injection of 106 cells in C3H/HeJ mice.
For the mixed antiglobulin experiments 
mouse antiserum to sheep erythrocytes was 
obtained by weekly intraperitoneal injection 
of 1 ml of a 10% solution of sheep eryth­
rocytes in phosphate-buffered saline (PBS). 
Animals were bled out 1 week after the fifth 
injection. Serum was obtained and com­
plement inactivated by heating to 56°C for 
30 minutes. Cell sensitization was a modi­
fication of that described previously.14 (Goat 
antimouse serum was obtained from Grand 
Island Biological Company.) Ten millilitres 
of a 4% solution of sheep erythrocytes in 
Hanks’ balanced salt solution was sensi­
tized with 0.05 ml of mouse antiserum at 
37°C for 30 minutes. After the cells were 
washed three times with PBS, they were 
doubly sensitized with 0.1 ml of goat 
antiserum to mouse serum at 37 °C for 
30 minutes. After a further three washings 
cells were suspended at a final concentra­
tion of 0.5% in Hank’s solution and stored 
a 4°C.
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TABLE I.—Survival of M ice after Injection 
of M ammary Adenocarcinoma
Survivors /  out of total ( and % )
Group Flank Leg
1  ........ 6/33 (18) 1/30 ( 3)
2  ....................  7/30 (23) 0/30 ( 0)
3  ...........................  15/32 (47) 21/30 (70)
4  ...........................  17/33 (52) 21/30 (70)
Growing coverglass cultures of mouse 
tumour cells were incubated for 30 minutes 
in 1 ml of Hanks’ solution in a Salk pattern 
hemagglutination tray. Serum from control 
tumour-bearing mice or those treated by 
excision or cryotherapy was added to give a 
final concentration of 10% in Hanks’ solu­
tion. Serum was collected after 2, 4 and 6 
weeks of tumour growth and 2, 4 and 6 
weeks after tumour treatment. After 30 
minutes’ exposure to serum, the coverglasses 
were washed in PBS and placed in 1 ml of 
0.5% double-sensitized sheep erythrocytes 
that were allowed to settle for 45 minutes at 
20°C. Coverglasses were then rinsed in three 
changes of PBS and stained with Giemsa 
stain. Coverglasses were mounted on glass 
slides with DePeX glue and examined under 
the microscope for adherence of red blood 
cells.
Results
Host acceptance of the transplanted 
mammary adenocarcinoma was 95 to 100% 
in all experiments. The few failures seemed 
to result from failure of the injection tech­
nique rather than from host resistance since 
rechallenge of these animals always resulted 
in acceptance. Tumour grew as a solid 
nodule with some irregularity in rate and 
pattern of growth and a tendency to central 
necrosis, especially in later generations. 
Tumour nodules reached 1 cm in diameter 
in 2 to 3 weeks. Detailed analysis of sur­
vival from initial injection was not cal­
culated but the length of survival after the 
tumour reached 1 cm in diameter ranged 
from 45 ±  5.1 (SEM) days initially to 
41.0 ±  4.38 days in later experiments. 
Death occurred from massive local growth 
and pulmonary metastases. Animals with 
flank or leg tumours 1 cm in diameter who 
were killed showed no evidence of gross 
metastatic tumour.
Results of the treatment of flank and leg 
tumours are shown in Table I. Animals were 
considered to have survived if they were 
alive 100 days after receiving initial treat­
ment. In the early control group of un­
treated animals six survived at 100 days, 
four with slowly growing tumour and two 
without evidence of tumour. Explanation for 
the survival of some of the control mice is 
not clear but tumour necrosis may have 
been a factor. Later generations of the same 
tumour were associated with 97% host 
death within 100 days in untreated animals. 
Anesthesia and exploration of the tumour 
did not affect ultimate survival. Death 
within 24 hours of treatment occurred in 1 
of 32 animals in group 3 and 3 of 33 ani­
mals in group 4. If early deaths are excluded 
then 15 of 31 survived excision and 17 of 
30 survived cryotherapy. Surviving animals 
were all free of gross tumour.
Because of the high rate of local recur­
rence, the site of injection was changed to 
the leg, which could be amputated with the 
tumour. The results are summarized in 
Table I. Animals subjected to anesthesia and 
operation died at an average of 49.7 ±  3.72 
(SEM) days after operation while control 
animals died 41.0 ± 4 .3 8  days after initial 
treatment; the difference was not signifi­
cant. The 100-day survival for each method 
of treatment was 70% and all surviving ani­
mals were free of gross tumour at that time. 
There was one early postoperative death 
in the amputation group and three such 
deaths in the cryotherapy group. Early 
deaths were not excluded from Table I; if 
they are excluded, the survival for amputa­
tion is 21 of 29 (72%) and for cryosurgery 
21 of 27 (78%). Freezing was so ex­
tensive that the treated leg became atrophic 
and of little use.
The spontaneous mammary adenocarci­
noma could be grown in tissue culture only 
once; the pattern of growth showed some 
epithelial and some fibroblastic properties. 
A fibroblast line might have been isolated 
with malignant transformation in vitro, but 
this seems unlikely. Reinjection of 106 
tumour cells into the same host mice 
resulted in tumour growth similar to that 
seen initially and the histologic appearance 
was similar.
With a sensitive mixed antiglobulin tech-
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nique that has been effective in other ex­
periments14 we were unable to demonstrate 
appreciable levels of antibody in either the 
control or treated animals; cryotherapy 
treated animals had no detectable antibody 
to the isolated tumour cells. We had in­
tended to assess cellular immunity by study­
ing the ability of peritoneal cells to suppress 
the growth of the cultured tumour cells, 
but infection in the cell line 2 months after 
isolation resulted in loss of the cells and 
further tumour cell cultures could not be 
established.
Two groups, each containing 13 animals 
were treated for leg tumours successfully by 
amputation or cryotherapy; these animals 
all were reinjected in the left flank with 
0.1-mm:{ fragments of tumour. Tumour 
grew in all animals and mean survival from 
initial injection was 84.7 days for the ampu­
tation group and 97.8 days for the cryo­
therapy group (Fig. 1). Although the final 
proportion of host acceptance and survival 
figures are similar, tumour growth was 
initially suppressed in the animals treated 
previously with cryotherapy. Five weeks 
after this injection the tumour averaged 1.6 
cm in diameter in mice treated surgically 
and 0.8 cm in mice treated by cryotherapy.
D iscussion
The spontaneous mouse mammary adeno­
carcinoma is a syngeneic and weakly anti­
genic tumour that may therefore relate more 
to behaviour of human tumours than to chem­
ically induced mouse tumours or the Walker 
tumour of rats. There were some problems 
with the mammary adenocarcinoma used 
here due to slow or irregular growth and a 
tendency to central necrosis. Initial cryo­
therapy experiments were not promising. 
One problem was the difficulty in localizing 
injected tumour precisely to the sub­
cutaneous tissues. Also, later experiments 
with leg tumours showed that the visual 
assessment of freezing was inadequate. The 
leg experiments show that cryotherapy with 
proper temperature control can be just as 
effective as radical amputation and may be 
less deforming. Some of the local recur­
rences after cryotherapy may have resulted 
from tumour spread about the femur due to 
incomplete freezing of the tumour mass.
Fig. 1.—Survival of C3H/HeJ mice after re­
challenge with mammary adenocarcinoma follow­
ing previous successful treatment by surgery or 
cryotherapy.
Failure to detect antibody after cryo­
therapy may simply be due to the mixed 
antiglobulin technique, although it has 
been successful in other systems. The cul­
tured cells resembled the parent tumour but 
may have had some antigenic differences. 
Cellular immunity may be more important 
than humoral immunity in the inhibition of 
tumour growth; it was especially disap­
pointing that such studies could not be com­
pleted before infection set in and killed the 
tumour culture.
Initial delay in tumour regrowth after 
cryotherapy suggests a weak response, pos­
sibly immunologic. But the survival of mice 
subjected to previous cryotherapy or surgery 
was similar; this points to an ineffective 
response.
We observed a sharply defined cryo­
surgical lesion with little bleeding;15 bone 
may be devitalized but structure is pre­
served.16 Those tumour cells close to blood 
vessels may be protected from freezing; this 
may explain local recurrences. Multiple 
freezing procedures and low temperatures 
are effective in producing tumour cell 
death.11 Cryotherapy of human tumours 
may augment the immune response;6 metas­
tatic tumour has been shown to regress after 
cryotherapy of primary prostatic carcino­
ma,7' 17 but cases are few in number and 
not well documented. Antibody response to 
prostate and other glands has been detected
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after cryotherapy in experimental ani­
mals. 18 ' 20  Rats may be cured of the allo­
geneic Walker tumour by cryotherapy and 
rats that were cured were resistant to re­
challenge with the same tumour. 21 Chemi­
cal or virus-induced tumours in mice may 
also be cured in some cases by cryotherapy, 
but these animals show little if any increase 
in tumour immunity after cryotherapy over 
that achieved by surgery alone. 1 0 ' 1 2 ’ 22 
Also these experiments considered only 
initial tumour growth and did not assess 
host survival.
It appears, therefore, that cryotherapy 
could be used as primary treatment for 
human tumours but that immunologic ad­
vantages are not obvious. The ultimate cos­
metic result achieved with cryotherapy is 
usually good although early edema and dis­
charge do occur. 5 The finding of residual 
tumour after cryotherapy for basal-cell car­
cinoma emphasizes the need for repeated 
freezing and careful temperature monitor­
ing. 5 Among the advantages of cryotherapy 
are the relative absence of hemorrhage and 
pain; the profuse prolonged postoperative 
discharge is a disadvantage, however. Tu­
mour adjacent to major nerves may be 
treated successfully by cryotherapy with 
return of nerve function.8' 23  Experimental 
work has shown that cryotherapy is well 
tolerated by the liver and may be curative 
for hepatic tumour in animals.9’ 24
The experiments reported here show no 
apparent change in tumour growth after 
barbiturate anesthesia and tumour explora­
tion without excision. Operative trauma has 
been reported to increase local growth of tu­
mour25 or increase the number of met- 
astases. 26 Surgical trauma may reduce cell- 
mediated immunity2 7 "29  although the effect 
may be short-lived. 30  The type of anesthesia 
may affect tumour metastases. In rats, ether 
anesthesia may be associated with a greater 
frequency of pulmonary metastases than 
barbiturate anesthesia. 31
We conclude that cryotherapy can com­
pletely destroy a syngeneic mouse mammary 
tumour, but there is little immunologic ad­
vantage over standard surgical excision. No 
levels of antibody to tumour cells were 
detected after cryotherapy. The success of 
cryotherapy is strongly dependent on multi­
ple freezing and careful temperature con­
trol. In this experimental model tumour 
growth was not effected by operative trauma 
and anesthesia alone.
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SECTIONING OF THE PITUITARY 
STALK IN DIABETIC RETINOPATHY
In 1953 Poulsen reported regression o f diabetic 
retinopathy after the development o f Sheehan’s 
syndrome. Pituitary stalk surgery seemed 
therefore a logical procedure for the treatment 
o f diabetic retinopathy. Zimmerman and 
Molnar (M ayo Clin Proc 52: 233, 1977) 
studied the records o f 40 patients treated at 
their centre and reviewed the literature on 
pituitary ablation. They anticipate that a syn­
thetic analogue o f somatostatin with a long 
half-life and without adverse effects on plate­
lets will be developed for the treatment of 
diabetic retinopathy. Meanwhile ablative sur­
gery should be considered for the young sub­
ject with diabetes in the prefibrotic stages of 
florid retinopathy.
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CONGENITAL CYSTIC DILATATION OF THE COMMON BILE DUCT:
REPORT OF TWO CASES*
S. E. O’BRIEN, MD, FRCS[C], FACS and R. WEITEMEYER, BSc, MD
Congenital choledochal cyst is rare and is there­
fore seldom diagnosed preoperatively and is 
often improperly managed. The authors report 
two cases of this condition. In one case the 
diagnosis was confirmed by endoscopic retro­
grade cholangiopancreatography. The etiology 
and clinical features are reviewed. The treat­
ment of choice lies between excision and Roux- 
en-Y choledochocystojejunostomy. For the sur­
geon who encounters the condition only rarely 
the latter procedure is probably safer.
Le kyste congenital du choledoque est une af­
fection rare; de ce fait, il est rarement dia- 
gnostique dans la periode preoperatoire et il 
est souvent traite de mauvaise facon. Les au­
teurs en signalent deux cas. Dans un cas, le 
diagnostic a ete pose grace a la cholangiopan- 
creatographie endoscopique retrograde. L’etio- 
logie et les caracteristiques cliniques de l'af- 
fection sont passees en revue. Le traitement de 
choix se situe entre I’excision et la choledo- 
chocystojejunostomie de Roux-en-Y. Pour le chi- 
rurgien qui ne rencontre cette affection que ra­
rement, la derniere intervention est probable- 
ment la plus sure.
Choledochal cyst (congenital cystic dila­
tation of the common bile duct) is a rare 
anomaly of the biliary tree; few surgeons 
will have the opportunity to manage more 
than one case in their practice and many 
will never encounter the condition. Because 
, of this choledochal cysts are infrequently 
diagnosed preoperatively and, when recog­
nized at operation, are often mismanaged. 
At the time of writing 995 cases have been 
reported in the world literature.1
Experience with two recent cases 
prompted us to review the subject. We were 
unable to find additional cases after review­
ing the records at all four teaching hos­
pitals in Hamilton over the past 10 years.
Case R eports
Case 1 .— A 24-year-old woman presented
*From the department of surgery, McMaster 
University and St. Joseph’s Hospital, Hamilton, 
Ont.
Reprint requests to: Dr. S. E. O’Brien, Depart­
ment of surgery, St. Joseph’s Hospital, 50 Charl­
ton Ave. E, Hamilton, Ont. L8N 1Y2.
with a 4-day history of severe epigastric and 
right upper abdominal pain associated with 
anorexia and nausea. Her past history was un­
remarkable. She gave no history of jaundice, 
chills, or fever. On physical examination there 
was tenderness in the epigastrium and right 
upper quadrant. A positive Murphy’s sign was 
elicited but no mass could be palpated. Labo­
ratory findings included a leukocyte count 
of 9.1 x 109//. Serum bilirubin was within 
normal limits but the serum glutamic oxa­
loacetic transaminase value was 250 mg/dl 
(normal, 50 mg/dl) and alkaline phosphatase 
value was 270 mg/dl (normal, 80 mg/dl).
The provisional diagnosis was acute chole­
cystitis. On two successive cholecystograms the 
gallbladder was not visualized. Laparotomy 
through a right subcostal incision revealed a 
normal gallbladder. However, a large retroperi­
toneal cystic lesion (diameter, 20 cm) was 
found behind the duodenum. When the cyst 
was aspirated with a fine needle, clear bile was 
obtained. The lesion was considered to be a 
choledochal cyst and operative cholangio­
graphy was carried out (Fig. 1). The cyst was 
then opened and its interior explored; normal 
right and left hepatic ducts were identified, 
but the distal opening of the common duct 
was not found. A side-to-side choledochocys- 
toduodenostomy was then carried out using a
Fig. 1.—Case 1. Intraoperative cholangiogram 
demonstrating cystic dilatation of common bile 
duct.
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two-layer anastomosis. The gallbladder was 
left in situ.
The patient’s postoperative course was un­
eventful; she was discharged 10 days after op­
eration.
Four weeks later, the patient was readmitted 
with severe upper abdominal pain; again there 
was no accompanying jaundice, chills, or 
fever. Radiographic investigation revealed a 
well-functioning anastomosis with free reflux 
into the biliary tree. Conversion of her anas­
tomosis to a Roux-en-Y choledochocystojejun- 
ostomy was contemplated, but the patient’s 
symptoms subsided and she has remained well 
for 2Vi years.
Case 2.—An 18-year-old girl experienced an 
attack of severe right upper abdominal pain 1 
month before admission; the pain was relieved 
with Demerol. Another attack of lesser severity 
had occurred 3 months earlier. The patient 
gave no history of jaundice, chills, or fever, 
but passed dark urine a few days before admis­
sion. Functional inquiry revealed some in­
tolerance to fatty food and a bloating sensation 
after meals. The patient’s history was unre­
markable and physical examination was nor­
mal apart from slight tenderness in the right 
upper quadrant. No mass could be palpated 
in the abdomen. Cholecystography revealed 
what appeared to be a double gallbladder 
shadow. Intravenous cholangiography showed 
cystic dilatation of the common and the in- 
trahepatic bile ducts. The diagnosis was 
choledochal cyst. Laboratory studies including 
a complete blood count and sequential mul­
tiple analysis (SMA)/12 were normal. Endo­
scopic retrograde cholangiopancreatography 
(ERCP) was carried out; this further delineated 
the large choledochal cyst and again showed 
intrahepatic ductal dilatation (Fig. 2).
Operation through a right paramedian in­
cision revealed a normal gallbladder. The 
duodenum was displaced forward by a large 
retroperitoneal cystic mass, while the cystic 
duct entered the upper portion of the cyst. 
The gallbladder was removed and found to 
contain soft cholesterol deposits. The duo­
denum was mobilized further to expose the 
large choledochal cyst (diameter, 15 cm) that 
was then opened at its most dependent por­
tion. A segment of the cyst wall was removed 
for histologic examination. As in the previous 
case, the interior of the cyst was explored 
and the right and left hepatic ducts were 
readily entered, but again the distal opening 
of the common duct into the duodenum could 
not be identified. A Roux-en-Y choledochocys- 
tojejunostomy was carried out bringing the
defunctioned jejunal loop through a defect in 
the transverse mesocolon. The patient’s post­
operative course was uneventful; she was dis­
charged 10 days after operation and has re­
mained well. Liver biopsy, done at the time 
of operation, was reported to be normal; 
histologic examination of the gallbladder 
showed chronic cholecystitis and cholelithiasis 
with acute and chronic inflammation of the 
common duct wall.
D iscussion
Types of Cyst
Four types of choledochal cyst are rec­
ognized:1 type 1, diffuse aneurysmal dilata­
tion of the common duct (as seen in our 
two cases) makes up the largest segment 
(86.7%); type 2, a “diverticulum” arising 
by a narrow neck from the lateral wall of the 
common duct is present in 3.1% of cysts; 
type 3, the so-called choledochochocele, 
is associated with a dilatation of only the 
intraduodenal portion of the common duct 
and is seen in 5.6% of cases; finally, type 
4, multiple cystic dilatation of the intra­
hepatic ducts, was described by Caroli2 in
Fig. 2.—Case 2. Endoscopic retrograde cholan- 
giopancreatogram outlines choledochal cyst and in­
trahepatic ductal dilatation.
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TYPE 1 ( 8 6 . 7 % )
TYPE 3 (5 .6 % )
Fig. 3. —Classification 
dilatation.
of four types of ductal
1958 and is known as Caroli’s disease (Fig. 
3). This type makes up only 2.6%  of all 
choledochal cysts. An additional 2%  of 
cysts are associated with biliary atresia.
Incidence and Etiology
The choledochal cyst is more common 
in women than in men (3:1); it has a higher 
incidence among the Japanese than among 
other racial groups. Stones are rarely found 
in the cysts but occasionally, as in our case 
2, are found in the gallbladder. The cyst 
wall, which may or may not be lined by 
epithelium, contains no muscle. The most 
commonly accepted etiologic explanation for 
this malformation is that offered by Yotuya- 
nagi,3 who postulated that an inequality of 
epithelial cell proliferation occurs at the 
embryologic stage when the primitive biliary 
ducts are still solid. Subsequent vacuoliza­
tion then results in dilatation; this usually 
occurs in the proximal duct where epithe­
lial proliferation is greatest. Babbitt, Star- 
shak and Clemett4 proposed an alternative 
concept of etiology based on a study of the 
anatomical abnormalities found in seven 
cases; in these, the common duct joined at 
right angles to the pancreatic duct some
distance from the ampulla of Vater. Since 
this junction occurred proximal to the 
sphincter mechanism, Babitt’s group pos­
tulated that pancreatic juice was refluxing 
into the common duct. This reflux resulted 
in inflammation and scarring of the distal 
bile duct with secondary proximal dilatation. 
The high amylase content in the cyst as­
pirate found by the group tends to support 
their theory.
Kozloff and Joseph5 reported five cases 
of choledochal cyst in adults they believed 
were acquired. They took this position be­
cause although previous common-duct ex­
plorations were normal, cysts were found at 
subsequent reoperation.
Signs and Symptoms
The classic triad of epigastric pain, jaun­
dice and an upper abdominal mass in a 
young woman is pathognomonic of con­
genital choledochal cyst, but is seen in only 
one third of the cases. Our two patients 
presented with upper abdominal pain only. 
It is also noteworthy that a mass is present 
in only 58%  of all cases and tends to 
appear and disappear as the cyst fills and 
empties, while jaundice occurs in approxi­
mately 65%  of patients with choledochal 
cysts.
In the absence of jaundice, the diagnosis 
is best made as in case 2 by intravenous 
cholangiography. In patients with jaundice, 
either transhepatic cholangiography or, 
more recently, ERCP may demonstrate the 
cyst. Many cases will remain undiagnosed 
and even unsuspected until operation for 
cholecystitis when, as in case 1, the dilated 
duct is demonstrated by operative cholan­
giography.
Complications
Once diagnosed, appropriate surgical 
treatment is mandatory because of the risk 
of complications. Recurrent cholangitis with 
associated intrahepatic abscess is a com­
mon complication that may be fatal, and 
rupture of the cyst leading to peritonitis may 
result from trauma or may occur spontane­
ously. There are 23 reports in the literature 
of spontaneous rupture in pregnancy and 
during labour.1
Long-standing obstruction may lead to
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biliary cirrhosis, portal hypertension and 
upper gastrointestinal hemorrhage. Pan­
creatitis may also complicate choledochal 
cysts. Finally, the incidence of carcinoma 
of the bile duct associated with choledochal 
cysts is approximately 2.5% (20 times the 
normal incidence for bile duct carcinoma).
Operative procedures
While there is no doubt that surgery is 
the treatment of choice, there is considerable 
controversy regarding the most appropriate 
procedure.
External drainage of the cyst is men­
tioned only to be condemned, as are any 
anastomotic procedures between the gall­
bladder and the gastrointestinal tract. For 
many years side-to-side choledochocysto- 
duodenostomy, as recommended by Gross,6 
was the operation of choice. However, long­
term follow-up by Trout and Longmire7 has 
shown that there is a complication rate of 
65% during the first 5 postoperative years. 
Of these patients 40% developed stricture 
resulting in recurring bouts of cholangitis 
and required reoperation to revise the 
choledochoduodenal anastomosis.
The choice of treatment today appears to 
lie between excision of the cyst and Roux- 
en-Y choledochocystojejunostomy as per­
formed in case 2. Excision is the preferred 
operation in type 2 cases with a narrow 
neck. In type 1 cases, excision with sub­
sequent hepaticointestinal anastomosis has 
the added advantage of eliminating the risk 
of subsequent carcinoma of the bile duct; it 
would seem to be a formidable operative 
procedure, but according to Ishida and col­
leagues,8 it is the treatment of choice in 
Japan. For the average surgeon who will 
encounter this lesion infrequently, cho­
ledochocystojejunostomy is the safest and 
most satisfactory procedure. With an ade­
quate length of defunctioned jejunum, the 
incidence of cholangitis and stricture at the 
anastomosis should be low. Peptic ulcer due 
to biliary diversion has been reported as a 
late complication in approximately 10% 
of cases.9
Cholecystectomy should be carried out at 
the time of operation, even though the gall­
bladder appears normal, since late develop­
ment of cholelithiasis and cholecystitis is not 
uncommon.7 Type 3 cases (choledochocele) 
are readily treated by transduodenal ex­
cision.
We thank Dr. J. E. Mullens who did ERCP 
studies in case 2 and Dr. G. Ciok who allowed 
us to report case 1.
A ddendum
Since this manuscript was prepared the first 
patient has been readmitted. The choledocho- 
cystoduodenostomy was converted to a Roux- 
en-Y choledochocystojejunostomy because she 
had recurring bouts of cholangitis. At opera­
tion there was a fairly tight stricture of the 
choledochoduodenal anastomosis with small 
calculi in the proximal bile duct.
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Introducing 
the first oral prostaglandin 
for labour induction
*
4
Prostin E2
■  (dinoprostone)
When labour induction is indicated, Prostin E2 Tablets can make the therapy 
more acceptable and convenient for both patient and medical staff.
Oral therapy eliminates the discomfort of venipuncture and permits the 
patient unrestricted movement. Because there is no need for continuous ^
monitoring of intravenous infusions, nursing time is reduced.The relatively 
short induction-delivery interval with Prostin E2 Tablets helps ensure efficient -
use of obstetric facilities. These time savings also mean cost savings and often reduce "
the total cost of Prostin E2 Tablets therapy below that of intravenous agents.
In clinical trials conducted in Canada involving 336 women, Prostin E2 Tablets effectively f
induced labour in more than 87% and were particularly successful in multiparous patients w
and in those with a Bishop Score of six or more.
Gastrointestinal side effects occurred but were seldom severe. Uterine hypertonus was also **
occasionally reported. *
THE UPJOHN COMPANY OF C A N A D A / DON MILLS, ONTARIO
761X REGISTERED TRADEMARK: PROSTIN ▼
PRODUCT OF
Upjohn
PROSTAGLANDIN
RESEARCH
IRADEMARK: PROSTIN
M a y  1977 THE CANADIAN JOURNAL OF SURGERY 261
Prostin E2 Tifefetb THE BACKYARD BARBECUE SYNDROME
Indications and C lin ica l Uses: Prostin E2 is indicated as a uterine stimulant tor induction of labour at 
or near term in:
1. Elective induction.
2. Indicated induction such as: postmaturity, hypertension, toxemia of pregnancy, premature rupture of 
amniotic membranes, Rh incompatability, diabetes mellitus, intra-uterine death, or fetal growth 
retardation.
Contraindications:
1. Gynecological, obstetrical or medical conditions that preclude vaginal delivery.
2. Prostin E2 is considered inappropriate in such conditions as:
a) Patients with a history of cesarean section or prior major uterine surgery
b) Patients with cephalopelvic disproportion.
c) Patients with fetal malpresentation.
d) Patients with suspected or clinically evident pre-existing fetal distress.
e) Patients with a prior history of difficult labour and/or traumatic delivery.
f) Patients with overdistension of the uterus (multiple pregnancy, polyhydramnios).
g) Patients with pre-existing uterine hypertonus.
h) Circumstances that make it impossible for a responsible physician to be present.
3. Patients who are hypersensitive to Prostin E2 (dinoprostone).
4. Prostin E2 should not be used simultaneously w ith other oxytocics.
Warnings: Prostin E2 (dinoprostone), like other effective oxytocic agents, should be used with strict 
adherence to recommended dosages, by medically trained personnel in hospital surroundings that can 
provide immediate intensive care and facilities for immediate surgical intervention.
The sequential use of oxytocin immediately following Prostin E2 has been carried out. It has been found 
that prostaglandins might potentiate the effect of oxytocin. THEREFORE. INFUSION OF OXYTOCIN 
SHOULD NOT BE STARTED UNTIL AT LEAST ONE HOUR HAS ELAPSED FOLLOWING THE LAST 
ORAL DOSE OF PROSTIN E2.
Reports of epileptic seizures with other forms of prostaglandin by routes other than oral have been 
published. The association of prostaglandin with seizures has not been conclusively proven. One 
epileptic patient under poor control, when treated with Prostin E2 Tablets, did experience a grand mal 
seizure. Therefore, it is recommended that Prostin E2 Tablets be used in known epileptics only when 
their epilepsy is under good control and then only w ith maximum care and observation on the part of 
the physician in charge. Elective induction of labour should not be employed in these patients. 
Precautions:
1. In patients with a history of asthma, increased intraocular pressure, or glaucoma. Prostin E2 should 
be used with caution.
2. During oral administration, uterine activity, fetal status, and the progression of cervical dilatation 
should be carefully evaluated to detect possible evidence of unphysiological responses, e.g. hyper­
tonus, sustained uterine contraction, or fetal distress. It is recommended that uterine activity and 
the state of the fetus be monitored throughout labour.
3. As with the use of any effective oxytocic agent, uterine rupture and/or cervical laceration should be 
borne in mind.
Adverse Reactions: The most frequent adverse reactions observed with the use of Prostin E2 (dino­
prostone) for the induction ot labour are vomiting, with or without nausea and diarrhea. These side 
elfects occur in about 21% of patients induced with a total dose of 0 .5 -  3.0 mg (1-6 tablets) of Prostin 
E2, in about 39% of patients induced with a total dose of 3 .5 -6 .0  mg (7-12 tablets) of Prostin E2 and in 
about 50% of patients induced with a total dose of more than 6.0 mg (more than 12 tablets) of Prostin E2 
Fetal heart rate changes were observed in 6.5% of patients induced with Prostin E2.
Uterine hypertonus occurred in 3.1% of patients. It is usually manageable by the temporary discon­
tinuation of Prostin E2. a reduction in the dose of Prostin E2, and the administration of oxygen. In the 
rare instance where these measures are not effective, prompt delivery is indicated.
Other side effects reported in less than 1% of patients include the following: headache, hypertension, 
hypotension, postpartum hemorrhage, fever, dizziness, chills, hiccough, flushing, tachycardia, 
dyspnea, bronchospasm, rash. The relationship of these side effects to Prostin E2 therapy has not 
been established.
Symptoms and Treatment of Overdosage: No cases of accidental or intentional overdosage with 
Prostin E2 tablets have been reported. Should such overdosage occur in nonpregnant patients it would 
be expected that nausea and vomiting and possibly diarrhea would occur
Hyperpyrexia may occur. Patients who are pregnant should be carefully observed for severe uterine 
hypercontractility Because of the extremely short duration of action of Prostin E2 once it is absorbed, 
no specific treatment to counteract drug effect need be taken. However, vomiting should be induced 
(if not already occurring) to remove any unabsorbed drug from the stomach.
In one published report, the intravenous infusion of 500 ml of 10 per cent ethaqpl per hour for one hour 
inhibited uterine activity initiated and maintained by an infusion of either prostaglandin F2<r or E2 when 
given simultaneously with the prostaglandin.
Dosage and Adm inistration: An initial dose of 0.5 mg (one tablet) should be given followed in one 
hour by a second dose of 0.5 mg (one tablet). All subsequent doses should be given hourly. The lowest 
dosage that will produce satisfactory uterine response should be used. All doses should be taken with 
a small amount of water
For patients with a parity of 2 or greater, and those with a Bishop Score of 6 or greater, it is recom­
mended that 0.5 mg of Prostin E2 be administered hourly and maintained throughout the induction 
(unless excessive uterine activity dictates elimination of the hourly dose). In nulliparous or multiparous 
patients who are historically resistant to induction (Bishop Score of 0-5). an increment in individual 
doses may be justified. If satisfactory labour has not been initiated in these patients after two (2) hours 
of administration of Prostin E2. subsequent doses may be increased by 0.5 mg (one tablet) increments 
at each hourly interval. A SINGLE DOSE SHOULD NEVER EXCEED 1.5 mg (3 tablets).
Once labour has been initiated (regardless of the dose), it is recommended that 0.5 mg (one tablet) of 
Prostin E2 be given hourly for maintenance of the progress of labour It may, however, prove reasonable 
to occasionally eliminate this maintenance dose to determine if labour will progres without additional 
medication.
If vomiting occurs at any time during the treatment period, examine the vomitus for the presence of an 
intact tablet of Prostin E2. If one is found, the dose should be repeated at once If only a part or parts of 
the tablet is (are) seen (this is considered as evidence of tablet disintegration) or, if no tablet is seen in 
the vomitus. the dose should not be repeated and the next dose should be given only at the scheduled 
time. If two (2) successive doses are vomited and an intact tablet is seen each time, it is recommended 
that the patient be allowed to rest until the next scheduled dose The effectiveness of medication to 
treat the nausea and/or vomiting which may occur with the use of Prostin E2 has not been determined. 
Uterine activity is considered excessive if the frequency of contractions is greater than 5 per 10 minutes 
and/or the internal tonus consistently exceeds 15 mm Hg. In this event, administration of Prostin E2 
should be stopped to allow stabilization and evaluation. Note: The intravenous administration of 10% 
ethyl alcohol may reverse the effect of Prostin E2.
If Prostin E2 fails to elicit regular uterine contraction by the end o f 8 hours, the case should be classified 
as a failed induction. Subsequent management is left to the discretion of the physician.
The total treatment period w ith P rostin E2 should not, in any instance, exceed 18 hours.
Availability: Prostin E2 is supplied in glass bottles containing 10 tablets each.
Each U-shaped compressed tablet contains 0.5 mg of dinoprostone. Prostin E2 tablets should always 
be stored under normal refrigeration (4°C). and they are stable for at least 2 years under these condi­
tions. Once the bottle is opened, the tablets should be used within 90 days 
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We recently reviewed the syndrome of 
spontaneous esophageal rupture —  Boer- 
haave’s syndrome (Can J Surg 19: 226, 
1976) and followed up with a discussion on 
the great Boerhaave himself (Can J Surg 
19: 446, 1976).
A new esophageal syndrome has come to 
our attention —  the “backyard barbecue 
syndrome” (JAMA 235: 2637, 1976).
Steaks cooked on a barbecue are frequently 
overdone on the outside and are underdone 
on the inside. This makes for difficult 
chewing. The beer, good fellowship, excite­
ment and talking that frequently accom­
pany such a repast also predispose to 
inadequate mastication. Frequently under 
these circumstances, cutlery is not pro­
vided —  the guest “bites off more than he 
can chew”; he can do nothing socially deli­
cate; he must swallow. Impaction of a 
swallowed food bolus is most likely to oc­
cur distally in or near the ampulla. The 
embarrassed and indisposed guest retches 
and strains, in an effort to dislodge the 
bolus; if he drinks, he tends to regurgitate 
— he may aspirate and he can die.
On admission, the patient should be fully 
evaluated. A Levin tube should be passed 
nasally to the obstruction and suction main­
tained, thus removing all fluid above the 
bolus; a chest radiograph should be taken, 
followed by contrast esophageal fluoroscopy 
with a water-soluble contrast medium.
Two forms of treatment are available —  
digestion with papain and removal under di­
rect vision using a metal esophagoscope and 
three-pronged retracting forceps. After 
aspiration, about 20 ml of a strong aqueous 
papain solution is instilled; this is aspirated 
every 20 to 30 minutes and followed by an­
other fresh infusion of papain solution. The 
patient often feels the mass suddenly clear. 
If clearing does not occur within 3 hours 
the patient is sedated with diazepam (given 
intravenously) and the mass is removed 
using a hollow metal esophagoscope. The 
patient is hospitalized overnight and re­
leased the following day.

In treating any serious infection involving gram-negative organisms, 
PYOPEN makes a lot of sense.
Because PYOPEN is a penicillin, it provides the traditional margin of 
safety common to all penicillins.
PYOPEN is free from dose-related toxicities, yet it provides bactericidal 
effectiveness against Pseudomonas aeruginosa and other gram-negative 
organisms including Proteus species often resistant to other antibiotics.
If a gram-negative infection is suspected,make sure you request a 
PYOPEN sensitivity test.
CONTRAINDICATIONS: C arben ic illin  should not be used in pa tie n ts  w ith  a h is to ry  o f p e n ic illin  o r cepha losporin  allergy. C a rb e n ic illin  is 
hydrolyzed by staphy lococca l beta-lactamase and is, therefore, con tra ind ica ted  in in fe c tio n s  caused by beta-lactam ase-producing 
staphy lococc i. PRECAUTIONS: The same as fo r pe n ic illin  G. Resistant organ ism s have arisen during  treatm ent. Adequate dosage 
should therefore be m ainta ined and in te rm itten t sens itiv ity  te s ts  carried out. W ith  h igh  doses o f PYOPEN the co ncom itan t ad­
m in is tra tion  o f sodium  may be hazardous in pa tien ts  w ith  serious card iac disease. One g o f  PYOPEN con ta ins 6.5 mEq o f sodium  ion. 
Therefore, large doses o f the  drug should be adm in istered w ith  cau tion  to pa tien ts  w ith  congestive heart fa ilure, severe hypertens ion , or 
edema. ADVERSE REACTIONS: S im ila rto  those reported w ith  p e n ic illin  G. A lso reported: pain and rashes at s ite  o f i.m. in je c tio n ; th ro m ­
boph leb itis  a fte r prolonged adm in is tra tion ; p ru ritus; eos inoph ilia ; nausea; occasional rise  in SGOT and alka line phosphatase levels; one 
case o f an unexplained drop in hem oglobin level; one case o f seizure in a hem ip leg ic  p a tien t on high doses and one case o f  increased 
m uscle weakness in a pa tien t w ith  myasthenia gravis have been reported. Prolonged b leed ing  tim e has been reported in 22 o f a series o f 
30 pa tien ts  receiv ing between 5 0 0 and 750m g/kg  da ily  o f PYOPEN during  14 days (giving b lood  levels o f 200-400 ^g /m l). A ggregation  o f 
p la te le ts  by adenosine d iphosphate  was decreased in all 30 pa tien ts . The de fect appeared w ith in  12 hours after s tarting therapy and to o k  
from  3 to  7 days to  disappear a fte r d iscon tinu ing  the drug. Two w om en receiving 30 g o f PYOPEN da ily  developed hypokalem ia a fte r 7 
and 9 days respectively. Potassium  levels were 2 and 1.5 m E q /l. Oral po tassium  c h lo rid e  rapidly corrected the e lec tro ly te  d isorder. 
DOSAGE: Relatively h igh doses o f carbenic illin  are required in the  treatm ent o f severe Pseudom onas in fections. ADULTS— Severe and 
overw helm ing in fe c tio n s  (septicem ia, extensive burns and w ounds, pneum onia, m e n ing itis , periton itis ): 12 to  30 g da ily in travenously  o r 
by in fus ion  w ith  or w ithou t 1 g o f probenecid o ra lly  3 tim es da ily. In m oderately severe in fections: 1 g every 4 hours fo r 5 to  10 days. 
CHILDREN — Dosage, accord ing to  weight and age and severity o f in fe c tio n , may vary from  100-300 mg /k g  /body  weight. AVAILABILITY: 
Vials con ta in ing : 1 g or 5 g carben ic illin . Com plete p rescrib ing  in fo rm a tion  and references available on request.
Only regular sensitivity testing will tell 
you how effective PYOPEM can be 
in treating:
Ayerst
MEMBER 
|PMACj
Q ua lity  has 
no substitute
AYERST LABORATORIES
D iv is io n  o f  A y e rs t, M cK enna & H a rriso n  L im ite d  M o n tre a l, C anada 
Made in Canada by arrangement w ith  BEECHAM, INC. ‘ Reg'd
5 2 5 0 /3 /6 /E
264 THE C AN AD IA N  JOURNAL OF SURGERY Vol. 20
COMPLETE TRANSECTION OF THE BODY 
OF THE STOMACH RESULTING FROM BLUNT TRAUMA*
J. E. LEDDY, MD, FRCS[C], FRCS (Edin), FACSf and E. M. S. FREW, 
MB, ChB, FRCS(Edin), FRCS[C]
Gastric perforation due to blunt trauma is rare, 
especially in children. The authors present a 
case of complete transection of the stomach in 
a 10-year-old boy who was thrown across the 
steel back of a seat in a school bus. Associated 
injuries included hematoma, a torn spleen, a 
seromuscular tear of the duodenojejunal flexure 
and complete transection of the pancreas and 
rectus abdominis muscle. The boy's postopera­
tive course was complicated by the development 
of peritonitis with abscess formation and a 
pancreatic fistula. To the authors' knowledge 
this is the first case of complete transection of 
the stomach, due to blunt trauma reported in 
the English literature.
La perforation de i'estomac due a un trauma- 
tisme contondant est un evenement rare, par- 
ticulierement chez I'enfant. Les auteurs presen- 
tent un cas de section transversale de I’estomac 
se produisant chez un enfant de 10 ans qui fut 
projete contre le dossier d’acier d’un siege 
d'autobus scolaire. Les autres blessures in- 
cluent un hematome, une dechirure de la rate, 
une dechirure seromusculaire de la courbure 
duodenojejunale et une section transversale com­
plete du pancreas et du muscle grand droit an- 
terieur de I'abdomen. Devolution postoperatoire 
s'est compliquee par I'apparition d'une peritonite 
avec formation d’abces, et d'une fistule pancre- 
atique. Selon les auteurs, a leur connaissance, 
il s'agit du premier cas de section transversale 
complete de I'estomac dii a un traumatisme 
contondant qui soit signale dans la litterature 
de langue anglaise.
T r a u m a t ic  rupture of the stomach is a rare 
condition carrying a high morbidity and 
mortality. A case of complete transection of 
the stomach is presented. To our knowledge 
this is the first such case reported in the 
English literature. The management of the 
patient is described and the literature re­
viewed.
*From the department of surgery, St. Paul’s Hos­
pital, University of Saskatchewan, Saskatoon, Sask. 
Presented at the annual meeting of the western 
division of the Canadian Society of Clinical Sur­
geons, Mar. 5, 1976.
fClinical professor of surgery, University of Sas­
katchewan.
+ Senior resident in surgery, University of Sas­
katchewan.
Reprint requests to: Dr. J. E. Leddy, Department 
of surgery, St. Paul’s Hospital, 1702-20th St. 
W, Saskatoon, Sask. S7M 0Z9.
C ase  R epo r t
A 10-year-old boy was thrown forward 
across the steel back of a seat when a school 
bus struck an unexpected excavation. One hour 
after the accident the boy wais seen in the 
emergency department. He was pale, restless 
and in considerable pain; he appeared to be 
in shock, but he was conscious and lucid. On 
physical examination his pulse was rapid and 
thready; the blood pressure was 84/54 mm 
Hg. Abrasions were noted on the left forehead 
and legs; the chest was clear with no ex­
ternal evidence of trauma to the thoracic cage; 
the abdomen was rigid with generalized re­
bound tenderness; bowel sounds were absent. 
His hemoglobin was 10.2 g/dl. The chest 
radiograph appeared normal, but abdominal 
radiographs showed free gas under the left 
hemidiaphragm. Shortly after admission the 
patient vomited 200 to 300 ml of blood. He 
was catheterized and the urine obtained ap­
peared clear. Initial treatment consisted of the 
administration of 1.2 l of saline intravenously 
followed by 1 l of blood.
Laparatomy was done 2Vz hours after the 
accident through an upper left paramedian in­
cision. The peritoneal cavity contained over 
500 ml of blood and clot. There was an almost 
complete transection of the stomach from 
greater to lesser curvature with only 0.5 cm 
of lesser curve wall intact as a bridge between 
the two halves of the stomach (Fig. 1). The 
gastrohepatic omentum was intact so that the
Complete transection of stomach and 
rupture of spleen in 10-year-old boy.
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neurovascular structures, particularly the 
nerves of Latarjet, were undamaged. There 
was no food in the peritoneal cavity; the in­
jury had occurred about 4 hours after the last 
meal.
Further injuries included a large retro­
peritoneal hematoma, a torn spleen, complete 
transaction of the pancreas, a 2.5-cm sero­
muscular tear of the duodenojejunal flexure 
extending up to the jejunum along the ante- 
mesenteric border, and complete transection 
of the left rectus abdominis muscle in a trans­
verse plane.
Bleeding from the stomach was controlled 
by occlusion clamps. Treatment consisted of 
end-to-end anastomosis of the severed stomach, 
splenectomy and removal of the distal half of 
the pancreas. The seromuscular tear of the 
duodenojejunal flexure was sutured. Finally, 
the peritoneal cavity was carefully irrigated 
with saline and large sump drains were placed, 
one in the lesser sac adjacent to the site of pan­
creatic resection and the other close to the 
head of the pancreas and the gastric an­
astomosis. The abdomen was closed in layers 
using tension sutures. Total blood loss during 
the procedure was approximately 2.5 l; with 
the aid of central venous pressure monitoring 
we were able to replace this loss adequately.
Postoperatively the patient had a com­
plicated course. For 2 days ampicillin (500 mg, 
q6h) was prescribed for a fluctuating fever, 
but when cultures of fluid from the sump 
drains grew Bacteroides sp., //-hemolytic 
streptococcus and Staphylococcus aureus, 
ampicillin was discontinued and cloxacillin (1 
g, q6h) and clindamycin (150 mg, q8h) were 
administered. Hazy infiltrates in the left lung 
were thought to be caused by lung contusion 
at the time of the accident.
On the 5th day left thoracocentesis yielded 
500 ml of serosanguineous fluid. The daily 
serum amylase value was never greater than 
78 Somogyi units/! (normal range 60-100 
units//) and the urine amylase value reached 
11 000 Somogyi units// in 24 hours (normal 
range, 800-3200 units//). On the 8th day a 
meglucamine diatrizoate (Gastrografin) swal­
low showed an intact anastomosis though 
there was some dilatation of the proximal 
stomach. The patient’s temperature continued 
to fluctuate and on day 15 a pelvic abscess 
developed, which was drained suprapubically. 
A pancreatic fistula developed through the 
more laterally placed sump drain; the fistula 
closed after 3 weeks. A barium meal done 
on day 35 was normal. The patient was dis­
charged on day 40 after operation and has 
been well since.
D iscussion
Rupture of the stomach due to blunt 
trauma is rare. Allen and Curry1 and Luc- 
cioni and Mammucari2 have estimated that 
such injury occurs in 0.07 to 1.3% of all 
cases of blunt trauma. Wolf3 was able to 
collect only 69 cases. Yajko, Seydel and 
Trimble4 could find only 35 cases in the 
English literature from 1930 to 1975. After 
a thorough search of the literature we were 
unable to find another case of complete 
transection of the body of the stomach. 
However, Bienkowski3 reported a small tear 
of the anterior and posterior walls of the 
stomach in a 2-year-old boy after closed 
abdominal trauma and Muschter6 reported 
a case in which the stomach was severed 
from the duodenum following blunt abdomi­
nal trauma.
Most injuries of the stomach are lacera­
tions of the lesser curvature. Less frequently 
the greater curvature or the anterior or 
posterior wall of the stomach may be in­
jured. Only rarely are both walls of the 
stomach injured simultaneously. Stomach in­
jury is more common in adults than child­
ren, the peak incidence occurring early in 
the 4th decade; men are affected approxi­
mately four times more frequently than 
women. These injuries are most commonly 
associated with automobile accidents and 
falls, especially when the stomach is full. A  
mortality of 40 to 66% has been reported2 
and there is a high morbidity among the 
survivors.7 Isolated gastric rupture is un­
common; usually there are associated in­
juries to the spleen and pancreas. The time 
since the last meal and the nature of the 
meal appear to be of considerable prognostic 
importance as this to some extent deter­
mines the degree of peritoneal contamina­
tion. However, our patient’s stomach was 
empty at the time of injury, yet peritonitis 
with abscess formation posed a serious 
problem in management. The cause of in­
jury is usually a left-sided blow over the 
lower thorax and upper abdomen.7 We 
suspect that our patient was thrown upward 
and forward in an arc and his left upper 
abdomen and lower chest struck the steel 
seat-back, the mid-stomach being crushed 
against the left side of the vertebral column 
along with the spleen, pancreas and jejunum.
266 THE CANADIAN JOURNAL OF SURGERY Vol. 20
This theory would also account for the con­
tusions in the lower lobe of the left lung.
In cases of stomach rupture, the physical 
findings are usually nonspecific, but abdomi­
nal pain, rigidity and tenderness are often 
present. A large amount of free air under 
the diaphragm is highly suggestive of gastric 
perforation, but may be present in only 
50% of cases.7' 8 Peritoneal tap and lavage 
can help to establish the diagnosis when this 
is in doubt. Whenever laparotomy for 
trauma is undertaken, a careful examination 
of the stomach must not be omitted for, on 
occasion, the stomach ruptures and there 
are few early signs or symptoms, especially 
in cases where the tear is posterior.
Conclusions
Gastric perforation due to blunt trauma 
is rare, especially in children. In rupture of 
the stomach without associated injury there 
is a high mortality; when there is associated 
injury the mortality is increased further. 
Even with prompt recognition of the rup­
ture, mortality is substantial. This is mainly 
due to septic complications. The extent of 
the gastric injury in our patient is probably 
unique, but the postoperative course il­
lustrates the difficulties and problems en­
countered in treating gastric perforation.
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observed prior to the administration of Trasylol.
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PREOPERATIVE HAIR REMOVAL*
H. W. HAMILTON, MB, ChB, FRCS(Edin), FRCS[C], K. R. HAMILTON, MB, BSf 
and F. J. LONE, MD, FRCP[C]
This study compares the efficiency, safety and 
cost of hair removal before surgery, with a 
safety razor, an electric clipper and a depilatory. 
It was found that both the razor and the clipper 
damaged the surface of the skin, while the 
depilatory caused a mild lymphocytic reaction in 
the upper dermis. The depilatory was expensive 
and may cause sensitivity reactions in a few 
individuals, but was found to be the easiest and 
most efficient method of removing hair. It was 
concluded that if hair has to be removed a 
depilatory is the agent of choice.
Cette etude examine I'efficacite, la surete et le 
cout de I'enlevement des cheveux avant la chi- 
rurgie avec un rasoir, un rasoir electrique et une 
creme depilatoire. On a trouve que le rasoir 
ainsi que le rasoir electrique endommageaient 
la peau tandis que la creme depilatoire ne cau- 
sait qu'une simple reaction lymphocytique dans 
la region de I'epiderme. La creme depilatoire est 
plus couteuse et peut causer une reaction aller- 
gique a certains individus, mais c'est la methode 
la plus efficace et la plus facile pour I'enleve­
ment des cheveux. Nous avons conclus que la 
methode de choix pour I’enlevement des cheveux 
serait avec la creme depilatoire.
In order to determine the best method of 
hair removal in preparation for surgery we 
studied the efficiency, safety and cost of 
three agents: a safety razor, an electric 
clipper and a depilatory.
M eth o ds a n d  C o sts
The safety razor was used dry, the 
electric clipper was Oster Model 89. The 
depilatory (Neet; Whitehall Laboratories, 
Toronto, Ont.) contained 4 to 5% cal­
cium thioglycolate and had a pH of 11.5 to 
12.5; it was used in aerosol form, sprayed 
on the skin, left for about 5 minutes and 
then washed or wiped off. Each method of 
removing hair was assessed by direct ob­
servation, photography, scanning electron 
microscopy and light microscopy.
*From the departments of surgery, and bacteri­
ology and pathology, Port Arthur General Hos­
pital, Thunder Bay, Ont.
fK ing’s College Hospital medical school, Den­
mark Hill, London, England.
Reprint requests to: Dr. H. W. Hamilton, 11 Sum­
mit Ave., Thunder Bay, Ont. P7B 3N7.
To determine the effectiveness of hair 
removal and any damage done to the sur­
face of the skin, replicas prepared by the 
method of Bernstein and Jones1 were ex­
amined with a Cambridge Stereoscan 600 
scanning electron microscope using a beam 
accelerating voltage of 15 kV. To verify the 
accuracy of the replica technique, skin 
biopsies fixed in formalin vapour, dehy­
drated and coated with gold were also ex­
amined with the scanning electron mi­
croscope.
The tissue response to the various meth­
ods of hair removal was determined by 
skin biopsy. The biopsy material, taken from 
the edge of the wound at operation, was 
fixed in formalin, stained with hematoxylin 
and eosin and examined with a light micro­
scope.
To assess cost we arbitrarily chose to 
compare the expense of removing the hair 
of 1000 patients from 0.09 m2 of skin in 
1 year. We included in our assessment the 
cost of a safety razor plus a new blade for 
each patient, the cost of an electric clipper 
and annual repairs and the retail cost of 
the depilatory. The cost of the depilatory 
was reached by spraying five 200-g aerosol 
bottles over a measured area to give a 
generous coat of foam as recommended for 
the removal of hair. Each bottle produced 
a similar quantity of foam; the average area 
covered was just over 0.386 m2.
R e su l t s
Efficiency and Safety
Direct observation showed that the safety 
razor often caused gross cuts and the clip­
pers tended to nip loose skin. Nipping was 
noted particularly over the flexor creases. 
The depilatory caused no visible injuries.
Close-up colour photographs confirmed 
the impression that the depilatory and razor 
removed more hair than the clipper.
Replicas examined with the scanning 
electron microscope showed that the de­
pilatory removed virtually all the hair (Fig. 
1), the razor sliced off the hair close to the 
skin surface (Fig. 2) and the clipper nipped
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F>g- 1.—Replica of skin after hair removal with 
depilatory (reduced by 72% from x 100).
Fig. 4.—Replica of skin after hair removal with 
razor (reduced by 72% from x 50).
Fig. 2.—Replica of skin after hair removal 
razor (reduced by 72% from x 100).
with Fig. 5.—Replica of skin after hair removal with 
clipper (reduced by 72% from x 200).
Fig. 3.—Replica of skin after hair removal with 
clipper (reduced by 72% from x 500).
Fig. 6.—Replica of skin after hair removal with 
depilatory (reduced by 72% from x 50).
off the hair leaving a longer length of 
stubble (Fig. 3).
The scanning electron microscope also 
revealed injuries to the surface of carefully 
prepared skin, which appeared undamaged 
to the naked eye. The razor caused multiple 
slices perpendicular to the line of progress 
of the blade (Fig. 4) and the clipper caused 
widespread nicking (Fig. 5). The depilatory
did not appear to damage the skin surface 
(Fig. 6).
The surface of a biopsy of skin shaved 
with a razor and viewed with the scanning 
electron microscope (Fig. 7) is comparable 
to the replica technique (Fig. 4). The ap­
pearance of such a biopsy smeared with a 
mixed culture of bacilli and cocci is shown 
in Fig. 8.
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Fig. 7.—Skin biopsy after hair removal with 
razor (reduced by 72% from x 200).
Fig. 8.—Scanning electron photomicrograph of 
skin biopsy smeared with bacteria after hair re­
moval with razor. Two red blood cells lie ad­
jacent to slice. Bacteria are randomly scattered 
over skin surface and in depths of slice (reduced 
by 72% from x 2000).
Stained sections of skin biopsies examined 
with a light microscope appeared normal 
when the hair had been removed with a 
razor or clipper. The epithelium was intact 
and covered with a thin layer of keratin. The 
upper dermis showed no cellular infiltrate 
and the vessels and adnexa were unre­
markable. When the depilatory was used 
immediately before operation no abnormal­
ity was detected. When the depilatory was 
applied the day before the operation a slight 
lymphocytic infiltration, particularly adja­
cent to the vessels, was observed. When the 
depilatory was applied 2 days before the 
operation the lymphocytic infiltration was 
more marked but still minimal (Fig. 9). 
When the depilatory was applied 3 days 
before the operation the biopsies again ap­
peared completely normal.
When the depilatory was cultured in
Fig. 9.—Photomicrograph of section of skin 
after hair removal with depilatory 2 days before 
biopsy (stain, reduced by 63% from x 320).
solid and liquid media, under aerobic and 
anaerobic conditions, no bacteria grew.
Among more than 500 cases studied 
clinically the depilatory caused a reaction 
in only 3. None of these was of sufficient 
severity to delay the operation. The ex­
perience of other workers is shown in 
Table I .2'4
In a more detailed review of 160 of our 
clean cases the wounds were photographed 
by a standard technique at 2 weeks. To 
determine the quality of healing the redness 
of the wound was compared colorimetrically 
with the surrounding skin. Perfectly healed 
wounds have an absorption density dif­
ferential of less than two; that is, the wound 
was less than twice as red as the sur­
rounding skin at 2 weeks. Infected wounds 
were substantially more erythematous and 
always rated more than three. Different 
methods of skin preparation had little in­
fluence on the average erythema of the 
wounds, though those in which the depila­
tory was used were most erythematous 
(Table II).
Cost
The cost of using the clipper ($4.95/
The open and 
shut case for
TRIPLE I3A N T IB IO T IC  POWDER SPRAY
for routine topical antibacterial cover
□ A spray lasting only a few 
seconds on each exposed tis­
sue layer is sufficient to 
overcome most pathogenic 
organisms encountered in 
surgical procedures.
□ Reduced surgical sepsis- 
rate proved over 13 years in 
a wide range of surgical 
procedures.1'5
□ Broad-range and bacte­
ricidal: T he broad spectrum 
of Polybactrin covers almost 
any pa thogen ic  contingen­
cy, and its combined action 
(neomycin +  polymyxin B 
+  bacitracin) is highly bac­
tericidal and  effective.
E m erg en ce  o f re s is tan t 
strains rarely occurs.
□ Sterile-packed with unidi­
rectional spray which preclu­
des contam ination with any 
foreign m a tte r  th a t  m ig h t 
cause granulomas.
0  Polybactrin (stenie)
TRIPLE ANTIBIOTIC POWDER SPRAY
INDICA TIONS
T h e  contro l o f pathogenic  organism s 
w hich m ay infect tissues exposed d u r­
ing surgery, and  con tam inate  w ounds 
and  burns. Useful in casualty  and  pel­
vic su rgery , o pen  o rth o p ed ic  an d  
neurological procedures, as well as in 
general abdom inal, pelvic and  thoracic 
surgery, and  the  trea tm en t of burns. 
PRECAUTIONS
Prolonged use o f an tib io tics m ay result 
in the overgrow th o f non-susceptiblc 
organism s, includ ing  fungi. A ppro ­
pria te  m easures should be taken if this 
occurs.
DOSAGE
A spray  lasting only a  few seconds on 
each exposed tissue layer is sufficient to 
control m ost pathogen ic  organisms.
SUPPLIED
Each gram  o f off-white to yellow sterile 
pow der co n ta in s: neom ycin  su lfa te  
equivalent to 330 m g of neomycin base, 
zinc bacitracin  25,000 I.U ., polymyxin 
B sulfate 100,000 I.U . pressurized with 
inert chlorofluorohydrocarbon propel­
lan ts; availab le in 109 gram  aerosol 
con ta iner units. Pow der content is 1.5g. 
REFERENCES
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♦  Trade Mark
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'
'
C a lm ic  L im ite d
M ontrea l Toronto
A W e llco m e  C o m p a n y r'
SUGGESTED MANNER OF USE 
Spray before incision. Subsequently, spray as 
each tissue layer is exposed, e.g., at the levels 
of the fascia and the peritoneum. Spray when 
exposing the hepatic pedicle prior to incision. 
Spray as the gallbladder is raised to 
expose the cystic duct and artery and spray 
each layer as closing.
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TABLE I.—Summary of Experience with Depilatories
Year Author Depilatory
No. of 
cases Adverse reactions
1952 Vestal2 Imra cream* 460 No appreciable tissue reaction
1963 Prigot and Froix3 Surgexf >1000 Minimal and transient. Marked temporary ery­
thema developed in 6 patients, and in 30 pre­
existing severe dermatitis was aggravated
1971 Seropian and 
Reynolds4
Surgexf 157 Irritation developed in 2 patients
*Artra Cosmetics, Inc., Montclair, NJ. 
fCrookes-Barnes Laboratories, Wayne, NJ. 
jCIBA Pharmaceutical Co., Summit, NJ.
m-*1000 persons'yr) was less than half the 
cost of using the razor ($11.40/m-* 1000* 
yr) and more than 11 times cheaper than 
the depilatory ($56.70/m-*1000*yr). We 
have tried using the depilatory as a cream 
and lotion but found these forms less ef­
fective and more time-consuming.
Discussion
Some dexterity is required to use a 
safety razor well; the electric clipper also 
requires some skill. On the other hand no ex­
pertise is needed to spray on a depilatory. It 
is recommended, however, that the mucous 
membranes of the genitalia and the face be 
avoided. The speed and ease with which the 
depilatory removes hair to some extent com­
pensates for its extra cost; in addition it does 
a complete job.
A safety razor can be sterilized without 
difficulty and the cutting end of most 
clippers can be removed for sterilization. 
The depilatory in the aerosol form is sterile 
and thus cannot contaminate the skin during 
the process of hair removal.
The method of removing hair is impor­
tant. Seropian and Reynolds4 in a study 
of 406 cases reported an infection rate of 
5.6% after razor preparation and only
0.6% after depilatory preparation. More­
over they found the postoperative wound 
infection rate became greater the longer the 
interval between the razor shave and the 
surgery. Cruse and Foord3 in a study of 
18 090 cases reported an infection rate of 
2.3% after razor shaving, 1.7% after no 
shaving (apart from removal of the pubic 
hair with a clipper) and 0.9% when no hair 
at all was removed. Our figures (Table II), 
though not statistically significant, support 
the belief that removing hair with a razor 
increases the rate of infection.
It is possible that skin commensals or 
transient bacteria lodge in the microscopic 
injuries caused by the razor or clipper (Fig. 
8), multiply and later infect the wound.
Conclusions
We have shown that Neet —  a widely 
available depilatory —  is an efficient and 
rapid method of removing hair. Unlike a 
razor or clipper it does not damage the sur­
face of the skin. It does, however, cause a 
transitory lymphocytic reaction and may 
cause sensitivity reactions in a few in­
dividuals. The depilatory is expensive but 
this is offset by the time and labour saved.
The experience of Cruse and Foord
TABLE II.—Influence of Various M ethods of Skin Preparation on D egree of E rythema
Preparation
None Depilatory Clipper Razor
Injection_____________________________________ (n = 41) (n = 32) (n = 31) (w = 56)
Superficial
No. of cases.................................................... 2 2 3 4
Average erythema......................................... 2.6 3.6 2.2 2.3
Deep
No. of cases....................................................  1 o 0 2*
Average erythema......................................... 6 .— __ 3
*One deep infection developed 5 mo after operation, the wound rating for erythema was only 1.5 at 2 wk.
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should encourage us not to remove any hair. 
If, in preparation for surgery, it must be 
removed, we believe a depilatory is the 
agent of choice.
We thank Lakehead University and the N a­tional Research Council of Canada for allowing us to use their scanning electron microscope, Phy­sicians Services Incorporated for their support in an ongoing study of wound infection, Dr. A. D. Booth, president of Lakehead University for the colorimetric analysis of healing wounds and Mr. A. Mackenzie and Mr. C. Mallard, department of scientific instrumentation, Lakehead University and Mr. P. Fenlon, department of bacteriology and pathology, Port Arthur General Hospital for 
their advice and assistance.
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FACIAL FRACTURES AND SNOWMOBILE ACCIDENTS*
BRUCE M. RIGG, M D, FRCS, FRACS, FRCS[C]
Snowmobile accidents are now common in 
winter; there is a local pattern of facial frac­
tures associated with accidents involving these 
machines. Facial fractures connected with snow­
mobile accidents over a period of two succes­
sive winters were reviewed; 14 were found to 
be of special interest because of their severity 
and localized extent. Compared with motor 
vehicle accidents most of these fractures were 
isolated; the patients often had suffered only 
minimal trauma elsewhere. After reviewing the 
histories of these patients it was clear that 
alcohol, night driving, inadequate facial protec­
tion and the use of unknown terrain were com­
mon precipitating factors. Elimination of these 
hazards and the use of appropriate protective 
head-gear would probably reduce the number 
and severity of such injuries.
Les accidents de motoluge sont maintenant 
chose courante en hiver; les fractures du visage 
reliees aux accidents inpliquant ces vehicules, 
presentent des caracteristiques locales parti- 
culieres. Les fractures du visage associees aux 
accidents de motoluge qui sont survenus au 
cours de deux hivers consecutifs, sont passees 
en revue; on a considere que 14 d'entre-elies 
avaient un interet special en vue de leur gravite 
et de leur etendue. Comparativement a ce qu'on 
retrouve lors d'accidents d'automobiles, la plu- 
part de ces fractures etaient isolees; souvent, 
les autres traumatismes subits n'etaient que
*From the department of surgery, Peterborough Civic Hospital, Peterborough, Ont.
Reprint requests to: Dr. B. M. Rigg, 452 Charlotte St., Peterborough, Ont. K9J 2W3.
mineurs. A la revue des rapports de ces pa­
tients, il est clair que I'alcool, la conduite de 
nuit, une protection inadequate du visage et 
I’utilisation de terrains inconnus ont constitue 
les facteurs declenchants les plus frequents. 
L'elimination de ces risques et I'emploi de 
casques-protecteurs appropries pourraient pro- 
bablement reduire le nombre et la gravite de 
ces blessures.
T h e  snowmobile is a self-propelled snow 
machine with an engine situated in the for­
ward section, driving a cleated rubberized 
track. The latter is centrally placed and the 
steering is performed through handle-bar 
control of two front-end skiis. Snowmobiles 
today have up to 60 horse power and can 
attain speeds of 128 km /h .
It is estimated that there are now ap­
proximately 350 000 snowmobiles in On­
tario —  the same number as were in use 
in the whole of North America only 5 
years ago. Injuries associated with the use 
of snow machines have paralleled their in­
creased use. N o  accurate provincial accident 
statistics for snowmobiles are available, but 
in 1973-74 and 1974-75 the number of 
deaths from snowmobile accidents in On­
tario was recorded as 43  and 47, respec­
tively.
Martyn1 was the first to describe the 
distribution and type o f  injury associated 
with snowmobile accidents. He described a 
variety of injuries including extensive facial
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soft-tissue injuries but did not record any 
facial fractures.
A review of my experience with injuries 
resulting from snowmobile accidents was 
undertaken to document the incidence and 
type of facial fracture. It was also my pur­
pose to consider the mechanisms of facial 
injury and the methods by which such in­
juries might be prevented.
Case Material
Over two successive winters I treated 14 
patients (11 males and 3 females), ranging 
in age from 7 to 53 years, for injuries re­
sulting from snowmobile accidents. The 
details of their injuries are set forth in Table 
I.
F indings and Discussion
Cause of Accidents
As with automobile accidents, alcohol, 
speed and night driving are often combined. 
Machine failure was an infrequent cause 
although one accident occurred when an 
accelerator cable jammed in a “full on” 
position. Collision with fixed objects such 
as fence rails, wire fences and protruding 
tree branches often occurred when the 
operator was travelling in unfamiliar ter­
ritory.
Types of Fracture
The distribution of 14 facial fractures was 
as follows: mandible 5, zygoma 2, nose 4 
and maxilla 3. The facial fractures described 
were peculiar because of their isolated, lo­
calized nature. In all patients the fracture 
was moderately severe to severe. Zygomatic 
and orbital injuries commonly extended 
deeply into the orbital floor and included 
an isolated middle third fragment that was 
mobile. These injuries were frequently as­
sociated with an ethmoidal or nasal fracture. 
The nasal fractures were comminuted; often 
there was no overlying soft-tissue damage. 
There was no particular pattern in the man­
dibular fractures and the maxillary fractures 
were usually not associated with any other 
fracture.
Other head injuries were unusual in these 
patients. Only one patient had a mild con­
cussion in sharp contrast to our experience 
with automobile accidents in which concus­
sion frequently accompanied facial trauma. 
In addition, in my series the facial fracture 
was not associated with chest, head, abdom­
inal or peripheral injuries. The fractures 
were often complex and comminuted in 
contrast to those that might result from a 
fist-fight injury in which fractures tend to 
be simple and often occur along the lines 
of least resistance.
TABLE I —Summary of E xperience with 14 Cases of Facial Bone F racture 
in Snowmobile Accidents
Sex Age, yr Type of fracture Cause of fracture Associated injuries
M 23 Le Fort I Drove into barbed wire 
fence a t night
None
F 33 Zygoma and naso-orbit Fell off machine in organ­
ized race
None
M 34 Nose and zygoma At night, accelerator cable 
jammed a t “full on” and 
ran into parked car
Mild concussion
M 18 Angle mandible At night, hit handle-bars 
of machine
None
F 22 Le Fort I Hit rail fence and machine 
toppled
Mild face lacerations only
M 25 Le Fort II At night, drunk, drove off 
cliff, hit handle-bars
Head injury
M 43 Mandible Hit machine None
M 7 Compound fracture of nose Skiing and hit by machine NoneM 46 Zygoma and orbit Drunk, fell off NoneM 53 Compound fracture of nose Struck by automobile Fractured tibia and fibula. 
Extensive facial laceration. 
Severe head injuriesM 31 Mandible, right neck and 
left anterior body
Ran into barbed wire fence 
a t night
Laceration of mouth
M 49 Compound fracture of nose Driving 55 mph, ran into 
wire fence. Drunk
Central face laceration
F 46 Mandible, midline anterior 
comminuted
Ran into wire fence, fell off 
and hit tree a t night
None
M 12 Mandible, bilateral neck Struck stationary object None
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Mechanism of Accident
Facial contact was made by either striking 
the forward part of the machine, particu­
larly the handle-bars (five patients), or, more 
commonly, by striking a stationary object 
(eight patients) (Table 1). An unseen wire 
fence was a typical obstacle causing the 
latter type of injury. Facial lacerations were 
often associated with such injuries because 
the fence was usually of the barbed wire 
variety.
R ecommendations
The dictum: if you drink don’t drive and 
if you drive don’t drink could be applied 
to snowmobile drivers as well as to car 
drivers. Night driving should be avoided 
unless absolutely necessary. Courses in the 
proper use of the machine and in safety 
measures are offered by many snowmobile 
clubs; drivers should be encouraged to asso­
ciate themselves with such organizations. 
Ideally drivers should use established trails 
in defined areas. This would eliminate the 
possibility of collision with mobile or sta­
tionary automobiles, and unexpected sta­
tionary objects such as trees and fences. 
The handle-bar steering mechanism provides 
an irregular, hard, potential contact point 
that is a source of direct trauma in facial 
fractures; this section could be padded and 
protected. The helmet design should include 
a more durable face shield than is presently 
available.
Conclusions
A review of my experience with snow­
mobile accidents has shown that facial frac­
tures are a common feature. The injuries 
tend to be severe and localized; they are 
usually not associated with injuries to 
the head, chest, or other areas. These 
fractures differ from those seen in auto­
mobile accidents. Restricted use of estab­
lished trails, better protective head-gear, less 
use of alcohol, more controlled speeds and 
better driving conditions would reduce the 
number of accidents associated with snow­
mobile use. Instruction in the safe use of 
the vehicle should be required of all drivers.
Reference
1 Martyn JW: Snowmobile accidents. Can Med 
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GLIMPSES OF SURGICAL HISTORY: 
O FOR OPERATING TABLES
DAVID A. E. SHEPHARD
The first OPERATING TABLES were used 
by priests and divines. Long ago priests used 
wooden tables to support the bodies of small 
animals whose intestines were examined for 
divining the future, and in some prehistoric 
era, as an anatomic diagram on the Riviere 
Stone in southern Europe suggests, dissec­
tions were performed on sacrificial altar 
stones.
Early surgical operating tables were none 
other than pieces of domestic furniture, but 
by the time of Hippocrates a special table 
had been designed to aid physicians reduce 
dislocations of the legs. This was the scam- 
num; fitted with posts and levers, it was 
used by medical attendants at wrestling 
matches. Its use continued into Scultetus’ 
day. The way limbs were secured to the 
scamnums may have suggested to surgeons, 
later, a means of immobilizing patients on 
regular tables.
Except when the scamnum was used, 
early surgeons chose whatever table was 
handy. A popular type was the trestle-table, 
for the patient could be carried to and fro 
on the table-top. Formal operating tables 
came into use about the 15th century. All 
were made of wood; some were finely 
decorated. Metal tables were introduced 
about the middle of the 19th century. As 
the emphasis changed from speed to un­
hurried surgery so functional design became 
an important factor.
Operating tables today are sophisticated 
pieces of machinery. Like many other items 
in the surgeon’s armamentarium, operating 
tables require the services of surgeon’s lay 
colleagues, who respond to the complex re­
quirements of modern surgery. Once simple, 
operating tables illustrate the theme of this 
series —  that surgery has developed in part 
through advances made in many disciplines 
and crafts other than surgery.
Today’s operating tables are far removed 
from the early ones but the operating table 
remains the symbol of support for the pa­
tient who entrusts himself to the care of 
those who minister to him. Over the ages 
the operating table has retained its sig­
nificance to the healing art.
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CORRESPONDENCE
CARCINOMA OF THE THYROID 
GLAND
To the editor: The editorial by Wright (Can 
J Surg 19: 288, 1976) outlined several 
challenging suggestions for the treatment of 
cancer of the thyroid gland. Our experience 
coincides with his impressions.1 We com­
pared the end results in 70 patients with 
papillary or follicular cancer, or both, 
treated before 1960, with 252 patients 
treated after 1960 on the basis of a dif­
ferent method of management in these two 
periods.
Before 1960 management consisted of 
the following:
1. Lobectomy unless both lobes were in­
volved.
2. Elective radical neck dissection.
3. Radical therapeutic neck dissection.
4. Postoperative follow-up examination 
by clinical surveys (thyroid stimulating hor­
mone [TSH] and radioactive iodine [RAI] 
were not used).
5. No direct treatment of presumed re­
currences unless they were clinically evident 
by palpation, focal localizing symptoms and 
signs, or radiographic studies.
6. Thyroid hormone only and if required 
physiologically (it was not used to control 
or prevent cancer).
After 1960 the therapeutic regimen in­
cluded the following:
1. Total thyroidectomy.
2. No elective, prophylactic neck dissec­
tion.
3. Limited therapeutic neck dissection.
4. Postoperative regular and frequent 
follow-up examinations with TSH and RAI.
5. RAI therapeutic elimination of any 
areas of uptake in the thyroid field, post- 
operatively.
6. Thyroid hormone intake, to tolerance, 
permanently after operation.
The findings at the end of the first period 
revealed that 83% of the patients were 
alive and well after 13 to 21 years com­
pared with 95%  alive and well for 1 to 14 
years in the second period. The difference
Contributions to the Correspondence section are 
welcomed. They should be typewritten and double 
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between these two figures is not statistically 
significant and can be accounted for by the 
shorter follow-up in the second period, espe­
cially since occult recurrent thyroid cancer 
may appear even after 20 to 30 years.
This study convinced us that limited ex­
tirpation of the primary lesion (lobectomy), 
therapeutic limited excision of involved cer­
vical nodes, clinical and radiographic studies 
for possible recurrence, and postoperative 
exogenous intake of thyroid hormone as re­
quired physiologically are the basic require­
ments in the management of papillary and 
follicular cancer of the thyroid.
Total thyroidectomy and radical neck dis­
section are to be used only if the geographic 
extent of the disease necessitates such ex­
tensive operations to assure extirpation of 
the clinically obvious disease.
There is no indication for the routine use 
of TSH and RAI to delineate occult areas of 
uptake in the thyroid field, to be followed 
by their total elimination with therapeutic 
doses of RAI unless there is clinical evidence 
of cancer. There is no clinical basis for the 
presumption that cancer of the thyroid can 
be prevented or eliminated with suppres­
sive doses of thyroid hormone.
S. L. P erzik, m d
Department of surgery,
Cedars-Sinai Medical Center,
Los Angeles, CA.
R eference
1. P erzik SL: Surgery in Thyroid Disease: The 
Place of Total Thyroidectomy, New York, 
Stratton Intercon, 1976, p 212
To the editor: Dr. Perzik’s contribution 
brings further important data to bear on the 
question of the treatment of thyroid carci­
noma. There is, of course, no prospective, 
randomized, controlled clinical trial avail­
able to answer the controversial questions 
concerning what operation should be per­
formed for cancer of the thyroid, the place 
of radical neck dissection, and whether 
long-term therapy with thyroid hormones 
should be administered. Perzik does, how­
ever, compare two large personal series; 
in the first, before 1960, patients under­
went lobectomy and radical neck dissection
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preserves lysosome and cell membranes, thereby preventing the release of destructive 
lysosomal enzymes3
preserves platelets thereby reducing the risk of intravascular coagulation1 
preserves leukocyte integrity thereby helping to maintain the pulmonary architecture1
The recovery of patients in shock is often complicated by a pattern of deteriorating pul­
monary function, commonly described as shock lung. This pulmonary insufficiency 
progresses despite restoration of haemodynamic balance and apparent stabilization of 
the acute episode.
Cinder conditions of prolonged shock, lack of oxygen at the cellular level causes 
alterations in the oxygen-carbon dioxide exchange mechanism. These 
changes in cell metabolism lead ultimately to interstitial oedema and peri­
vascular haemorrhage.1 Polymorphonuclear leukocytes aggregate in 
the pulmonary capillaries and obstruct the pulmonary vascular 
bed. As these trapped cells break down, they release lyso- 
somes, tiny subcellular particles containing proteolytic 
enzymes.1 These enzymes attack their host cell and 
go on to damage or destroy other cells.2 The re­
sulting tissue damage may not readily repair 
itself even if the shock patient survives. 
When administered in conjunction with 
standard therapeutic measures, Solu- 
Medrol exerts a protective effect 
on the lung and improves the 
patient’s chance of survival.
Prescribing information on page 282
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and in the second, after 1960, patients had 
total thyroidectom y but limited therapeutic 
neck dissection.
As in all previous reports on the long­
term  results of operations for thyroid cancer 
it was not possible to  dem onstrate any dif­
ference according to the therapeutic regimen 
used. Perzik therefore draws the inescapable 
conclusion that limited extirpation of the 
prim ary lesion should be perform ed with 
limited excision of cervical nodes if and 
when they are macroscopically involved. 
The m ore aggressive approach of total thy­
roidectomy and radical neck dissection could 
only be justified with evidence that the pa­
tient is being offered significant benefit in 
exchange for the increased operative risk 
and postoperative sequelae. N o such 
evidence exists.
Dr. Perzik’s last point, that suppressive 
doses of thyroid horm one have not yet been 
shown to prevent or eliminate cancer of the 
thyroid, is well taken. Thyroid hormone 
therapy is now being given so extensively to 
patients after the primary treatm ent for 
papillary cancer of the thyroid that it should 
certainly be possible to answer this ques­
tion in a few years with careful follow-up.
C. J. Wright, mb, ch b, m sc, frcs[c], 
frcs(edin)
Department of surgery,
University Hospital,
University of Saskatchewan,
Saskatoon, Sask.
RUPTURE OF OVARIAN BENIGN 
CYSTIC TERATOMA CAUSING 
ACUTE ABDOMEN
To the editor: A n acute abdomen secondary 
to  rupture of a benign cystic teratom a is 
rare. A lthough teratom a is the m ost com ­
m on neoplasm in the young woman, it is 
often asymptomatic. Torsion is its most 
common complication, and rupture may 
occur in less than 2 % .1' 2 In  Paterson’s 
series,1 out of the 13 cystic teratom as that 
ruptured, five patients presented with acute 
abdomen. The following report is of interest 
because of its presentation.
Case Report
A 45-year-old woman, previously in good 
health, presented with acute onset of ab­
dominal pain. Two days before admission she 
had experienced abdominal fullness and vague
PRODUCT OF
Upjohn
STEROID
RESEARCH
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pelvic discomfort. Sharp lower abdominal pain 
awakened her at night, became steady and 
worse, and within 4 hours involved her whole 
abdomen. Breathing was difficult and ag­
gravated the pain. She denied any menstrual 
irregularity and she had had her last menstrual 
period 2 weeks earlier. Apart from mild nau­
sea there were no gastrointestinal symptoms 
and there were no urinary symptoms. She 
denied any vaginal discharge or previous epi­
sode of similar pain. Both of her pregnancies 
had terminated in vaginal delivery at term.
She was an anxious obese woman in obvious 
distress due to abdominal pain. Her blood pres­
sure was 120/70 mm Hg, pulse was 110 beats/ 
min. Respirations were 40/min and shallow. 
She was afebrile. The chest was clear but dia­
phragmatic excursion was limited and ab­
dominal splinting was obvious. Bowel sounds 
were minimal. Direct and rebound tenderness 
was elicited in all abdominal quadrants. On 
pelvic examination, the cervix was normal. 
A large, exquisitely tender pelvic mass ex­
tended into the abdomen. The leukocyte count 
was elevated but hemoglobin and hema­
tocrit values and the results of urinalysis were 
all within normal limits.
At laparotomy there was a large amount of 
murky fluid (950 ml) containing sebaceous ma­
terial and hair. A tense right adnexal mass, 15 
cm in diameter, had a small leak. The cystic 
mass was decompressed by suctioning the 
material. A purse-string suture was placed at 
the opening to prevent further spillage. The 
other pelvic organs appeared normal. Follow­
ing total hysterectomy and bilateral salpingo- 
oophorectomy the abdomen was lavaged with 
normal saline and two sump drains were 
placed, one into each lower quadrant. The 
adnexal mass was a ruptured benign cystic 
teratoma.
Conservative surgery for benign cystic 
teratoma (dermoid) is preferred when repro­
duction is desirable. Unilateral oophorec­
tomy or even cystectomy with inspection of 
opposite ovary may be adequate, though 
some surgeons recommend resection of a 
normal-looking ovary. Most women have 
regular pelvic examinations and as a result 
ovarian tumours are often discovered before 
they become clinically symptomatic. Thus, 
asymptomatic benign cystic teratomas rarely 
present as an acute abdomen.
Stefan Semchyshyn, md
Department of obstetrics & gynecology,
Ohio State University,
Columbus, OH.
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CARCINOEMBRYONIC ANTIGEN IN 
RECURRENT CANCER OF THE 
COLON
To the editor: In their paper on the prog­
nostic value of carcinoembryonic antigen 
(CEA) (Can J Surg 20: 64, 1977) Drs. Oh 
and MacLean conclude that preoperative 
and immediate postoperative CEA concen­
trations are predictive of recurrent colonic 
cancer. As their data was analyzed without 
reference to the pathological stage of the 
disease, it can be interpreted in an entirely 
different manner. The authors, themselves, 
admit that a good correlation has been ob­
served between preoperative CEA values 
and the extent of the disease and that there 
was a significantly higher preoperative CEA 
value in patients in whom the CEA concen­
tration failed to return to normal after sur­
gery. Surely the most likely explanation of 
this data is that if tumour is left behind at 
the time of resection recurrence is more 
rapid —  something surgeons have long 
known.
To make their point Drs. Oh and Mac- 
Lean would have to tell us that all 22 pa­
tients in their groups 2 and 3 had curative 
resections and that the pathological stage 
of the cancer was identical in both groups. 
If this were so, then the evidence in their 
paper would indeed suggest that surgeons 
should measure CEA after curative resec­
tion and regard an elevated value as a sign 
of poor prognosis.
M. M. Cohen, mb, frcs(edin), frcs[c]
Associate professor,
Department of surgery,
University of British Columbia,
Vancouver, BC.
To the editor: In response to Dr. Cohen’s 
letter, all 22 patients in groups 2 and 3 in 
our study had, in the opinion of the oper­
ating surgeon, a curative resection of the 
colonic cancer. The pathological stage of 
the cancer was not identical in that a greater
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portion of patients in group 3 were found 
to have lymph-node involvement than in 
group 2, explaining the much higher aver­
age value of preoperative CEA in group 3. 
Nevertheless, the point that we were trying 
to make was that postoperative CEA can 
reflect the effectiveness of surgery; thus, 
a failure of CEA to return to normal after
apparently curative surgery is more likely 
indicative of cancer spread undetected at 
the time of surgery.
J. O h , m d , ph  d
L. D. M acL ean , m d , ph  d , fr c s[c]
Department of surgery,- 
Royal Victoria Hospital,
Montreal, PQ.
DAVIS & GECK SURGICAL ESSAY AWARD FOR RESIDENTS
Davis & Geek annually awards $1000.00 to the surgical resident submitting the 
best paper on a surgical topic to the Canadian Journal of Surgery. This award is in­
tended to promote scientific and literary excellence among Canadian surgeons in 
training.
The conditions of entry for the 1977 award are the following: —
1. Candidates shall be currently engaged in a recognized surgical residency program 
leading to eligibility for the Fellowship of the Royal College of Physicians and 
Surgeons of Canada in one of the surgical specialties (cardiovascular and thoracic 
surgery, general surgery, neurosurgery, obstetrics and gynecology, ophthalmology, 
otolaryngology, orthopedic surgery, plastic surgery and urology).
2. The material to be submitted shall be in the form of a manuscript relating to 
work in which a surgical resident is or has been the prime or major investigator. 
Prior oral presentation at a Royal College meeting or a Surgical Forum meeting 
will not be a disqualification, but prior publication as a formal paper in a 
journal will. The paper should relate to any field of surgical interest. The manu­
script must conform to the style requirements of the Journal and must not 
exceed 3000 words of text and six tables and/or six figures. Coauthors are 
permitted on the understanding that the candidate shall be the first author and 
that only the first author shall be eligible for the award.
3. Entries must be received in the office of the Journal no later than June 30, 1977. 
Each entry must be submitted to E. M. Cooperman, MD, FRCP[C], at the 
office of the Canadian Journal of Surgery, PO Box 8650, Ottawa, Ont. 
K1G 0G8, with a letter stating that the paper is being submitted as an entry 
for the Davis & Geek Surgical Essay Award.
4. All papers submitted shall be the property of the Canadian Journal of Surgery 
unless returned to the author without publication.
All papers submitted will be judged by an independent committee comprising at 
least one member of the editorial board of the Journal, one fellow of the Royal College 
of Physicians and Surgeons of Canada, and one representative of The Canadian Medical 
Association, together with other fellows invited to serve at the discretion of the three 
permanent members of the committee. For the purpose of judging, the candidates will 
be anonymous. The judges’ decision shall be final.
The name of the successful candidate and the title of the paper will be announced 
in the November 1977 issue of the Journal.
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Advances in Nephrology from the Necker Hos­pital. Vol. 6. Edited by Jean Hamburger, Jean Crosnier and Morton H. Maxwell. 474 pp. II- lust. Year Book Medical Publishers, Inc., Chi­cago, 1976. Price not stated. ISBN 0-8151- 4115-7.Advances in Surgery. Vol. 10. Edited by William P. Longmire, Jr. 330 pp. Illust. Year Book Medical Publishers, Inc., Chicago, 1976. Price not stated. ISBN 0-8151-5632-4.The Anesthesiologist’s Handbook. 2nd ed. Donald G. Catron. 201 pp. Illust. University Park Press, Baltimore, 1976. $8.95, paperbound. ISBN0-8391-0956-3.Arthritis Surgery. Leonard Marmor. 548 pp. Il­lust. Lea & Febiger, Philadelphia; The Mac­millan Company of Canada Limited, Toronto, 1976. $54.30. ISBN 0-8121-0537-0._Chirurgie Plastique Cutanee de la Main et de la Puipe. R. Vilain and J. Michon 162 pp. Illust. Masson & Cie, Paris, 1977. $26.00. ISBN 2- 225-45122-2.Clinical Microneurosurgery. Edited by W. Th. Koos, F. W. Bock and R. F. Spetzler. 317 pp. Illust. Georg Thieme Verlag, Stuttgart; Chimera Press Inc., Willowdale, 1976. (Distributed in Canada and U.S. by Publishing Sciences Group, Inc., Acton.) $41.50. ISBN 3-13-523601-3.Die Untersuchung der Bauchspeicheldriise. I. Hamburger Medizinisches Symposium 12 and 13 Dezember 1975. Edited by Heinrich Bartel- heimer, Meinhard Classen and Friedrich-Wil- helm Ossenberg. 1972 pp. Illust. Georg Thieme Verlag, Stuttgart, 1976. DM 50,00, paperbound. ISBN 3-13-5446-01-8.Early Care of the Injured Patient. 2nd ed. TheCommittee on Trauma, American College of Surgeons. 443 pp. Illust. W. B. Saunders Com­pany, Philadelphia, 1976. Price not stated. ISBN 0-7216-1161-3.Handbook of Critical Care. Edited by James L. Berk, James E. Sampliner, J. Sheldon Artz and others. 574 pp. Illust. Little, Brown and Com­pany Inc., Boston, 1976. Price not stated. ISBN 0-316-09170-7.The Hip. Proceedings of the Fourth Open Scien­tific Meeting of The Hip Society, 1976. The Hip Society. 270 pp. Illust. The C. V. Mosby Company, Saint Louis, 1976. $31.00. ISBN 0-8016-0036-7.Immunology for Surgeons. Edited by J. E. Castro. 401 pp. Illust. University Park Press, Baltimore, 1976. $29.50.Motor Disorders of the Esophagus. Robert D. Henderson and John O. Godden. 231 pp. Illust. The Williams & Wilkins Company, Baltimore; Burns and MacEachern Limited, Don Mills, 1976. $24.75. ISBN 0-683-03947-4.Moyer’s Fluid Balance: A Clinical Manual. 2nd ed. John C. Vanatta and Morris J. Fogelman. 117 pp. Year Book Medical Publishers, Inc., Chicago, 1976. $18.50. ISBN 0-8151-8962-1. Practical Ophthalmic Plastic and Reconstructive Surgery. Merrill J. Reeh, Charles K. Beyer and Gerard M. Shannon. 205 pp. Illust. Lea & Febiger, Philadelphia, 1976. Price not stated. ISBN 0-8121-0547-8.Principles of Surgery. 2nd ed. D. J. du Plessis. 186 pp. John Wright & Sons Ltd., Bristol, 1976. Price not stated, paperbound. ISBN 0-7236- 0445-2.Roentgen Diagnosis of Bones. A Self-Teaching Manual. M. Eiken. 85 pp. Illust. F.A.D.L.s
Forlag, Denmark; Year Book Medical Publish­ers, Inc., Chicago, 1975. Price not stated, paper- bound. ISBN 87-7437-514-8.Special Tumors of Ovary and Testis and Related Extragonadal Lesions. Comparative Pathology and Histological Identification. 2nd ed. Gunnar Teilum. 513 pp. Illust. Munksgaard Interna­tional Publishers Ltd., Copenhagen; J. B. Lip- pincott Company of Canada, Toronto, 1976. $59.50. ISBN 0-397-58197-1.Surgery in Thyroid Disease. The Place of Total Thyroidectomy. Samuel L. Perzik. 273 pp. Illust. Stratton Intercontinental Medical Book Corporation, New York; Longman Canada Limited, Don Mills, 1976. $20.75. ISBN 0- 88372-090-6.Surgical Immunology. Edited by Andrew M. Munster. 327 pp. Illust. Grune & Stratton, Inc., New York; Longman Canada Limited, Don Mills, 1976. $26.00.Techniques of Patient Care. A Manual of Bedside Procedures. 2nd ed. Clarence E. Zimmerman. 272 pp. Illust. Little, Brown and Company Inc., Boston, 1976. Price not stated, paperbound. ISBN 0-316-98868-5.Textbook of Gynecology. Edited by Russell Ramon De Alvarez. 546 pp. Illust. Lea & Fe­biger, Philadelphia; The Macmillan Company of Canada Limited, Toronto, 1977. $45.00. ISBN 0-8121-0515-X.Le Traitement des Metastases Osseuses. J. Duparc and J. Decoulx, 274 pp. Illust. Masson & Cie, Paris, 1976. Price not stated, paperbound. ISBN 2-225-45529-5.Transactions of the Sixth International Congress of Plastic and Reconstructive Surgery. Paris, 24- 29, August, 1975. Edited by Daniel Marchac. 735 pp. Illust. Masson & Cie, Paris, 1976. Price not stated. ISBN 2-225-45485-X.Tumeurs Nerveuses O.R.L. et Cervico-Faciales. VIHe Congres de la Societe Franchise de Car- cinologie Cervico-Faciale. Edited by J. Leroux- Robert. 199 pp. Illust. Masson & Cie, Paris, 1977. $28.00. ISBN 2-225-46453-7.Venous Thromboembolism. Prevention and Treat­ment. Edited by John L. Madden and Michael Hume. 240 pp. Illust. Appleton-Century-Crofts, New York, 1976. $15.00. ISBN 0-8335-9406-9.Visible & Palpable Lesions in Children. C. Everett Koop. 123 pp. Illust. Grune & Stratton, Inc., New York; Longman Canada Limited, Don Mills, 1976. $15.15. ISBN 0-8089-0958-4.Volumenregulation und Flussigkeitslunge. Sym- poseom Hamburg, November, 1975. Edited by Peter Ecket. 103 pp. Illust. Georg Thieme Ver­lag, Stuttgart, 1976. DM 39,80. ISBN 3-13- 236201-8.
Wound Repair. 2nd ed. Erie E. Peacock, Jr. and Walton Van Winkle, Jr. 699 pp. Illust. W. B. Saunders Company, Philadelphia, 1976. Price not stated. ISBN 0-7216-7124-1.
The Year Book of Orthopedics and Traumatic Surgery. 1976. Edited by Mark B. Coventry. 480 pp. Illust. Year Book Medical Publishers, Inc., Chicago, 1976. Price not stated. ISBN 0- 8151-1875-9.Year Book of Surgery 1976. Edited by Seymour I. Schwartz and associates. 520 pp. Illust. Year Book Medical Publishers, Inc., Chicago, 1976. Price not stated.
The Year Book of Urology. 1976. Edited by John T. Grayhack. 385 pp. Illust. Year Book Medical Publishers, Inc., Chicago, 1976. Price not stated. ISBN 0-8151-3910-1.
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Just published
“This book is good reading, and a lesson in writ- usual and customary multiple authors . . .  it is 
ing, medical or otherwise. It is an undertaking o f enthusiastically recommended to everyone with 
unusual proportion and a remarkable achieve- an interest in gastroenterology” 
ment indeed. It illustrates the advantages o f  —From a Review of the First Edition
single authorship, with its evenness o f  style and ?few E" 9land Journal of Medicine
quality and lack o f tedious repetition over the November 12,1970
CLINICAL GASTROENTEROLOGY Second Edition
Howard M. Spiro, M.D., Yale University School of Medicine; Attending Physician (Director 
Gastroenterology Section), Yale—New Haven Hospital, New Haven
The updated secon d  edition of this au­
thoritative, well-illustrated volume deals 
with the many diseases that affect the 
human gastrointestinal tract— from congen­
ital lesions, infections, motor abnormalities, 
and structural disorders to metabolic disor­
ders, inflammatory disorders, and tumors. 
The author maintains a practical, clinical 
approach throughout the 60 chapters and 
places special emphasis on common gas­
trointestinal disorders. The book contains
over 500 outstanding illustrations, up-to- 
date bibliographies, and instructions for var­
ious diets of gastroenterologic significance.
Many new sections have been added— 
among them a widened treatment of the 
APUD cell system and pancreatic cholera, 
and considerable information on the new 
uses of endoscopy and angiography, as well 
as scans and echoes.
1977 1289 pages Illus. $51.95
Available soon
BASIC SURGERY Edited by John A. McCredie, M.B., B. Ch„ B.A.O., M. Ch. 
(Belt), F.R.C.S. (Eng. & Edin.), F.R.C.S. (Can.) EA.C.S., Associate Professor of Surgery 
and Therapeutic Radiology, University of Western Ontario; Illustrated by Carol Donner, 
B.F. A., A.M.I., Society of Illustrators
This lavishly illustrated, multiauthored 
textbook and reference in surgery has been 
prepared as a guide to understanding 
pathophysiologic processes and explaining 
clinical phenomena. Its four main units en­
compass the basic medical sciences; general 
principles common to the care of all surgical 
patients; fundamentals of general surgery; 
and principles of specialty surgery, including 
orthopedic surgery and fractures, car­
diopulmonary surgery, peripheral vascular
surgery, urology, reconstructive and plastic 
surgery, neurosurgery, and pediatric 
surgery.
Hundreds of outstanding illustrations, in­
cluding a four-color atlas of surgical 
anatomy, reinforce important points and 
simplify difficult concepts. Wherever possi­
ble, references that constitute a review of a 
particular subject are cited. 1977
7 6 8 pages (approx.), Illus., Paper$17.75
Please send me the following book(s):
□  Clinical G astroenterology, Second Edition, 
by Howard M. Spiro, @  $51.95 each.
□  B asic  S urgery, by McCredie and Donner, 
@  $17.75 each.
1 have enclosed my cheque □  or money order □
for $_________________
Price includes postage and handling.
MAIL TO: COLLIER MACMILLAN CANADA, LTD., 
Dept. C., 1125B Leslie Street,
Don Mills, Ontario. M3C 2K2
Name ___
Address _
City ______
Province _
Postal Code
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B O O K  R E V I E W S
CLINICAL NEUROSURGERY. Proceedings 
of the Congress of Neurological Surgeons, 
Atlanta, GA, 1975. Edited by Ellis B. Kee­
ner and associates. 562 pp. Illust. The Wil­
liams & Wilkins Company, Baltimore; Burns 
& MacEachern Limited, Don Mills, 1976. 
$28.50.
William H. Sweet, a neurosurgeon, whose in­
quisitive mind has long-influenced American 
neurosurgery, was the honoured guest at the 
1975 annual meeting of the Congress of Neuro­
logical Surgeons. This volume, its proceedings, 
is dedicated to him. Testimony to the man’s 
abilities is present in the diversified papers 
that he delivered, which are reproduced herein. 
His broad interests encompass pain surgery, 
the radical treatment of craniopharyngioma, 
trigeminal neuralgia and his sparkling address 
“The Difference Between Zero and One”. We 
are exhorted in it to “look thoughtfully at in­
dividual novel events, analyze them carefully 
and decide whether or not they may contain 
the kernel of a new concept”.
But the text has even more to offer. A guest 
faculty of experienced cerebrovascular sur­
geons examine in their papers the cerebrovas­
cular tree from the carotid artery to the corti­
cal vessel, from atherosclerosis to intracranial 
aneurysm and from strokes in children to hy­
pertensive intracerebral hemorrhage in the 
elderly. For those previously overwhelmed by 
the flurry of reports on cerebral revasculariza­
tion surgery, there are five lucid papers that 
are the current benchmarks in this area of in­
terest.
Another major section enumerates various 
neurosurgical complications of aneurysm and 
spinal surgery, cerebrospinal fluid shunting 
procedures, fluid and electrolyte balance, sub­
dural hematoma and infection. When faced 
with a surgical complication, many of us 
might, as one author states, wish for an in­
stant “replay”. Instead we are treated to a 
“coaches clinic” comprised of 12 papers de­
tailing those problems (and their management) 
and reassuring those of us who previously felt 
lonely with our complications.
Notwithstanding the above, there is in Amer­
ican neurosurgery today an all-consuming issue 
that preoccupies every practitioner regardless 
of his academic interests — malpractice. It 
seems appropriate that a volume that begins 
with Sweet’s advice to the neurosurgeon when 
faced with litigation should end with chapters 
on the law, therapy and prognosis of profes­
sional liability.
It is difficult therefore not to maintain one’s 
enthusiasm for this annual publication of the 
Congress of Neurological Surgeons.
R. P. H umphreys
Division of neurological surgery,
The Hospital for Sick Children,
Toronto, Ont.
CORONARY ANGIOGRAPHY AND A N ­
GINA PECTORIS. Symposium of the Euro­
pean Society of Cardiology, Hanover, 
March, 1975. Edited by P. R. Lichtlen. 383 
pp. Illust. Georg Thieme Publishers, Stutt­
gart, 1976. DM 68,00. $27.40 approx.
This book is the end result of a symposium 
sponsored by the European Society of Car­
diology. The first section is devoted to the 
technical aspects of coronary angiography and 
includes discussions on the developments in 
radiologic equipment such as the new image 
intensifiers, newer developments in cine films 
and photography, craniocaudal projections in 
coronary arteriography and advances in coro­
nary angiography using the Judkins and Bou- 
rassa techniques.
The next section is devoted to the clinical 
aspects of coronary and left ventricular angio­
graphy; it includes papers on myocardial in­
farction with normal coronary angiograms, 
coronary angiography in variant angina pec­
toris, unstable angina and the usual progres­
sion of coronary artery disease.
The ventriculographic aspects of coronary 
artery disease include papers on the value of 
left ventricular catheterization and angio­
graphy, determination of left ventricular per­
formance and the use of computers, pressure 
volume studies, and finally the value of the 
left ventricular angiogram in coronary artery 
disease.
The section on coronary angiography and 
left ventricular angiography is particularly 
interesting. The reports on angiographic stu­
dies in patients following revascularization 
surgery are detailed and include comment on 
graft patency, progression of native vessel 
disease and the effect of bypass surgery on left 
ventricular function. This section is followed 
up with some papers dealing with special tech­
niques related to coronary angiography. These 
include papers on morphometric analysis of 
coronary arteries, the technique for measuring 
the diameter of coronary arteries and venous 
bypass grafts and the use of myocardial 
imaging and scanning techniques.
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The final section details a workshop on the 
formation of collateral blood supply in the 
treatment of angina pectoris. This review in­
cludes a discussion on the use of calcium an­
tagonists in coronary artery therapeutics and 
papers on the development of collateral blood 
supply, the coronary steal syndrome and the 
use of nifedipine beta blockers, dipyridamole 
and nitroglycerin.
Cardiologists would be particularly inter­
ested in the natural history studies and some 
of the anatomic details of coronary angiogra­
phy. The technical aspects of coronary angio­
graphy are well reviewed, but the authors have 
assumed that the reader has some knowledge 
in the field. The papers on nifedipine, a new 
calcium antagonist that acts as a coronary 
vasodilator, are particularly interesting since 
the drug is not yet available in North America. 
The cardiovascular surgeon would be parti­
cularly interested in the postoperative angio­
graphic studies as they relate to vein graft 
occlusion, the progression of disease and the 
native coronary circulation and the effect of 
bypass surgery on left ventricular performance.
In summary, this book is not intended for 
students; it would be of interest to cardiac 
radiologists, cardiologists and cardiovascular 
surgeons. The quality of the papers is variable 
but there are enough good ones to make this 
book a worthwhile addition to the libraries of 
the above-mentioned specialists.
D. S. Beanlands
Chief of cardiology,
University of Ottawa cardiac unit,
Ottawa Civic Hospital,
Ottawa, Ont.
EARLY CARE OF THE INJURED PA­
TIENT. 2nd ed. The Committee on Trau­
ma, American College of Surgeons. 443 pp.
Illust. W. B. Saunders Company, Philadel­
phia, 1976. Price not stated.
The authors of this second edition have cov­
ered almost all the problems that confront the 
surgical staff in an emergency department; 
they have properly included the often less- 
dramatic conditions including burns, bites and 
stings. One entire section is devoted to cardiac 
arrest. It is obvious that the contributors each 
have a wide experience in the subjects they 
discuss; the treatments recommended are 
founded on practical experience rather than 
on theory.
The early chapters deal with primary assess­
ment, the general principles involved in caring 
for open wounds, the treatment of shock and 
the general considerations that must be given
to the prophylaxis and treatment of infection. 
A chapter on the choice of anesthesia is in­
cluded; it is useful and indicates that anes­
thesia is not a routine matter.
The authors of this book recognize that a 
single surgeon should be in overall charge 
of the patient with multiple injuries; it is hoped 
that this concept will be given more considera­
tion in the various surgical training programs 
and a higher priority in the treatment of this 
type of patient.
Chapters are included on head injuries and 
injuries to the spine and spinal cord; general 
surgeons are involved in a high percentage of 
these cases. Knowledge vital to the safe treat­
ment of these injuries is therefore included.
The assessment and treatment of injuries to 
the chest, abdomen and genitourinary tract are 
covered in separate chapters in a sound and 
acceptable manner. Fractures are dealt with 
in a section that outlines the general consider­
ations and safeguards; the most frequent frac­
tures are dealt with individually and specific­
ally.
My interest in this subject dates back about 
40 years; I can agree wholeheartedly with the 
principles expressed in this book and re­
commend it as a sound text on the subject.
J. C. Samis
267 O’Connor St.
Ottawa, Ont.
ESOPHAGEAL HIATUS HERNIA. Ra­
tionale and Results of Anatomic Repair. 
Thomas Gahagan and Conrad R. Lam. 189 
pp. Illust. Charles C Thomas, Publisher, 
Springfield, IL, 1976. $19.50.
This monograph presents a 20-year experience 
with surgery for hiatus hernia at the Henry 
Ford Hospital and gives the personal views of 
a respected senior surgeon, Conrad Lam.
With Gahagan, his co-author, Lam presents 
the story of the development of surgery for 
hiatus hernia and esophageal reflux, with a 
multitude of personal details and anecdotes. 
He describes with clarity the attitudes, posi­
tions, ideas and operations of individuals and 
groups as they have developed over the years. 
His personal stature has permitted him to know 
the cast of characters well and to describe the 
unique contributions of each as the story un­
folds. A stickler for precision, accuracy and 
clarity of definition, Lam spends time on each 
of the controversial areas of anatomy and sur­
gery. He defines his terms and explains the 
origin of opposing or obtuse views.
The book contains a detailed description and 
critique of current diagnostic techniques; in
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an equivalent depth the authors describe sur­gical methods of dealing with esophageal re­flux and hiatus hernia. Convinced of the efficacy of the transthoracic Allison repair, they present a lengthy description of this tech­nique and the results against which other re­sults must be measured. Lam also describes the surgical operations and problem of fundo- plication and gastroplexy and reports on the 
outcomes. The value of each procedure is not measured in terms of the alterations or physio­
logy or radiographic analysis of the swallow­ing mechanism, but rather in terms of the long range surgical outcome. Esophagoscopy, mano­
metry and acid tests occupy less than two pages of the manuscript. Motility studies, electrical activity of the esophagus and manometry of the cardioesophageal area are left for the re­search laboratory and are properly given little or no place in this monograph. There are three principles to which the authors adhere; elimi­
nate the sac, reduce the viscus, and make sure that the cardioesophageal junction is intra­
abdominal.This little monograph, comprising a histor­ical review of the development of surgery for hiatus hernia and the experience of the Henry Ford hospital in this area, is a delightful book for the average surgeon, but is probably re­
dundant for the esophageal expert.
C. B. Mueller
Department of surgery,McMaster University,Hamilton, Ont.
GLAUCOMA IN INFANTS AND CHIL­
DREN. Marvin L. Kwitko. 651 pp. Illust.Appleton-Century-Crofts, Meredith Corpo­
ration, New York, 1973. Price not stated.
This book is a welcome addition to the library of those interested in glaucoma as manifested 
in young patients. It is large and well ref­
erenced.The author first reviews the anatomical and embryologic causes of glaucoma and describes 
the differences between normal and glauco­matous eyes. He includes a number of helpful photographs and diagrams of the angle changes in glaucoma; most are in black and white. Of particular interest is the chapter on the pathogenesis of symptoms in congenital glaucoma. The section on differential diag­nosis contains some long tables and descrip­tions of various disease processes such as molluscum contagiosum, arcus juvenilis and Wilson’s disease, whose association with glau­
coma is marginal.In the chapter on treatment, the author de­
scribes in detail the various procedures used in the management of glaucoma; he includes tables summarizing the results of specific treat­ments. Particular emphasis is placed on the treatments of primary congenital glaucoma.Although the treatment of primary conge­nital glaucoma is described the book does not contain enough information on the manage­
ment of other forms of glaucoma in infants and children. For example, treatment of Stur- ge-Weber, Weill-Marchesani and Rieger’s syn­
dromes are not well outlined; a review of the 
various procedures that have been attempted in connection with these rare syndromes would have been helpful. Kwitko is to be congratu­
lated; he has produced a good book. It is re­commended for ophthalmologists and their 
residents.
W. Rock
Ste. 407267 O’Connor St.,Ottawa, Ont.
HEPATIC SUPPORT IN ACUTE LIVER 
FAILURE. Edited by Gustavo G. R. Kus- 
ter. 301 pp. Illust. Charles C Thomas, Pub­
lisher, Springfield, IL, 1976. $23.50.
The editor has assembled in this book the con­tributions of several experts in the manage­ment of acute hepatic failure. As he observes in his introduction, the long-term outlook in hepatic failure due to chronic liver disease is poor, but there are a number of patients with 
acute massive liver cell injury whose prognosis would be improved if an efficient method were 
available to support life over a short period of time. Development of such a technique, an­
alogous to dialysis for acute renal failure, 
would also increase the scope for new thera­pies in chronic liver disease, including the clinical application of hepatic transplantation.
The results from the techniques described 
are disappointing: exchange transfusion and plasmapheresis have a beneficial effect in less than 20% of cases; extracorporeal perfusion of a baboon liver appears complex and ex­pensive, but was helpful in several trials; cross-circulation with human volunteers cannot be justified; temporary support with auxiliary liver transplantation in man has had poor results to date and the mortality rate from asanguineous hypothermic body perfusion (total body washout) in the reported cases ap­
proaches 50%.
Although the contributors provide an im­pressive display of ingenuity and perseverance, this reader is left wondering if any of the listed
Availability;
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methods can be developed into a practical 
method of hepatic support, or whether the 
field awaits a new approach.
R. M. Preshaw
Division of surgery,
University of Calgary medical school,
Calgary, Alta.
INSTRUCTIONAL COURSE LECTURES.
Yol. XV. American Academy of Orthopedic
Surgeons. 247 pp. Iilust. The C. V. Mosby
Company, Saint Louis; The C. V. Mosby
Company, Ltd., Publishers, Toronto, 1976.
$36.25.
In this volume three chapters are worthy of 
special comment; they demonstrate that basic 
science knowledge gained in the laboratory 
has clinical applications.
The first chapter is a review of current re­
search on bone graft physiology. The basic 
science aspects of bone grafting are first re­
viewed, then the incorporation of this knowl­
edge into a specific area of orthopedic prac­
tice is outlined briefly. We learn, for example, 
that in treating avascular nonunion of the 
tibia, grafts laid on the medial side of decor­
ticated bone without application of a com­
pression plate, will yield the highest rate of 
success.
The second chapter by Robert Jackson deals 
with surgery of the patellofemoral joint. This 
is an excellent update on current basic re­
search. Biomechanical stresses across the joint 
were measured in various degrees of flexion; 
the minimal force across the patellofemoral 
joint is present when the knee is in complete 
extension. This finding reinforces the prin­
ciple of performing isometric exercises in full 
extension for patellofemoral pathology. Jack- 
son stresses that after a careful clinical exam­
ination of the patella, arthroscopy is valuable 
in diagnosing chondromalacia. On the basis of 
an appreciation of the biomechanical and bio­
chemical problems involved in the etiology, 
he then outlines a classification of chondro­
malacia.
Augusto Sarmieto covers the subject of 
functional cast bracing in a variety of specific 
situations. This is the best review article in 
the volume. He describes the biomechanical 
support theory behind functional bracing. 
Sarmieto states that functional bracing cannot 
be used in all fractures; in some instances 
the reduction cannot be maintained and con­
ventional methods of fracture management 
must be used. The principle of using a cast to 
immobilize only the fracture, and not the joints 
above and below, allows for early ambulation
and prevents joint stiffness and muscle a- 
trophy. This concept is one of the most im­
portant recent advances in fracture manage­
ment. As usual, the American Academy of 
Orthopedic Surgeons has produced an excel­
lent volume of instructional course lectures. 
Orthopedists at the resident and staffman 
level will enjoy reading it; they will also profit 
from the experience.
D. H. Johnson
Director,
The sports medicine clinic,
Carleton University,
Ottawa, Ont.
MEDICAL MANAGEMENT OF THE SUR­
GICAL PATIENT. S. G. Smiddy, 280 pp.
Edward Arnold (Publishers) Ltd., London;
Year Book Medical Publishers, Inc., Chica­
go, 1976. Price not stated.
This is a synopsis of the pathophysiology and 
treatment of medical conditions commonly en­
countered by surgeons in practice. Smiddy has 
organized the subjects to help especially the 
candidate facing oral examinations; at the 
same time the successful candidate who no 
longer feels compelled to pursue the literature 
with such pre-examination zeal will benefit 
from the review and enjoy the process.
The author begins each subject with a brief 
historical summary dating back to the earliest 
description of the topic under consideration; 
he then discusses the current state of the art. 
The book has covered many subjects well but, 
surprisingly, hepatitis and cancer immunology 
are not included. Much of the information 
does not reflect experience beyond 1970; this 
is the most serious weakness of the book. For 
example we are not told that intravenous furo- 
semide (Lasix) is used more commonly than 
mannitol for the prevention of acute renal 
failure, no mention is made of dopamine in 
the treatment of shock and the primacy of 
rifampin in the treatment of tuberculosis is 
not acknowledged.
Some inaccuracies, overstatements and un­
derstatements occur; in part these result from 
the brevity of the publication. The gonococ­
cus, for instance, is incorrectly said to be gram 
positive; treatment of patients with nonketotic 
hyperosmolar hyperglycemic coma is discussed 
without pointing out the extreme sensitivity of 
these patients to insulin; and the author fails to 
caution the reader about the hazards of tetra­
cycline in patients with renal insufficiency. 
In addition, the ingestion of phenacetin for a 
short period of time does not, as the author 
incorrectly suggests, lead to chronic nephritis.
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Smiddy is to be complimented for under­
taking such an ambitious project. Some of the 
pharmacologic details, however, are neither 
relevant nor helpful; by updating the material 
and providing a more recent bibliography the 
book would be of still greater use.
E. Z. R abin
Division of nephrology,
Ottawa Civic Hospital,
Ottawa, Ont.
PRINCIPLES OF SURGERY IN THE FIRST
SIX MONTHS OF LIFE. S. Frank Redo.
180 pp. Illust. Harper & Row, Publishers,
Inc. Hagerstown, MD, 1976. $22.50.
The author has summarized the surgical prob­
lems common to the early months of life. He 
has not included congenital heart problems, 
and the orthopedic section is brief and incom­
plete by any standard. The author has promised 
to follow-up with a companion book in an 
atlas style, which will cover the surgical steps 
in the correction of operable lesions.
This book is about the size of a standard 
journal; , the illustrations, including many 
radiographs, are large and clear, the print 
is sharp and the headings are bold. The 
writing is crisp and interesting. The references 
that follow each chapter are divided by sub­
ject and therefore may be used independent­
ly of the text; unfortunately most of these are 
at least 10 years old. The introductory chapter 
by Krauss on physiology is a brief introduction 
to the subject; here the references are more 
recent than those used in the rest of the book, 
but space limitations have forced the author 
to introduce each subject rather than discuss 
it in depth.
This is another handy reference book for all 
who deal with children. It will be of most use 
to medical students preparing for oral exam­
inations, and to 1st year residents in pediatrics 
and pediatric surgery. As such, it is well done.
E. M. COOPERMAN
THE SPINE. A RADIOLOGICAL TEXT 
AND ATLAS. 4th ed. Bernard S. Epstein. 
856 pp. Illust. Lea & Febiger, Philadelphia; 
The Macmillan Company of Canada Lim­
ited, Toronto, 1976. $45.00.
This new edition of Epstein’s textbook on the 
spine is comprehensive and well organized; it 
continues to deserve the excellent reputation 
it has always enjoyed.
To make things easy to find, the book is
divided into 10 sections and 43 chapters with 
as many as 21 divisions in each chapter. The 
book is long, but not dull; it may be read 
from cover to cover or in random fashion. 
The index is extensive; information is easy 
to extract. High quality illustrations are found 
on almost every page and at the end of each 
division there are numerous up-to-date ref­
erences.
The chapters dealing with trauma and neo­
plastic disease are particularly useful; an en­
tire chapter is appropriately devoted to both 
spondylolisthesis and multiple myeloma.
This book is probably the best in its field 
and deserves to be in the library of all radiol­
ogists and other physicians and surgeons in­
terested in the spine.
A. M. QuARRINGTON
Department of radiology,
Ottawa Civic Hospital,
Ottawa, Ont.
SURGICAL IMMUNOLOGY. Edited by An­
drew M. Munster, 327 pp. Illust. Grune &
Stratton, Inc., New York; Longman Canada
Limited, Don Mills, 1976. $26.00.
This is a book “for all seasons” though the 
title is misleading. The book is more a sum­
mary of current clinical immunology than an 
immunology text for surgeons. The immuno­
logy of transplantation and management of 
clinical problems related to renal transplanta­
tion are properly stressed. Also included are 
chapters on congenital and acquired immuno­
deficiency syndromes, autoimmune disease, 
mono- and polyclonal gammopathies, the HLA 
system and disease susceptibility, cancer im­
munology and immunologic laboratory tech­
niques.
The historical introduction is of special in­
terest. Munster tells of the mythology and folk­
lore that antedated modern scientific work. 
Surgical interest in immunology increased 
when Emerich Ullman, a Viennese surgeon, 
published a paper on kidney transplantation in 
the dog. Carrel, working in Chicago during 
the same period, attempted vascular anasto­
mosis in transplanting a variety of organs in 
the experimental animal; he was the second 
surgeon after Kocher to win the Nobel prize.
In 1943 Kolff in Holland developed the 
first artificial kidney. In 1947 the first clin­
ical renal transplant was attempted at the 
Peter Bent Brigham Hospital in Boston, and 
the first kidney transplant was performed suc­
cessfully between identical twins in 1954. In 
1959 Burnet explained the clonal selection
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theory of immunity, and the following year he 
and Medawar shared the Nobel prize. Burnet 
taught that developing clones or cell families 
are exposed to antigens present in the tissues of 
the fetus; cells programmed to react to these 
antigens are wiped out forever. This mechan­
ism allows us in later life to live rather than 
self-destruct.
A clear distinction is drawn in later chap­
ters between the thymic dependent T cell and 
the bursa dependent B cell. The former me­
diates its effect through a series of soluble 
lymphokines while the latter is responsible for 
classical antibody production. The T cell, 
among other things, has a “helper” function 
and cooperates with the B cells in antibody 
production. The immunologically competent 
cell (ICC) occurs in all lymphoid tissues. Any 
portion of the host’s own cell, such as the nu­
cleus that has never before been in contact with 
an ICC, may escape its protected environment 
and be recognized as nonself; an immune reac­
tion may follow, resulting in damage to the 
organ of origin. The whole body is a constant 
state of immunologic surveillance in which 
abnormal cells, mutants and other potentially 
dangerous nonself materials are recognized 
and destroyed on a regular basis by the system. 
Failure of the surveillance mechanism leads to 
the survival and multiplication of abnormal 
cells; some see this as an explanation of the 
pathogenesis of cancer.
Munster has kept repetition in this multi- 
authored book to a minimum, but what re­
mains will be welcomed — especially by those 
who are uninitiated in the field. Each chapter 
begins with an informative summary followed 
by a clear description of the subject matter and 
ends with a list of references and suggestions 
for further reading; each may be read separate­
ly. There is enough detail to please the expert, 
yet a clarity of style that does not put off the 
novice. The book is a sound introduction to a 
rapidly expanding field.
E. M. C ooperman
THE ULTRASTRUCTURE OF COLLAGEN.
Edited by J. J. Longacre. 549 pp. Illust.
Charles C Thomas, Publisher, Springfield,
IL, 1976. $41.50.
This book stems from the proceedings of an 
international symposium on wound healing, 
held in May 1973 at the Research Institute of 
the Children’s Hospital in Cincinnati; the em­
phasis is on the ultrastructure of collagen and 
the surgical management of hypertrophic scar.
There are some 30 chapters in this multi- 
authored book; each topic is presented by a
distinguished international personality. Basic 
concepts are reviewed as are newer concepts 
of pathogenesis and treatment.
Of particular interest are chapters dealing 
with the histologic demonstration of tension 
in collagen, the cytokinetic aspects of wound 
healing, collagen metabolism and degrada­
tion in normal and abnormal tissues, the role 
of oxygen in wound healing, collagen meta­
bolism in keloids, electron microscopic scan­
ning studies of hypertrophic scars and the 
control of mitoses in wound healing.
Clinical papers on the long-term results of 
expansion and meshed skin grafts and the ef­
fects of triamcinolone and vitamin A on 
wound healing in postburn hypertrophic scar­
ring are excellent. Of practical use to the 
plastic surgeon in particular is the report on 
the recent biophysical and biochemical studies 
on scar.
This book will be of special interest to 
plastic surgeons; however, I would recom­
mend it as a reference text for university and 
hospital libraries. Serious students of wound 
healing will find it to be of great value.
P. R. Benoit
Ste. 104,
340 McLeod St.,
Ottawa, Ont.
THE YEAR BOOK OF ORTHOPEDICS 
AND TRAUMATIC SURGERY 1976. 
Edited by Mark B. Coventry. 480 pp. Illust. 
Year Book Medical Publishers, Inc., Chica­
go, 1976. Price not stated.
Texts in the Year Book series have a well- 
earned reputation for accuracy, brevity and 
clarity. The year book on orthopedics and 
traumatic surgery is now under the editorship 
of Mark B. Coventry, who recently retired 
from clinical practice at the Mayo Clinic.
Trends in modern orthopedics may be dis­
covered in the changing organization of the 
table of contents. For example, the word 
rheumatism is deleted, the neck is grouped 
with the spine and pelvis, and the subject of 
peripheral vascular surgery is deleted. The 
new section on anesthesiology in orthopedics 
indicates the importance of the specialty to 
the work of the orthopedic surgeon.
I have been a reader of this volume for 20 
years and especially appreciate the increased 
number of editorial comments from the staff 
of the Mayo Clinic. For example, the editorial 
comments by R. N. Stauffer on the use of 
chymopapain include not only the assessment 
of an abstract on the use of this drug but also
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comment on the current attitudes of the Fed­
eral Drug Administration to the drug.
Abstracts of articles from the European 
literature are particularly noteworthy, since 
they would not otherwise be accessible to the 
practising orthopedic surgeon in North Amer­
ica. A good example is the abstract of an ar­
ticle on surgical repair of the cruciate liga­
ments of the knee, from Toulouse, France. 
In some cases, such as the abstract on patellar 
readjustment in lateralized femoropatellar ar­
throses, the value is lost because of poor trans­
lation.
This book is worthwhile, occasional read­
ing for the orthopedic surgeon. The new edi­
tor is to be congratulated.
J. W. H azlett
122 Sydenham St.,
Kingston, Ont.
CRITIQUE OF ITEM 580
For patients with positive nodes, routine 
postoperative radiation is now much less 
widely practiced than formerly because the 
survival rates are not increased by radia­
tion therapy.
Prophylactic oophorectomy does not alter 
recurrence or survival rates but often brings 
on menopausal problems. Oophorectomy is 
effective in about one third of the cases 
when patients have recurrences and are un­
der 50 years of age.
5-Fluorouracil does not increase survival 
rates when given as an adjuvant to radical 
mastectomy. This drug may produce tem­
porary remissions in patients with proven 
metastases. Thio-tepa produces neither a 
substantial relief of symptoms nor an in­
creased survival time. r n
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